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Although the population is growing enormously in most of the developing countries, infertility 
remains the major problem, affecting about 15% of the couples. Impaired fertility of male 
partner is causative or contributory in approximately 50% of all couples unable to conceive 
spontaneously. During the last couple of decades considerable importance is being given to 
male-factor infertility. Impairment of sperm function may be due to biochemical, 
environmental or genetic reasons or interplay of all these factors.   
The objectives of this study were to determine the difference between semen and spem 
quality of patients underwent IVF/ICSI therapy. Besides, to determin ROS, total antioxidant 
(TAS), of seminal plasma and other sperm characteristic parameters (count, morphology, 
HOS, maturity, strand break, and membrane integrity). Moreover, the relationship between 
smoking and cotinine concentration in seminal plasma on the sperm parameters, in one hand 
and the effect of these investigated parameters on IVF/ICSI in the others.  
In the present study, 94 patients (57 IVF) and (37 ICSI) were included. The semen 
concentration of ROS, TAS, selenium, zink and  sperm parameters like concentration, 
motility, vitality, membrane integrity (HOS-test) morphology, Chromatin condensation 
(Maturity, CMA3, DNA Fragmentation (Tunel-test, DNA denaturation (AO) were investigated 
and there effects on IVF/ICSI outcome were analysed. In addition, the semen parameters 
and cotinine concentrations in seminal plasma of 46 patients were investigated and 
spermatozoa quality and their influrence on IVF/ICSI outcome of heavy smokers (11) and 
non smokers (35) patients who underwent IVF, ICSI therapy were compared and evaluated. 
Semen samples of patients underwent IVF/ICSI therapy was allowed to liquefy and assessed 
according WHO (1999) guidelines except for morphology which was evaluated according to 
strict criteria Krüger et al (1986).   
The seminal plasma on the top of the above layer of the two fraction 45% and 90% of 
PureSperm layer was withdrown after semen and gradient centrifugation and kept frozen at - 
80°C separately in two different tubes until the concentrations of ROS, TAS, cotinine were 
measured.. The pellet which contain morphologically normal spermatozoa was washed 
again, layered with 1 ml culture media and incubated at 37°C. The motile sperm was used for 
injection (ICSI) or insemination of oocytes (IVF).  
Smears were made from each semen sample before (native) and after semen preparation 
(motile sperm in the supernatant) in order to evaluate the morphology, sperm maturity 
(Chromomycin CMA
3
) and DNA stand break (Tunel assay) in addition to the count, motility, 
HOS-Test. Seminal plasma was examined for the concentrations of ROS, TAS and cotinine 
levels which were measured by the conventional colorometric assay using commercially 
available kits. ROS was measured by calorimetric assay for the quantitative determination of 
peroxide (Oxystat, kit Biomedical, Austria) and Semen antioxidant capacity was determined 
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with a photometer method based on the antioxidants inhibition of the absorbance of the 
radical cation 2.2`-azinobis (ABTS
 +)
. Cotinine concentration was measured with Bio Quant 
(Cotinine Direct ELISA) kit. DNA integrity was evaluated by Chromomycine (CMA
3
-test) and 
DNA damage was assessed by Acridine orange staining and terminal deoxynucleotidyl 
transferase (TDT) mediated d UTP nick end labelling (TUNEL-test).   
The sperm parameters and the concentration of ROS, TAS and cotinine in seminal plasma  
and other parameter (sperm concentration, morphology, maturity and Tunel results) was 
correlated with the IVF, ICSI outcome.  
From the women side following date was collected: The age of the women, ovarian 
stimulation protocol, number of retrieved, mature, injected oocytes and the fertilization, 
cleavage and pregnancy rates.   
Statistical analysis demonstrated significantly lower semen quality of ICSI in comparison to 
IVF patients. Significantly lower sperm density, vitality, motility and DNA integrity (CMA3) 
cleavage rate than those patients underwent ICSI therapy. Besides, semen volume, mean 
percentage of morphologically normal spermatozoa, DNA denaturation (AO) stand break and 
DNA fragmentation (TUNEL), ROS, TAS selenium and zinc concentaration in seminal 
plasma and fertilization rate were similar in ICSI patients in comparison to IVF patients.  
Pregnancy rate was higher in patient underwent IVF in comparison to those who underwent 
ICSI therapy (31.5% vs. 29.7%; p=0.392). In IVF patients group 18 (18/ 57) pregnancies was 
achieved. Whereas only (11 women become pregnant (11/37). Only 40 women become 
transfer in IVF and 18 in ICSI groups, the other patients ended up with total fertilization or 
cleavage failure.   
A negative non significant correlations were found between ROS concentration in seminal 
plasma and sperm concentration, motility, morphology, membrane and DNA integrity, DNA 
fragmentation, DNA denaturation, fertilization rate and pregnancy. Whereas, a positive 
correlations have been shown between TAS concentration in seminal plasma and Chromatin 
integrity, DNA denauration, pregnancy and zink, Ferritin, transferrin concentration. By 
comparing the smokers and non smokers, the following results have been shown:   
In the smokers  and non smokers patients groups, the sperm concentration, mean number of 
motil spermatozoa after sperm selection, morphologically normal spermatozoa, mean 
number cleaved and transferred oocytes and pregnancy rate were significantly higher in non-
somoking patients group in comparison to smoking one. The other sperm parameters were 
similar in both groups. However, cotinine concentration was significantly higher in somkers 
than non-smokers. An inverse correlations were found between cotinine concentration and 
ejaculate volume, sperm concentration, motility, vitality, morphology membrane integrity, 
DNA fragmentation (TUNEL) and DNA denaturation, TAS concenrtration and fertilization. 
Whereras, a positive correlation was shown between cotinine and ROS concentration. In the 
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smoker group three patients become pregnant (27.3%) and 11 patients achieved pregnancy 
in the non-smoking group (34%; p=0.001).  
ROS concentration in seminal plasma affect spermatozoa quality and consequently IVF/ICSI 
results. TAS concentration correlate positive with sperm  parameters and IVF/ICSI outcome. 
Besides, cotinine concentration in seminal plasma has an advers effect on seminal plasma 
anti oxidants, sperm parameters and ART outcome and increase the production of ROS in 
seminal plasma.  Therefore, it is recommended to quit smoking in childless patients who 
seeking ART therapy.  
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Trotz des rapiden Bevölkerungswachstums in den Entwicklungsländern bleibt die Infertilität 
für manche Menschen ein Problem, 15% der Bevölkerung sind davon betroffen. Bei Paaren 
mit Kinderwunsch beträgt zur Zeit die männliche Infertilität 50%. In den letzten 20 Jahren 
wurde viel Forschung betrieben um das Problem der männlichen Infertilität zu bewältigen.  
Der Dysfunktion der Spermien liegen folgende Ursachen zu Grunde; genetische Faktoren, 
Umwelteinflüsse, biochemische Stoffwechselreaktionen, es können auch Kombinationen 
dieser drei Faktoren eine Rolle spielen.  
Ziel dieser Arbeit ist es einerseits  die Unterschiede zwischen Samenflüssigkeit, sowie der 
Spermaqualität zwischen IVF-Patienten und ICSI-Patienten zu vergleichen.  Insbesondere im 
Hinblick auf die Samenflüssigkeit sollen die freien Radikalen (ROS), die totalen 
Antioxidanten (TAS), Selen und Zink bestimmt werden. Im Hinblick auf die Spermaqualität 
allerdings sollen die Anzahl der Spermien im Ejakulat, der Reifegrad der Spermien, die 
Membranintegrität (HOS-Test), sowie die DNA-Strangbrüche, Fragmentationen untersucht 
werden.  
In einer Untergruppe (46 Patienten) soll die Cotinine –Konzentration im Seminalplasma 
bestimmt werden. Diese Untergruppe konnte wiederum in 2 Bereiche geteilt werden; 
Raucher (11 Patienten) und Nichtrauchen (35 Patienten).  Insgesamt soll die Auswirkung der 
Parameter  auf die Spermaqualität einerseits, sowie als logische Konsequenz deren 
Auswirkung auf IVF-/ICSI-Patienten untersucht werden. Die Ejakulatproben von 94 Patienten 
(57 IVF und 37 ICSI) wurden nach den Kriterien der WHO (1999) untersucht, mit Ausnahme 
der Morphologie, welche nach den Krüger-Kriterien (1986) evaluiert wurde. Das Ejakulat 
wurde auf den PureSpermgradienten übertragen (45% und 90%).  
Nach der Zentrifugation wurde der Seminalplasmaüberstand abgehoben und bei -80° bis 
zum Zeitpunkt der Untersuchung aufbewahrt. Das Sediment  (Spermatozoen) wurde noch 
einmal gereinigt und für die routinemäßige Insemination, Injektion der Eizelle genutzt.  
Es wurden mehrere Abstrichen von diesen Spermatozoen angefertigt, luftgetrocknet, fixiert 
und zur Beurteilung der Morphologie, der Chromatin-Condensation (Chromomycin CMA3), 
DNA-Denaturierung (Acridine-Orange AO), sowie der DNA-Strangbrüche (Tunel-Test).  
Die Bestimmungen von ROS, TAS, Cotinine wurden mit einem kommerziellen Enzym Immun 
Assay (Alisa) durchgeführt.  
Die Ergebnisse dieser Analyse wurden mit den Ergebnissen der Spermparameter korreliert, 
um den Einfluss dieser Faktoren auf die Spermaqualität festzustellen. Von der Frauenseite 
aus wurden die Stimulationsprotokolle, die gesammelten Eizellen, die Fertilitsationsrate, die 
Teilungsrate, sowie die Schwangerschaftsrate erhoben und evaluiert. Diese Ergebnisse 
wurden wiederum mit dem Ejakulatparameter verglichen.  
Es wurde festgestellt dass die Spermaqualität (Anzahl der Spermien, Vitalität, Motilität, 
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CMA3) von ICSI-Patienten schlechter waren, als die der IVF-Patienten. Jedoch war das 
Spermavolumen, die Morphologie, AO, TUNEL, ROS, TAS, Selen- und Zinkkonzentrationen 
ähnlich, somit bestand kein signifikanter Unterschied.  
Darüberhinaus konnte kein Unterschied zwischen der Fertilisationsrate, der Teilungsrate, 
sowie der Schwangerschaftsrate (31,5% vs. 29,7%, p=0.392) bei IVF- und ICSI-Patienten 
gefunden werden. In der IVF-Patientengruppe wurden 18 Schwangerschaften erzielt (18/57), 
in der ICSI-Patientengruppe wurden 11 (11/37) erreicht. Es ist hierbei zu erwähnen, dass 
nicht bei allen Frauen ein Transfer durchgeführt wurde. Bei dem IVF Programm bekamen 40 
Frauen einen Transfer, bei dem ICSI Programm bekamen 18 Frauen einen Transfer.  
Im weiteren Verlauf konnte eine negative Korrelation festgestellt werden zwischen ROS im 
Seminalplasma, der Spermkonzentration, Mortilität, Morphologie, Membran, DNA-Integrität, 
DNA-Strangbrüche, DNA-Denaturierung, Fertilisationsrate und der Schwangerschaftsrate.  
Jedoch wurde eine positive Korrelation zwischen TAS im Seminalplasma und der 
Chromatinintegrität, der DNA-Denaturierung, der Zink-, Eisen-, Transferrinkonzentration und 
der Schwangerschaftsrate gezeigt.  
Bezüglich der Raucher/ Nichtrauchergruppe war die Zahl der Spermakonzentration, der 
Spermamotilität nach Selektion, die Zahl morphologisch normaler Spermien, die Zahl der 
geteilten Eizellen, die Zahl der Transferierten, sowie die Schwangerschaftsrate bei 
Nichtraucher signifikant höher im Vergleich zur Rauchergruppe. Alle anderen Parameter 
ähnelten sich jedoch. Die Cotininkonzentration war in der Rauchergruppe signifikant höher 
im Vergleich zu der Nichtrauchergruppe.  
Eine negative Korrelation konnte zwischen der Cotininkonzentration und dem 
Ejakulatvolumen, der Spermakonzentration, der Vitalität, der Morphologie, der Membran und 
DNA-Integrität, der DNA-Denaturierung und DNA-Strangbrüchen (TUNEL) festgestellt 
werden. Dennoch bestand eine positive Korrelation zwischen der Cotininkonzentraion und 
ROS im Seminalplasma. In der Rauchergruppe wurden 3 Schwangerschaften erzielt (27,3% 
Schwangerschaftsrate). In der Nichtrauchergruppe wurden 11 Schwangerschaften (34% 
Schwangerschaftsrate, p= 0.001) erzielt.   
Die Konzentrationen von ROS und Cotinin im Seminalplasma haben einen negativen 
Einfluss auf die Spermaqualität und somit auch auf den Erfolg von IVF und ICSI. Im 
Gegensatz dazu konnte gezeigt werden dass TAS einen positiven Einfluss auf die 
Spermaqualität und somit auch auf den Erfolg von IVF und ICSI hat. Es ist daher zu 
empfehlen auf Nikotin zu verzichten, insbesondere bei kinderlosen Ehepaaren mit 
Kinderwunsch, welche im Verlauf sich einer Therapie mit IVF- und ICSI unterziehen.  
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Infinity of infertility  
  
Since the first appearance of humans on earth, infertility has been one of the most 
controversial medical and social issues. Some civilizations considered it to be a punishment, 
while others thought of it as an illness. Some blamed it on the woman; others could not 
explain it. This charge infertility has on the woman, had serious consequences on her social 
image and her psychological state (Morice et al., 1995). Additionally, physicians lack of 
knowledge of gonadal and sperm function, lead to mostly the female being considered to be 
the one responsible for infertility. It was not until the last decade that our knowledge of the 
human reproductive system has allowed us to determine that a very important parameter of a 
couples infertility is male infertility and more specifically, sperm malfunction (Hull et al., 
1985). According to the report by WHO, 1975, infertility is a worldwide problem, affecting up 
to 10% of all couples and in some countries up to 30% (WHO Scientific group, 1975). It 
results from female disorders in about 30%, a male disorders in 30% and disorders in both 
30%. No abnormalities are found in about 10% (Comhaire et al., 1987; Forti and Krausz , 
1998).   
Decreases in sperm concentrations, motility as well as morphological alterations are frequent 
findings in the semen analyses of these patients (Sigman et al., 1992). Many of these 
alterations have recently been linked to high levels of Reactive oxygen species (ROS) 
(Aitken , 1994, de Lamirande and Gagnon, 1994, Sharma  and Agarwal, (1996) and 
decrease in total antioxidant capacity (TAC) of seminal plasma (Ochsendorf  and Fuchs, 
1993).  
  
1-Reactive oxygen species an (ROS) and total antioxidants 
(TAS) effect on male infertility  
  
1-1. Normal and impaired sperm function  
Normal spermatozoa are those that successfully undergo a number of steps necessary for 
fertilization of the oocyte. The first step is the maturation of the spermatozoa, which is 
initiated in the male genital tract and is concluded with capacitation, the final step of 
maturation, occurring in the female genital tract. Fully mature spermatozoa must swim in the 
female reproductive system, reach the oocyte, undergo acrosome reaction (AR), penetrate 
the zona pellucidae and fuse with the oocyte pronucleus to form the zygote (Larson et al., 
2000a ; b).  
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Failed attempts to conceive, after a period of two years, define infertility and the couple has 
to visit an expert to seek diagnosis and possible treatment (Hull et al., 1985). The male 
partner undergoes semen analysis and is evaluated according to the World Health 
Organization reference values. However, there are cases where the semen analysis 
indicates normal sperm, but the male is still infertile (WHO, 1999). This proves that there are 
parameters affecting sperm function that cannot be determined by routine semen analysis. 
Semen analysis includes assessment of seminal volume, spermatozoal motility, density, 
viability and morphology. Oxidative damage to spermatozoa, induced by excessive 
production of free radicals or impairment of the natural antioxidant mechanisms, has been 
identified as such a parameter (Sikka et al., 1995).   
1.2. Free radicals origin   
By definition, a free radical is any chemical compound with one or more unpaired electrons. 
The free radicals that have been associated with infertility are oxygen and oxygen-derived 
oxidants, namely, the superoxide anion (O
2
-
), hydrogen peroxide (H
2
O
2
), peroxyl radicals 
(ROO
-
) and hydroxyl radicals (OH
-
) (Agarwal et al., 2005a; Bagchi and Puri, 1998). These 
oxidants are widely known as reactive oxygen species (ROS) and, due to the unpaired 
electron(s) tend to strongly react with other chemical compounds (Bagchi and Puri, 1998). 
More specifically, they seek stability by “stealing” electrons from nucleic acids, lipids and 
proteins, leading to the damage of cells and disease phenomena (Attaran et al., 2000; Pierce 
et al., 2004).  
Reactive oxygen species are produced in the body by mitochondria, phagocytes, 
arachidonate pathways and other physiological processes, in which they act as vital 
signalling molecules. They are products of natural oxygen metabolism and represent 
approximately 1 to 2% of metabolized oxygen (Fulbert and Cals 1992). The balance between 
production and disposal of oxidant molecules is essential for tissue homeostasis. Increased 
rate of free radical production or decreased rate of removal leads to free radical 
accumulation and cellular damage (Berry and Kohn 1999). Additionally, their production is 
induced by external factors, such as cigarette smoke, radiation ultraviolet light and others 
(Bagchi and Puri, 1998). Reactive oxygen species have been associated with the pathology 
of numerous diseases, such as neurodegenerative diseases (Gibson and Huang, 2004), 
vascular disease (Madamanch et al., 2005; Halliwell., 1996), cancer, diabetes, periodontal 
diseases (Halliwell., 1996; Lantos et al., 1997; Moore et al., 1994; Pinzani et al., 1998) and of 
course, human infertility (Agarwal and Allamaneni., 2004; Agarwal et al., 2005b; Agarwal et 
al., 2003; Aitken and Baker., 2004; Baker and Aitken 2005; de Lammirande et al., 1997; 
Henkel., 2005; Kim and Parthasarathy., 1998; Sanocka and Kurpisz., 2004).  
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1.3. ROS and oxidative stress (OS)  
The free radicals are a part of an organism’s chemical reactions, they are necessary 
signaling molecules, as well as being vital for the maturation processes of several structures. 
Most free radicals in biology fit within the broader category of reactive oxygen species 
(ROS), which include not only oxygen–centred radicals such as superoxide anion radical (O
2
-
), hydroxyl radical (OH
.
) or nitric oxide (NO
.
), but also some potentially dangerous non-radical 
derivatives of oxygen, such as H
2
O
2
 peroxynitrite anion (ONOO
-
), and hypochlorous acid 
(HOCL) (Halliwell., 1993). The most common ROS that have potential implication in 
reproductive biology include superoxide (O-
2
), anion, hydrogen peroxide (H
2
O
2
) peroxyl 
(ROO
-
) and hydroxyl (OH-) radicals.   
The free radical nitric oxide and (NO-) and peroxynitrite anion (ONOO-) also appear to play a 
significant role in reproduction and fertility. Oezezcan et al (1999) indicate that ONOO
-
might 
cause sperm dysfunction through an increase in lipid peroxidation, and total sulphydryl group 
depletion. The assumption that free radicals can influence male fertility has received 
substantial scientific support (Gagnon et al., 1991). Many reports have indicated that high 
levels of ROS are detected in semen samples of 25% to 40% of infertile men (Padron et al., 
1997) however small controlled amounts of ROS are vital for spermatozoa to develop 
normally, and be capable of fertilization structures (Gagnon et al., 1991; Aitken; 1999; Aitken 
et al., 1997).   
In addition, de Lamirande et al. and Zini et al. reported that H
2
O
2
 and O
2
- promote sperm 
capacitation and acrosome reaction, and that H2O2 promotes hyperactivation and oocytes 
fusion (de Laminarde and Gagnon., 1993a; Zini et al., 1996). Hydrogen peroxide and 
superoxide anion are of great importance to spermatozoa. They are necessary for controlling 
the tyrosine phosphorylation events associated with sperm capacitation (Aitken., 1999; 
Aitken et al., 1998a).   
1.4. ROS production by spermatozoa  
ROS are also undoubtedly produced by spermatozoa (Aitken et al., 1992; Gavella and 
Lipovac., 1992; Gil-Guzman et al., 2001; Hendin et al., 1999), mainly through their 
mitochondrial system (Plante et al., 1994), as well as round cells during the spermatogenesis 
process and epithelial cells. In the human ejaculate ROS are mainly produced by leucocytes 
and marginal amounts by spermatozoa (Aitken and Baker 2002). The production of ROS in 
ejaculated spermatozoa is initiated in immature germ cells (Gil-Guzman et al., 2001) and 
continues in the epididymis when the surface of the spermatozoa is remodelled. When the 
mitochondrial capsule is assembled, chromatin undergoes condensation and motility is 
acquired for the capacitation of spermatozoa (Agnihorti et al., 1999; Fisher and Aitken., 
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1997). However, superoxide (O
2
-
) production by spermatozoa has been questioned (Richer 
and Ford. 2001) on the basis that no free radical signal can be detected by EPR 
spectroscopy. Electron leakage from complexes I and II of the mitochondrial transport chain 
has been proposed as a source of superoxide in male gametes (Vernet et al., 2001). 
Numerous studies have shown that human sperm exhibit the capacity to generate reactive 
oxygen species (ROS) such as superoxide anion, hydrogen peroxide, and hydroxyl radicals 
(Aitken and Clarkson., 1987, Aitken et al., 1994). The production of ROS by human sperm is 
due to a membrane–bound NADH oxidase system (Aitken et al., 1989)  
  
1.5. Spontaneous generation under aerobic conditions  
  
Spermatozoa generate small amount of O
2
- 
and NO
. 
which are both tightly related to the 
cAMP pathway in the control of human sperm capacitation and protein tyrosine 
phosphorylation (Aitken et al., 1995; Belen-Herrero et al., 2000). Beckman et al., suggested 
that these two radicals could combine to form peroxy nitrite (ONOO
-
) (Beckman et al., 1990). 
Peroxy nitrite is not a free radical because the unpaired electrons of NO and O
2
-
 have 
combined to form a new N-O bond in peroxy nitrite, but it is a strong one or two electron 
oxidant and nitrating agent (Herrero et al., 2001). Nevertheless, generating controlled low 
amounts of endogenous ROS by spermatozoa play a significant role in inducing sperm 
capacitation acrosome reaction and acquisition of sperm-fertilizing ability (Gagnon et al., 
1991; de Laminarde and Gagnon., 1995).   
  
1.6. Retained cytoplasm (RC)  
  
The production of ROS is higher in spermatozoa that are either damaged or retain abnormal 
cytoplasmic inclusions (Gil-Guzman et al., 2001).   
Radical production has also been detected in immature germ cells (Fisher and Aitken ., 
1997). According to Iwasaki and Gagnon et al (1992), the capacity for ROS production is 
significantly enhanced in abnormal spermatozoa, and those sperm cells with retention of 
residual cytoplasm. Huszar and Vigue (1993) have found that morphological irregularities of 
sperm are significantly correlated with high CK activity. ROS production by spermatozoa has 
been associated with midpiece abnormalities, retained cytoplasm, cytoplasmic droplets and 
spermatozoa immaturity (Aitken et al., 1989; Gomez et al., 1996; Huszar and Vigue 1994).   
The primary product of the immature spermatozoa system generating free radicals appears 
to be the superoxide anion (O
2
.-
), which secondarily dismutates to H
2
O
2
 through the catalytic 
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action of superoxide dismutase (SOD) (Aitken and Krausz., 2001; Alvarez et al., 1987). 
Moreover, the most prevalent ROS, hydrogen peroxide (H
2
O
2
) is synthesized from O
2
 by 
mammalian spermatozoa (Tosic and Walton., 1946) by a two–stage reduction of superoxide 
(O
2
-)
 by H
+ 
as the intermediate product (Holland et al., 1982). The retention of residual 
cytoplasm in the sperm midpiece after spermination has been associated with excessive 
production of ROS by spermatozoa (Gomez et al., 1996). The ROS levels are expected to 
rise at a faster pace and in greater intensity in sperm samples in the presence of cytoplasm 
residues. Morphometric analysis of the amount of residual cytoplasm present in the sperm 
midpiece has revealed significant correlations with the production of ROS (Gomez et al., 
1996).  
The enzyme gloucose-6-phosphat dehydrogenase (G6PD), which is over expressed in 
sperm residual cytoplasm, generates NADH, which in turn stimulates ROS formation (Aitken 
et al., 1997; Aitken et al., 1994; Gomez et al., 1996; Huszar and Vigue., 1994).   
Sperm with cytoplasmic droplets show a higher cellular content of cytoplasm enzymes, 
including G6PD. This enzyme is responsible for the flux of glucose through the hexose 
monophosphate shunt and the associated generation of NADPH. It is theorized that the 
NADPH generated via this system serves as the major source of electrons responsible for 
the production of O
2
-
 by human spermatozoa. Therefore, the retention of residual cytoplasm 
creates a situation in which sufficient substrate would be available to support excessive 
NADPH–dependent ROS generation (Aitken et al., 1997; Baumber et al., 2000) 
Spermatozoa may generate ROS in two ways:   
 1- NADH-oxidase system at the level of sperm membrane level (Aitken et al., 1992) 
and   
 2- 2NADH-dependent oxido-reductase (diphorase) at the level of the mitochondria 
(Gavella and Lipovac., 1992). Besides, the biochemical markers of cytoplasm space, 
such as creatine kinase, are positively correlated with the induction of peroxidative 
damage (Huszar and Vigue., 1994; Gomez et al., 1996). Huszar and Vigue., (1994) 
have found a positive relationship between CK activity and the rate of lipid 
peroxidation, as measured by malondialdehyde (MDA) formation in sperm fractions. 
Hallak et al  have found an inverse relationship between creatine kinase (CK) levels 
and sperm morphological forms and suggested that CK levels can be used as a 
reliable marker for sperm quality and fertilizing potential in subfertile men (Hallak et 
al., 2001).   
 
Excessive ROS production by immature, morphologically abnormal spermatozoa with 
cytoplasmic residues such as those confronted in teratozoospermic semen specimens may 
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induce oxidative damage of mature spermatozoa during sperm migration from the 
seminiferous tubules to the epididymis and may be an important cause of male infertility 
(Sikka ., 2004). Immature spermatozoa are well-characterized source of ROS and a negative 
correlation between ROS production and semen quality has been documented (Gil-Guzman 
et al., 2001). The excessive generation of reactive oxygen species (ROS) by abnormal 
spermatozoa and by contaminating leukocytes (leukospermia) has been identified as one of 
the few defined aetiologies for male infertility.   
Many reports pointed out that biochemical marker of the cytoplasmic space, such as creatin 
kinase, are positively correlated with the induction of peroxidative damage (Gomez et al., 
1996; Huszar and Vigue., 1994). Only one third of ROS produced by spermatozoa is 
released extracellulary (Plante et al., 1994). In the case of oligozoospermic males whose 
spermatozoa generate particularly high levels of ROS, the source of cytotoxic oxygen 
radicals is frequently intracellular (Gomez et al., 1996). However, the main ROS-producing 
sources are immature spermatozoa, especially those with cytoplasmic droplets at the 
midpiece and leucocytes (Garrido et al., 2004).  
1.7. ROS production by leukocytes  
ROS are produced by leukocytes, which are present in the male reproductive system and in 
the ejaculate, as a result of their role in immunological defense against pathogenic germs 
(Tomlinson et al., 1992; Henkel 2005) Hence, their increased number in semen of men with 
conditions like spinal cord injuries is thought to be due to local immunological response.  
Leukocytes are present throughout the male reproductive tract and are found in almost every 
human ejaculate (El-Demiry et al., 1987) The majority of leukocytes in semen are 
granulocytes (50-60%), followed by macrophages (20% to 30%) and T lymphocytes (2% to 
5%) (WHO, 1999).  Leukocytes play an important role in immune surveillance (Pudney and 
Anderson, 1993; Kiessling et al, 1995) and phagocyte clearance of abnormal sperm 
(Tomlison et al., 1992). However, WBCs in human semen are also capable of ROS 
generation (Aitken and West, 1990; Kessopoulou et al., 1992). Genital tract inflammation and 
an increased number of leukocytes in the ejaculate have been repeatedly associated with 
male subfertility and infertility (Plante et al., 1994; Wolff., 1995; Ochsendorf, 1999; Sharma et 
al., 2001). Leukocytes are a particularly important source of oxidative stress in the ejaculates 
of patients exhibiting leukocytospermia secondary to infection or as consequence of 
paraplegia (Sharma and Agarwal, 1996). Activated leukocytes can produce 100-fold higher 
amount of ROS than nonactivated leukocytes (Plante et al., 1994). Leukocytes may be 
activated in response to a variety of stimuli including inflammation and infection (Pasqualotto 
et al., 2000). Whittington and Ford (1999) demonstrated that infiltrating leukocytes are the 
predominant source of ROS production in unspecified sperm preparations. Sperm damage 
from ROS that is produced by leukocytes occurs if seminal leukocytes concentrations are 
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abnormally high like in leukocytospermia (Shekarriz et al., 1995), or by removing seminal 
plasma during sperm preparation for assisted reproduction (Ochsendorf ., 1999).  
Leukocytospermia may induce alteration in sperm structure by means of excessive ROS 
production by activated granulocytes. It has been shown that leukocytospermia and 
excessive ROS levels are associated with an increase in chromatin alterations and DNA 
damage in sperm, as defined by the sperm chromatin structure assay (Alvarez et al., 2002) 
In patient samples that generated detectable ROS, the ability of the spermatozoa to retain 
motility for 24h after preparation on a 40/80% Percoll gradient was negatively correlated (r=-
0.310, p<0.05) with basal ROS production (Whittington, et al., 1999).. Besides, ROS 
production was also related to the outcome of in vitro sperm mucus penetration tests. Wang 
et al. (2003) demonstrated that mitochondrial function is inhibited in spermatozoa of infertile 
men and is significantly correlated with the sperm concentration and the level of ROS 
production.   
  
1.8. ROS and Male fertility: Physiological Association of ROS  
1.8.1. Association with subfertility  
Only in the case of excessive production of ROS or malfunction of the native antioxidant-
production mechanisms, do the free oxidants cause problems, by putting the several tissues 
under oxidative stress (OS) (Agarwal and Said., 2003; Aitken.,  2005; Aitken and Clarkson., 
1987; Balercia et al., 2003). ROS have been widely associated with both the 
etiopathogenesis in female infertility (Agarwal et al., 2005a, b, c), as well as with male 
subfertility and impaired sperm function, but their exact role is still not clear.  
It has been more than a decade that the possibility of ROS negatively affecting male 
infertility has been examined by scientists (Aitken and Clarkson., 1987; Gagnon et al., 1991) 
and there has been an increasing generation of scientific data supporting that view (Sharma 
et al., 1999). More than 60 years ago MacLeod and Ross et al., (1943) described the loss of 
sperm motility, when the latter is exposed to oxygen at 38
o
C and 36 years later the first 
association of oxidative stress (OS) and impaired sperm function came from the University of 
Cambridge (Jones et al., 1979). Since then, numerous scientific publications with very 
interesting data have come to light, presenting the role of ROS in sperm physiology and 
morphology (Gomez et al 1996; Aziz et al., 2004), and subsequently, the reproductive 
outcome.  
The plasma membrane of spermatozoa contains high amounts of polyunsaturated fatty acids 
(PUFA), making them highly susceptible to damage by OS (Alvarez and Storey., 1995; Lewis 
et al., 1995; Zalata et al., 2004). Furthermore, the concentration of scavenging enzymes, like 
superoxide dismutase (SOD) or glutathione peroxidase (Guerin et al., 2001), in spermatozoa 
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cytoplasm is very low, making the effect of OS more severe (de Laminarde and 
Gagnon1995; Lewis et al., 1995; Saleh and Agarwal. 2002; Saleh et al., 2002). Scientific 
data has been presented to support that ROS negatively affect sperm function by 
contributing to the occurrence of lipid peroxidation (Aitken et al 1989; Zalata et al., 2004; 
Griveau et al., 1995).  
Increased production of ROS or impaired action of antioxidant mechanisms can lead to 
surplus of ROS and hence, OS. However, semen analysis of infertile men showed that 
increased levels of ROS are a result of over-production of ROS, rather than decreased 
enrichment of the seminal plasma with antioxidants (Zini et al., 1993). It is important to note 
that due to the existence of leukocytes in the semen, the ability of spermatozoa themselves 
to produce ROS, as well as other sources capable of producing ROS in semen, the effect of 
ROS on male fertility is more of a quantitative matter, irrespective of pathological or non-
pathological conditions.   
The increased production of ROS from immature spermatozoa has been demonstrated in 
recent studies, indicating a negative correlation between the percentage of normal 
spermatozoa and levels of ROS production in semen. These results were obtained after 
calculating ROS production in a ejaculated sperm gradient of immature and mature 
spermatozoa (based on WHO parameters (WHO., 1999), presenting high and low ROS 
production respectively, and immature germ cells, which also presented low production of 
reactive oxygen species (Ollero et al., 2001; Gil-Guzman et al., 2001). This excessive 
production of ROS from immature sperm could cause DNA damage in mature sperm within 
the male reproductive tract and, hence, account partly for male infertility.  
The applied assisted reproduction techniques (ART), as their title indicates, aim at achieving 
fertilization that is not able to occur naturally. However, research studies have shown that 
repeated cycles of centrifugation in the process of sperm preparation can induce the 
production of reactive oxygen species by spermatozoa. This means that improving the 
motility of sperm through the routine preparation does not necessary mean that occasional 
DNA damage does not occur at the same time, endangering the outcome of fertilization 
(Agarwal et al., 1994; Lopes et al., 1998a).   
  
1.8.2. Sperm motility and hyperactivation  
ROS hydrogen peroxide in particular, plays a positive physiological role in sperm 
hyperactivation and capacitation. Low concentration of a NO–releasing compound, has been 
shown to be beneficial to the maintenance of post thaw human sperm motility and viability 
(Hellstrom et al., 1992).   
Besides, ROS production was also related to the outcome of in vitro sperm mucus 
penetration tests. Unstimulated levels of ROS production showed a significant (p<0.05), 
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negative correlation with the number of progressively motile spermatozoa present in the 
mucus after 15 minutes (r=-0.379) and 60 (r=-0.362) min. (Whittington et al., 1999).  
1.8.3. Sperm capacitation  
The molecular basis of sperm capacitation is still unclear. The calcium uptake, an increase in 
cAMP concentration, a rise in intracellular pH, an efflux of cholesterol from the sperm plasma 
membrane (Yanagimachi, 1994; Visconti et al., 1998) and tyrosine phosphorylation of 
specific protein have been shown to occur during this process (Aitken et al., 1995; Leclerc et 
al., 1996). Capacitation of spermatozoa may thus occur by different ROS, but it takes place 
specifically by H
2
O
2
 following an increase in cAMP, the activation of protein kinase A, and 
downstream tyrosine kinase activation (Aitken et al., 1998b). It has also been demonstrated 
by many authors (Griveau et al., 1994; de Lamirande and Gagnon, 1995; Herrero et al., 
1999) that reactive oxygen species (ROS), such as superoxide anion (O
2
.-
) hydrogen 
peroxidase (H
2
O
2
) and nitric oxide (NO
.
) can induce sperm capacitation in vitro. Production of 
nitric oxide (NO
.
) by spermatozoa has also been reported (Herrero and Gagnon, 2001) and 
may serve as an additional oxidant source. NO has also been suggested to be involved in 
the capacitation of spermatozoa but only in the presence of H
2
O
2
 (Zini et al., 1996).   
1.8.4. Acrosome reaction  
Reactive oxygen species other than H
2
O
2
, such as nitric oxide and superoxide anion (O2-) , 
have been shown to promote sperm capacitation and acrosome reaction (Griveau et al., 
1995;  Zini et al., 1996). Stimulation of endogenous NADPH-dependent ROS generation in 
human sperm appears to regulate acrosome reaction via tyrosine phosphorylation (Leclerc et 
al., 1997).  
  
1.8.5. Sperm-egg binding  
Aitken et al. (1989) demonstrated that low level of ROS enhance the ability of human 
spermatozoa to bind zona pellucida, an effect that was reversed by the addition of vitamin E.  
Treatment of human spermatozoa with low concentration of NO- releasing compounds like 
sodium nitroprosside (SNP; 10
-7
 -10
-8
 M) in the capacitating medium increased the number of 
spermatozoa bound to the hemizona (Sengoku et al., 1998).   
 
1.8.6. Sperm egg fusion   
The production of low concentrations of hydrogen peroxidase (H
2
O
2
 and O
2
-
) by spermatozoa 
may have a functional role in the signalling events controlling capacitation and sperm-
oocytes fusion (de Lamirande and Gagnon, 1993 a, b; Aitken et al., 1995, 1998).   
However, poor sperm–oocytes fusion and in vitro fertilization experiments (Aitken et al., 
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1994; 1995) and in standard IVF (de Geyter et al., 1992; Krausz et al., 1994; Sukcharon et 
al., 1995; 1996) are related to high ROS production.   
Aitken and West., (1990) suggests that high failure rate of sperm-oocyte fusion bioassay can 
be related to increased generation of lipoperoxidase. In a subset of infertile patients sperm 
were refractory to the second messenger signal generated by calcium ionophore, 
excessively generated ROS and exhibited a high failure rate in sperm-oocytes fusion 
bioassays (Aitken and West., 1990).   
  
1.8.7. ROS level and fertilization.  
The redox status of human spermatozoa is likely to affect phosphorylation and adenosine 
triphosphate (ATP) generation with a profound influence on its fertilizing potential. However, 
one of the main features of sperm that might profoundly affect fertilization and subsequent 
development is chromatin structure (Sakkas et al., 1998). ROS generation during oxidative 
stress associated with the appearance of damage to the DNA especially in infertile patients, 
leading to high incidence of DNA strand breaks (Evenson et al., 2002; Agarwal and Said, 
2003). High levels of seminal ROS also impaired the sperm fertilizing capacity by DNA 
damage and apoptosis (Agrawal and Saleh., 2002; Agrawal and Said.,2003). Under normal 
circumstances, spermatozoa with damaged DNA would not participate in the fertilization 
process because of collateral peroxidative damage to the sperm plasma membrane 
(Kodama et al., 1996).   
 
1.8. 8. ROS level and cleavage (embryos) quality  
The production of ROS may also be involved in bovine embryo development (Blondin et al., 
1997). Zorn et al. (2003) found that high seminal plasma ROS levels are associated with 
impaired sperm fertilizing ability and lower pregnancy rates after IVF. In ICSI, a negative 
association of ROS with embryo development to the blastocyst stage has been observed.  
  
1.8. 9. ROS level and pregnancy  
After IVF, fertilization and pregnancy rates were negatively associated with ROS level. In 
ICSI, a negative association of ROS with embryo development to the blastocyst stage has 
been observed, and significant fewer ICSI derived embryos reached the morula-blastocyst 
stage on day 4 (Zorn et al., 2003).  
1.9. ROS and Sperm DNA Damage: Pathology of ROS  
Several studies have supported that oxidative stress caused by ROS production induces 
damage of the sperm DNA, even though sperm DNA appears to be more resistant than other 
types of cells, e.g. somatic cells (McKelvey-Martin et al., 1997) Specifically, sperm DNA is 
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protected by its advanced packaging on one hand (Fuentes-Mascorro et al., 2000) and the 
antioxidants of seminal plasma on the other (Twigg et al., 1998a; b). OS-induced DNA 
fragmentation, which is widely observed in spermatozoa of infertile men (Kodama et al., 
1997; Sun et al., 1997), may not directly affect the fertilizing ability of spermatozoa, but it 
directly affects their contribution to normal embryonic development (Lewis and Aitken., 2005) 
and the mutational load of the embryo (Aitken ., 1999) (see figure 2). Evidence also supports 
that OS causes significant damage not only to the nuclear, but also to the mitochondrial DNA 
of human spermatozoa (Sawyer et al., 2003).  
 
 
 
 
 
Figure 1. Schematic representation of the possible relationship between OS in the 
male germ line and abnormalities in the development of the embryo and the health and 
wellbeing of the offspring (Aitken and Baker., 2006).  
 
Along their way from the testis to the oocyte, spermatozoa encounter many factors and 
conditions that can target their DNA and potentially damage it. Defective packaging of 
chromatin in the nucleus, apoptosis and ROS are the causes that attract the most scientific 
interest (Sakkas et al., 1999; Shen and Ong., 2000). Sperm DNA damage may also account 
for the loss of the ability to conceive naturally (Evenson et al., 1999; Spano et al., 2000) and 
for a number of cases of unexplained pregnancy loss (Carrell et al., 2003). As far as ARTs 
are concerned, their association with DNA damage has been widely discussed and 
examined in a variety of studies, and extensively reviewed by Agarwal and Allamaneni 
(Agarwal and Allamanani ., 2004).   
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1.9.1. Oxidative stress induced Apoptosis  
The programmed death of eukaryotic cells, which occurs without inducing an inflammatory 
response, is called apoptosis (Majai et al., 2006). Apoptosis during spermatogenesis has 
been assessed, discussed and supported in several studies (Hikim et al., 1998; Kierzenbaum 
, 2001) and has been associated with male infertility (Hikim et al., 1998; Jurisicova et al., 
1999). However, research on apoptosis in ejaculated spermatozoa seems to still be in its 
developing stages, with only a few studies discussing it ( Sun et al., 1997; Gorczyca et al., 
1993; Irvine et al., 2000), the latest primary article being that of Wang et al. (Wang et al., 
2003). More specifically, the latter group reported positive correlation between the presence 
of apoptotic markers, due to OS-induced apoptosis, and spermatozoa DNA damage. OS-
induced apoptosis in ejaculated spermatozoa has also been reviewed recently by Agarwal 
and Said (Agarwal and Said., 2005).  
 
 
 
1.9.2. Role of NADPH and NADPH oxidase activity  
Reactive oxygen species are the intermediate steps of oxygen reduction, namely, O
2
-, H
2
O
2
 
and OH are the products of reduction by one, two or three electrons respectively. Also, HO
2
, 
the acid of superoxide anion, is another free radical with major contribution in the destructive 
lipid peroxidation process occurring in spermatozoa (Alvarez and storey., 1992). Exogenous 
molecules, like aromatic derivatives and iron complexes, with low molecular weight, can 
activate molecular oxygen, by catalyzing the electron transfer to it. They can also do that by 
activating the β-nicotinamide adenine dinucleotide phosphate (NADPH) oxidase, which 
theoretically exists in human spermatozoa and is believed to transfer electrons from NADPH 
to ground state oxygen, leading to the formation of the superoxide anion radical. The latter is 
then dismutated to hydrogen peroxide (H
2
O
2
), which is controlled by the antioxidant 
glutathione peroxidase. In case the function of the antioxidant is impaired for any reason, the 
spermatozoa experience hyperoxidation (oxidative stress status) (see figure 3) (Baker and 
Aitken ., 2005). Several other studies have supported the presence of NADPH oxidase-like 
activity, at the sperm plasma membrane, in human spermatozoa and the role of NADPH in 
O
2
- 
production and the subsequent consequences of the induced OS on the spermatozoa 
(Aitken et al., 1997; Fisher and Aitken ., 1997; Vernet et al., 2001; Lewis and Aitken 2005; 
Twigg et al., 1998a). The second ROS-generating system that has been proposed is a sperm 
diaphorase system, located in the middle piece and integrated into the mitochondrial 
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respiratory system of the spermatozoa (Aitken et al., 1997).  
  
 
Figure 2. Schematic representation of NAD(P)H oxidase activity. This enzymes transfers 
electrons from NAD(P)H to ground state oxygen to create the superoxide anion radical. The 
latter then dismutates to hydrogen peroxide under the influence of superoxide dismutase. The 
hydrogen peroxide is predominantly scavenged by glutathione peroxidase, since human 
spermatozoa possess little catalase activity. Once this peroxidase activity is overwhelmed, a 
state of oxidative stress may be induced that disrupts the fertilizing capacity of the 
spermatozoa and the integrity of their DNA. Baker and Aitken Reproductive Biology and 
Endocrinology 2005 3:67 :10.1186/1477-7827-3-67  
1.9.3. Leukocytospermia and male infertility  
Apart from their role as members of the immune-defensive mechanism, leukocytes are also 
vital for the clearance of defective sperm via phagocytosis (Tomlinson et al., 1992). 
Leukocytospermia is a condition which, according to WHO guidelines (1999), is determined 
by the existence of a concentration greater than 1 x 10
6
 /ml of peroxidase-positive leukocytes 
in semen and it is encountered in an average of 15% of infertile men (Sharma et al., 2001; 
Alvarez et al., 2002; Agarwal and said., 2003). Nevertheless, whether or not it is a 
pathological condition, leading to abnormal morphology and impaired sperm function is 
controversial among scientists.   
Specifically, there are studies that found negative and other studies that found positive 
correlation of poor sperm quality/function, with increased white blood cell (WBC) 
concentration (leukocytospermia) (Wolff., 1995). More specifically, Curi et al. concluded that 
there is no positive correlation between leukocytospermia and impaired sperm motility 
asthenozoospermia (WHO., 1999). In another individual study, Tomlinson et al. could not find 
any association of leukocyte concentration neither with impaired sperm quality, nor with 
conception rates (Tomlinson et al., 1993). Also, no correlation was found between leukocyte 
counts, sperm density and motility, sperm antibodies and growth of micro-organisms, by(El-
Demiry et al., 1987; Jeulin et al., 1989).  
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On the other hand, Yanushpolsky et al. (1996) presented a positive association of increased 
seminal granulocyte concentrations with abnormal semen parameters of statistical and 
clinical significance. In addition, Arata de Bellabarba et al. showed that increased WBC are a 
usual phenomenon in semen of infertile men and are associated with semen of poor quality 
parameters (Arata et al., 2000). Moreover, Lemkecher et al. supported the positive 
correlation, but also associated leukocytospermia with increased DNA fragmentation 
(Lemkecher et al., 2005). Aitken et al. also presented positive correlation between 
leukocytospermia and impaired sperm function, when leukocytes were introduced into the 
sperm mixture after preparation. The same correlation, when assessed during in vitro 
fertilization (IVF), was found to be negative (Aitken et al., 1994). In contrast, Vicino et al. 
showed that increases leukocyte concentration in semen can affect the results of both IVF 
and ICSI procedures (Vicino et al., 1999).  
Apart from sperm quality, the effect of leukocytospermia on sperm morphology is also a 
highly controversial issue between researchers. Hence similarly, several studies have 
presented positive correlation between increased leukocyte concentration in semen and 
abnormal sperm morphology. Specifically, Berger et al. showed positive correlation between 
morphologically normal sperm and sperm penetration ability, in contrast to morphologically 
abnormal sperm due to increased leukocyte concentration (Berger et al., 1982). Eggert-
Kruse et al. presented positive correlation between high rates of leukocytes of the round cells 
with increased morphological abnormality (Eggert-Kruse et al., 1992) and Yanushpolsky et 
al.( 1996) presented statistically significant differences in sperm morphology and leukocyte 
concentration of double threshold according to the WHO criteria (Yanushpolsky et al. (1996). 
Moreover, Thomas et al. and Menkveld and Kruger presented positive correlation between 
WBCs in general and polymorphonuclear granulocytes (PMN) respectively, with 
morphological defects (Menkveld  and Kruger., 1998; Thomas et al., 1997). Finally, two years 
ago, a primary article by Aziz et al. presented a highly significant negative correlation 
between leukocytospermia and impaired sperm structural integrity (Aziz et al., 2004).  
On the contrary, two more studies presented a statistically insignificant association between 
increased concentrations of leukocytes and morphologically abnormal sperm (Fedder et al ., 
1993; Van der Ven., 1987). To enhance the controversy concerning the role of leukocytes in 
abnormal sperm morphology, Kiessling et al. and Tomlinson et al. presented a positive 
correlation between increased leukocyte numbers and morphologically normal sperm, due to 
leukocytes’ physiological function of abnormal-sperm phagocytosis (Tomlinson et al., 1992; 
Kiessling et al., 1995).  
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2-Antioxidants and male infertility  
Types, role and origin  
ROS are necessary for physiological functioning of spermatozoa, but they need to be 
controlled and their concentration maintained at a level that is not deleterious to the cells. 
This function is carried out by antioxidants (Young et al., 2001) (see Diagram 1), present in 
the seminal plasma (Henkel., 2005; Alvarez and Storey et al., 1983; Sies ., 1993; Sikka ., 
1996; Zini et al., 2001a). The most common antioxidants, that protect spermatozoa from 
excess concentrations of ROS and OS-induced damage and altogether represent the total 
antioxidant capacity (TAC) of seminal plasma, are superoxide dismutases (SOD) (Alvarez et 
al., 1987) catalase (CAT) (Jeulin et al., 1989), the glutathione (GSH) peroxidase system with 
most discussed members selenium and selenoproteins like phospholipids hydroperoxide 
glutathione peroxidase (PHGPx) and the glutathione reductase system (Alvarez and Storey., 
1989), vitamins A, C (Niki.,  1991) and vitamin E (Chow ., 1991), glutathione (Kidd., 1997), 
spermin, thiols, urate (Gavella et al., 1997), albumin, taurine and hypotaurine (Alvarez and 
Storey., 1983), L-carnitine and zinc. Additionally, the possible protective antioxidant role of 
vitamins K and D has been reported in literature (Kodentsova et al., 1994). These 
antioxidants work together as a wide network of protection and many of them become 
radicals themselves while scavenging oxidants. The rest of the antioxidants in the network 
make sure that they are regenerated back to their original structure. For example, vitamin C 
and glutathione regenerate vitamin E. However, this antioxidant protection is not always 
strong enough to protect from OS. When the volume and distribution of the cytoplasm of 
spermatozoa is abnormal, antioxidant enzymes are unable to be hosted properly, and 
therefore their defensive, chain-breaking function is impaired (Aitken and Baker., 2002; Lewis 
et al., 1995).  
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Table 1. Some natural antioxidants.  
  
Adopted from: Scandalios JG: oxidative Stress: molecular perception and 
transduction of signals triggering antioxidants gene defences. Braz J Med Biol Res 
2005; 38: 995-1014  
  
A number of reports have discussed the possible origin of antioxidants in semen, but our 
knowledge on that is still limited. Some of the studies supported the testicular origin of semen 
antioxidants, while others have presented evidence that the source of antioxidant activity is 
post-testicular. More specifically, in 1994, Bauche et al., presented evidence that SOD is of 
testicular origin, protecting it from deleterious ROS concentrations (1994). In 1998, Yeung et 
al. supported that the source of antioxidants is post-testicular, probably mainly the prostate 
and seminal vesicles (Yeung et al., 1998). Four years later, Zini et al. empowered that report, 
showing that antioxidants are post-testicular products and their probable role is the protection 
of ejaculated spermatozoa from OS such as that which occurs in the female reproductive 
tract (Zini et al.,2001b).  
 
Association with Subfertility: A Remedy?  
ROS increase or antioxidant deficit have been associated with a number of pathological 
conditions by several scientific studies. The protective action of antioxidants against the 
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deleterious effect of ROS on cellular lipids, proteins and DNA has been supported by several 
scientific studies (Sies., 1993). In this review, we examined the literature using PubMed and 
separated the publications into three groups, namely, studies discussing natural (enzymatic), 
synthetic (non-enzymatic) and both, respectively.  
Antioxidants, in general, are free radical scavengers that suppress the formation of ROS and 
/or oppose their action. There are many antioxidants in seminal fluid; they can divide into two 
groups; Enzymatic like: Superoxide dismutase, catalase (Zini et al., 1993), and glutathione 
peroxidase (Alvarez and Storey. 1989) and nonenzymatic antioxidants, such as ascorbate, 
urate, alpha-tocopherol, pyruvate, glutathione, taurine, and hypotaurine (Saleh and Agarwal., 
2002). Antioxidants that are present in the seminal fluid compensate for the deficiency in 
cytoplasmic enzyme in the spermatozoa (Donnelly et al., 1999). Spermatozoa themselves 
posses high concentration of thiol groups, as well as smaller amounts of ascorbic acid, 
alpha-tocopherol, uric acid and glutathione (Li., 1975; Lewis et al., 1997; Ochsendorf et al., 
1998).  
  
ROS production and total antioxidant capacity (TAC) can be used as a marker of oxidative 
stress in seminal fluid and is correlated with male infertility. Infertile men with male factor or 
idiopathic diagnoses had significantly lower ROS-TAC scores than controls (Sharma  et al., 
1999). Said et al ( 2005) suggested that abnormal sperm morphology combined with 
elevated ROS production may serve as a useful indicator of potential damage to sperm DNA 
Lisak et al (2004) examined the effect of oxidation of protein and lipids by a 
thermochemiluminescence (TCL) analyzer and showed that thermochemiluminescence 
indices in seminal plasma closely correlate with sperm characteristics among patients with 
sperm disturbances. Morphologically abnormal and immature spermatozoa that retain 
cytoplasmic residues in the mid piece can be separated by a double-density gradient 
procedure (Hall et al., 1995; Ollero et al., 2001; Gil-Guzman et al., 2001).  
  
2.1. Enzymatic antioxidants  
  
2.1.1. Superoxide dismutase (SOD)  
Human sperm contains the enzyme system comprising glutathione peroxidase (GPX), 
glutathione reductase (GRD), and their substrates, glutathione (GSH) and glutathione 
disulfide (GSSG) (Alvarez et al., 1987; Alvarez and Storey ., 1989; Li ., 1975). This system 
functions as a defence against lipid peroxidation in human sperm by reducing formed lipid 
hydroperoxides, which are very reactive and damaging to the plasma membrane, and to 
hydroxylipids, which are essentially inert (Storey et al., 1998).   
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Superoxide dismutase (SOD), catalase, and glutathione peroxidase are antioxidants that 
convert superoxide (O
2
) and peroxide (H
2
O
2
) radicals to form O
2
 and H
2
O.  
  
2.1.2. Superoxide dismutase (SOD)  
One family of the antioxidants used by organisms as a defence mechanism against oxidative 
damage, is in the family of superoxide dismutases (SOD) (see figure 3) (Marklund., 1982; 
Marklund; 1984; McCord., 1969). One of the members of this family, namely, extracellular 
superoxide dismutase (EC-SOD), is a vital part of the defense against ROS-mediated tissue 
damage, and it is located in the extracellular matrix of tissues, hence, the name (Marklund et 
al., 1982., Marklund et al., 1986). SOD acts scavenges the superoxide anion, which is 
produced by a one-electron reduction of an oxygen molecule and initiates a radical chain 
reaction.  
 
 
 
 
 
 
 
 
Figure 3. The enzymatic dismutation of superoxide anion by SOD, such as EC-SOD.   
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In addition, the reaction of superoxide with nitric oxide to produce peroxynitrite anion is 
depicted along with the products of peroxynitrite decay. (Adapted from (Oury et al., 1996)  
  
In 2000, Potts et al., reported that seminal plasma contains antioxidants, whose role is to 
protect the spermatozoa from DNA damage and lipid peroxidation. Three years later, 
Lamond et al. presented evidence that adding SOD to the IVF media protects the sperm 
chromatin from breakdown (Lamond et al., 2003). Earlier, in 1992, Nonogaki et al. had 
shown that adding SOD to the culture medium protects the sperm viability and the 
development of the embryo in vivo and in vitro (Nonogaki et al., 1992).  
The SOD antilipoperoxidative defence system in human sperm relies almost entirely on the 
activity of a single enzyme, the Cu/Zn isoform (Lasso et al., 1994).  
SOD protects against spontaneous O
2
 toxicity and lipid peroxidase (Blum and Fridovich ., 
1985). SOD and catalase also remove (O
2
-
) generated by NADH-oxidase in neutrophils and 
can play an important role in protecting spermatozoa during genitourinary inflammation 
(Baker et al., 1996).  
The steady-state concentration of superoxide is under the control of extracellular SOD, the 
inhibition of which (by copper chelating) leads to the rapid disappearance of thiols (Miesel et 
al., 1993). A pivotal role of SOD in protection of testicular cells against heat stress–Induced 
apoptosis has been demonstrated in vivo and in vitro (Ikeda et al., 1999; Kumagai et al., 
2002).  
  
2.1.3. Catalase   
Catalase is a well known antioxidant enzyme. Its localization is limited to peroxisome. 
Catalase activity has also been determined in human spermatozoa and seminal plasma of 
fertile and infertile males (Jeulin et al., 1989). However, a difference in the seminal catalase 
activity of asthenozoospermic and oligo-asthenozoospermic with hyperviscosity have been 
shown (Siciliano et al., 2001).  
  
2.1.4. Protein and Sulfhydryl group (SH-group)  
  
A sulfhydryl group (SH-group) plays an important role in sperm metabolism and the 
antioxidative defence. Nakamura et al., (2002) demonstrated that seminal plasma superoxide 
dismutase, catalyse, glutathione peroxidase and sulfhydryl group levels are significantly 
lower in infertile patients  than those in controls, suggesting their relationship to male 
infertility.  
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2.1.5. Glutathione  
Reduced glutathione is also part of the antioxidant system in the seminal fluid. Glutathione is 
a tripeptidyl molecule and present in either reduced (GSH) or the oxidized form (GSSG) by 
forming a disulfide bond between two molecules.   
Lenzi et al found that glutathione injection (600mg/day, i. m.) for two months significantly 
improved the morphology and motility patterns of spermatozoa. Even the in vitro use of 
glutathione treatment increased the forward motility and migration from the pellet of 
spermatozoa obtained from leukospermia samples (Lenzi et al. 1992). Parinaud et al (1997) 
showed in vitro enhancement of sperm motility using a migration salt solution containing 
glucose and glutathione as an antioxidant..   
  
2.1.6. L, N-Acetyl-Cysteine.  
Glutathione (γ-glutamyl-cystenyl-glycine) is a natural, highly effective reducing agent. N –
acetyl-cysteine is a potential regulator of germ-cell death. It is a well established inhibitor of 
physiological cell death in several systems. N-acetyl-L cysteine, a reducing substance, has 
been shown to improve sperm motility in vitro together with a decrease of ROS levels in 
infertile patients with high seminal level of ROS. L, N-Acetyl-Cysteine (0.1, 1 and 5 mg/ml) 
has a dose dependent effect in reducing ROS levels; the reduction was greater in patients 
with high levels of ROS than in those with low levels (Oeda et al., 1997). N-acetyl-cysteine 
and /or a mixture of essential fatty acid and natural vitamin A and E reduced levels of 8-
hydroxy-2`-deoxyguanosine (8-OH-dG), which considered as a marker of oxidative stress-
induced sperm DNA damage (Agarwal ., 2004)..  
N, L Acetyl-L-Cysteine when given in concentration of 125, 100, 50 and 25 mmol/L 
suppressed germ cell death in a dose-dependent manner, However, more research is 
needed to validate its efficacy in vivo (Erkkilia  et al., 1998)..  
  
2.1.7.Glutathione peroxidase  
Glutathione peroxidase and catalase activities are of prostatic and multi-glandular origin, 
respectively (Yeung et al 1998)..   
Glutathione peroxidase, a selenium-containing antioxidant enzyme with glutathione as the 
electron donor, removes peroxyl radical from various peroxides including H
2
O
2
 to improve 
sperm motility. Minor alterations in sperm membranes in selected cases of dyspermia can be 
reversed by glutathione (GSH) therapy (Irvine , 1996). The presence of glutathione may 
prevent the accumulation of peroxynitrite (ONOO
-
) to toxic levels and may convert ONOO
-
 to 
secondary products with protective properties (Muijsers et al., 1997)..  
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Low level of NADH and glutathione, as a result of the increased activity of glutathione 
peroxidase to remove metabolites of membrane lipid peroxidation (LPO) will further affect 
cellular Ca
2
+ 
homeostasis (Alvares and Storey , 1989).  
The selenium-containing enzyme glutathione peroxidase destroys peroxides before they can 
damage cell membrane and interacts synergistically with vitamin E (Wefers and Sies., 1988).   
Glutathione peroxidase has been measured in seminal plasma and correlated with male 
infertility (Giannattasio et al., 2002). Yeung et al (1998) studied the GPX, GSH reductase, 
and superoxide dismutase activities of normozoospermic patients and patients undergoing in 
vitro fertilization treatment and suggested that the origin of the GPX, GSH, reductase, 
superoxide dismutase is neither  testicular nor epididymal..   
Glutathione peroxidase has been shown to be able to maintain sperm motility, through 
scavenging of peroxyl radicals (ROO-) (Calvin et al. 1981) and also protect sperm from lipid 
peroxidation (Lenzi et al., 1994). Additionally, GSH has been shown to be a vital antioxidant 
mechanism maintaining normal sperm motility (Sikka 1996; Baumber et al., 2000) and the 
ability of sperm to undergo acrosome reaction (Baumber et al., 2000; Sikka 1996). In an 
earlier study, Lenzi et al. presented that glutathione therapy for 2 months has a statistically 
significant positive effect on sperm motility and morphology (Lenzi et al., 1994). 
Phospholipids hydroperoxid glutathione peroxidase is expressed at higher levels in rat testes 
than in any other tissue (Roveri et al 1994).  
Phospholipid hydroperoxide glutathione peroxidase (PHGPx) is a unique intracellular 
enzyme. Its uniqueness lies in the fact that it has the ability to reduce intracellular membrane 
phospholipid hydroperoxides, hence, the name (Godeas et al., 1997). The highest activity of 
PHGPx has so far been measured in the testis, with a significant difference from that of other 
tissues, like brain and liver (Ursini et al., 1995; Maiorino et al., 2003). Due to the fact that 
sperm cells have high numbers of polyunsaturated fatty acids, they depend on PHGPx 
(together with other scavenging systems) to protect them from OS and lipid peroxidation 
(Lenzi et al., 2000) and that is the reason its concentration in spermatozoa is relatively high 
(Godeas et al., 1997).  
   
2.1.8. Glutathione reductase  
Glutathione reductase regenerates reduced GSH from its oxidized form (GSSG).  
GSH has a likely role in sperm nucleus decondensation.   
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2.1.9 Alpha-glutamyl transpeptidase  
Alpha-glutamyl transpeptidase is present in the midpiece and acrosomal region of 
spermatozoa and it may further regulate the GSH content of oocytes at the time of sperm 
penetration (Irvine, 1996).   
  
2.2. Non-enzymatic antioxidants  
Beside of enzymatic antioxidant system, there are numerous non-enzymatic low molecular 
mass antioxidants which are believed to be even more important scavengers than high 
molecular mass compounds (Zini et al., 1993).  
  
2.2.1. Nitric oxide  
Nitric oxide (NO) is synthesized from L-arginine by a family of enzymes known as the nitric 
oxide synthetases (NOS). NO is a molecule of great biological significance and has long 
been considered to play an important role in sperm physiology (Aitken and Fisher, 1994).   
NO can act as a free radical scavenger, inactivating (Alvarez et al., 1987; McCall et al., 1989) 
and even inhibiting production of superoxide anion (O
2
.
-
)(Chancy et al., 1992), which causes 
lipid peroxidation, a process which leads to functional impairment of spermatozoa 
(Jeyendran et al., 1984). NO produced directly by spermatozoa and that constitutive NOS is 
present in two isoforms similar to those present in both endothelial (ecNOS) and in brain 
(bNOS) cells. Besides, spermatozoa from normozoospermic samples appeared to have 
greater amounts of NOS and higher amounts of NO production than those from 
asthenozoospermic samples (Lewis et al., 1997).   
  
2.2.2. Albumin  
Human serum albumin (HSA) present in culture media serves an antioxidants. Human serum 
albumin has a cystein residue in position 34 which is not involved in a disulfide bond and 
may exist in different oxidative states: as a fully reduced sulfhydryl group, as a mixed 
disulfide with e.g cystein, glutathione or homocystein or in a higher oxidative state like 
sulfonic acid. Serum albumin is discussed as a marker for systemic oxidative stress (Oettl et 
al., 2005).   
Albumin is reported to exhibit an excellent ability to sustain sperm motility (Twigg et al., 
1998b).   
2.2.3. Vitamine C and E.  
The most important antioxidant in seminal fluid seems to be vitamin C and vitamin E (Chow, 
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1991; Niki et al., 1991). Concentration of vitamin C in seminal plasma is 10 times greater 
than in blood plasma (364 vs. 40 micro mol/L) (Lewis et al., 1997). During nonenzymatic 
recycling pathway for vitamin E regeneration that occurs in membrane, vitamin C reduces 
chromanoxyl radicals to recycle vitamin E and eventually being itself consumed by the 
process (Packer, 1993). Vitamin C intake may reduce DNA strand breaks (Green et al., 
1994) in human lymphocytes. Dietary supplementation of vitamin C protects human sperm 
from endogenous oxidative DNA damage (Fraga et al., 1991). Hughes et al. (1998; 1999) 
found that in vitro treatment of sperm with antioxidants (300 and 600µM ascorbic acid; 3 and 
60µM alpha-tocopherol, and 400µM urate) reduce the magnitude of DNA damages as 
measured by comet assay.  
Vitamin E is a term that encompasses a group of potent, lipid-soluble, chain-breaking 
antioxidants. Structural analyses have revealed that molecules having vitamin E antioxidant 
activity include four tocopherols (αβγδ) and four tocotrienols (αβγδ) (review Brigelius- Flohe, 
1999). Vitamin E is known to readily reduce alkyl peroxy radicals of unsaturated lipids 
(Burton et al., 1983). It is a major chain-breaking antioxidant in the sperm membranes and it 
appears to have a dose-dependent protective effect (Bolli et al., 2002).  
Vitamin E proved to be effective in preventing lipid peroxidation and other radical-driven 
oxidative events (Esterbauer et al., 1991). Vitamin E functions as a chain-breaking 
antioxidant that prevents the propagation of free radical reaction (Ingold et al., 1987; Kamal-
Eldin and Appelqvist., 1996). Vitamin E prevents loss of spermatogenesis in males and the 
failure to retain zygote in female rats (Evans and Bishop, 1922). Many investigators have 
found a reduction in concentration of oxidized DNA (8-hydroxy-2 deoxyguanosine) in sperm 
after antioxidants supplementation (Kodama et al., 1997; Comhaire et al., 2000).   
Vitamin E, inhibits lipoprrotein oxidation (LPO) in membranes by scavenging peroxyl (RO
.
) 
and alkoxyl (ROO
.
) radicals. However, the ability of alpha-tocopherol to maintain a steady-
state rate of peroxl radical reduction in the plasma membrane depends on the recycling of α-
tocopherol by external reducing agents such as ascorbate or thiols (Wefers and Sies, 1988).   
Semen vitamin E levels were not increased after 3 months treatment with 400 mg vitamin E 
plus 500 mg vitamin C daily, although there was a marked increase in serum concentration 
(Whittington, 1997).   
Ascorbic acid (vitamin C) is an important water-soluble antioxidant that reduces sulfhydryls, 
scavenger’s free radicals, and protect against endogenous oxidative DNA damage (Fraga et 
al., 1991). Small doses of vitamin C (200 mg), have been shown to increase the seminal 
level of ascorbate in smokers from 5.6 to 13.1 mg/dl, which is similar to the level achieved 
(16.1 mg/dl) after 1000 mg of vitamin C (Dawson et al., 1992). In infertile patients with a high 
level of oxidative DNA damage in spermatozoa, even the combination of vitamin C and E 
with glutathione induced only a slight increase in sperm concentration (Kodama et al., 1997). 
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Administration of vitamin C (350 mg/d) and E (250 mg) together in vivo were not able to 
prevent DNA sperm damage occurring after ejaculation (Hughes et al., 1998). Vitamin C may 
become a pro-oxidant when free transition metals are present (Guerin et al., 2001; 
Yamamoto and Niki, 1988). In 2005, Greco et al., presented an interesting study, supporting 
the antioxidant role of vitamins C and E. More specifically, they detected a reduction in 
ejaculated spermatozoa DNA fragmentation, after treatment with a combination of the two 
vitamins. The interesting aspect of this study was that it was the first one to present the direct 
effect of antioxidant treatment on sperm DNA integrity in vivo (Alvarez and Storey ., 1995).  
  
2.2.4. Urate   
Ascorbate, urate and protein sulfhydryls are the major antioxidants present in seminal 
plasma, while GSH is practically undetectable (Yeung et al., 1998).   
The proposed protective function of uric acid against free radicals in human blood (Becker, 
1993) has not been sufficiently investigated in seminal plasma. Very few data could be found 
in the literature on its presence in seminal plasma (Persson et al., 1991) and on its 
antioxidative defence properties (Thiele et al., 1995). Gavella et al. (1997) found changes in 
total seminal plasma antioxidative capacity chiefly due to ascorbate and urate. Orally 
supplemented ascorbic acid is rapidly distributed in all body tissue, with the highest 
concentration in seminal vesicles (Mann and Lutwak-Mann, 1981; Dawson et al., 1990).  
  
2.2.5. Selenium  
Selenium, in the form of selenocysteine, functions as the catalytic centre in the active sites of 
at least 9 human enzymes, including 4 glutathione peroxidase antioxidant enzymes (Cohen 
and Takahashi, 1986; Zhang et al., 1989; Chu et al., 1996).   
It is well known that, selenium is involved in male reproductive process. In maturing rats the 
testicular content of selenium increased greatly at the beginning of spermatogenesis (Behne 
etal., 1986). Selenium is also required for normal testicular development and 
spermatogenesis in rats (Behne et al., 1996). Rats with low selenium levels produced sperm 
with impaired motility and characteristic mid piece damage (Wu et al., 1996; Mc Coy and 
Weswig, 1969) indicating that selenium is necessary for normal sperm development.   
The specific role of selenium in spermatogenesis appears to be related to phospholipids 
hydroperoxide glutathione peroxidase, which is expressed depending on the development 
state of spermatids (Maiorino et al., 1998), and seems to be converted into a structural 
component in the midpiece of mature spermatozoa (Maiorino et al., 1998).  
Selenium deficiency is associated with impaired sperm motility, structural alteration of 
midpiece, and loss of flagellum (Brown and Burke, 1973). In mature spermatozoa, selenium 
is largely restricted to the mitochondeerial capsule, a keratin-like matrix that embeds the helix 
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of mitochondria in the sperm midpiece (Calvin et al., 1981). Phospholipids hydroperoxid 
glutathione peroxidase is expressed at high levels in rat testes than in any other tissue 
(Roveri et al., 1994).  
Deficiencies of selenium or glutathione can lead to instability of mid–piece of spermatozoa, 
resulting in defective motility (Ursini et al., 1999; Hansen and Deguchi, 1996). Deficiencies of 
selenium or glutathione can lead to instability of the mid–piece of spermatozoa, resulting in 
defective motility (Hansen et al. 2001; Ursini et al., 1999).  
  
2.2.6. Zinc  
Zinc is an element whose importance in the biological systems is undisputed. Its importance 
can be understood by considering that when it is deficient, severe pathological 
consequences occur, like for example, in acrodermatitis enteropathica, a rare autosomal-
recessive inheritable disease (Eggert-Kruse et al., 2002). As far as reproduction is 
concerned, this element has been shown to be highly important for conception, successful 
implantation and pregnancy outcome (Prasad ., 1995; Stephenson and Brackett ., 1999). 
Zinc is present in high concentrations in the seminal fluid and there is evidence that it may 
act in vivo as a scavenger of excessive O2- production by defective spermatozoa and/or 
leukocytes in semen after ejaculation (Gavella and Lipovac., 1998).  
There is evidence that Zinc plays a vital role in the physiology of spermatozoa and 
spermatogenesis. Specifically, Bedwal and Bahuguna reported that this element decreases  
testicular weight and causes shrinkage of seminiferous tubules (Bedwal and Bahuguna, 
1994). Its potential role in sperm production, viability and prevention of spermatozoa 
degradation and sperm membrane stabilization has also been supported (Lewis-Jones et al., 
1996). After ejaculation, the present abnormal spermatozoa are sources of oxidants, namely, 
superoxide anions, which bind with Zinc and reduce its concentration in seminal plasma. 
Thus, Zinc is considered to be a vital antioxidant, guarding normal spermatozoa against 
superoxide anion-induced OS (Plante et al., 1994; Irvine ., 1996). Chia et al. supported that 
zinc concentration in seminal plasma is significantly correlated with sperm density, motility 
and viability (Chia et al., 2000).  
The biological function of zinc and the characteristic features of zinc deficiency have been 
reviewed (Hidiroglou ., 1984; Prasad., 1985). Zinc is vital for spermatogenesis and for the 
development of primary and secondary sexual characteristics (Davies ., 1985). Experimental 
zinc deficiency in humans leads reversibly to reduced sperm count combined with reduced 
serum testosterone (Abbasi et al., 1980). There is a link between zinc deficiency and 
oligospermia (Piese., 1983).   
The total zinc content of mammalian semen is high, 800-3000 µm/g of dry weight, and it has 
been demonstrated that zinc deficiency induces atrophy of the seminiferous tubules and 
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causes failure of spermatogenesis in rats (Stoltenberg et al., 1997). It has been suggested 
that the zinc ion exchange takes place between the epididymal epithelium and sperm cells as 
they pass along the epididymal duct and it might be significant for the maturation process of 
rat sperm cells during their passage through the epididymis (Fujimori et al., 1988; 
Stoltenberg et al., 1996).   
 
 
3. Smoking and male infertility  
Smoking is one of the most extensively experienced and potentially hazardous social habits 
throughout the world. It is more common among the male population compared to the female 
one. Cigarette smoke contains a number of substances such as nicotine, carbon monoxide, 
and recognized carcinogens and mutagens such as radio active polonium, cadmium, 
benzo(a) pyrene, dimethylbenz(a) anthracene, dimethylinitrosamine, naphthalene and 
metaphthalene (Ravenhott, 1982; Zavos, 1989 ; Zenzes 2000). Because of the fact that 
cigarette smoke contains mutagens and carcinogens, there have been concerns that 
smoking may have adverse effects on male reproduction. However, the influence of cigarette 
smoking on male fertility and sperm fecundity remains as highly controversial issue. Several 
studies have suggested association between semen characteristics and smoking, tobacco 
chewing and other hazardous chemicals. Active or passive smoking, or inhalation of cigarette 
smoking, lead to absorption of these agents through vasculature and blood-borne circulation 
throughout the body (Stillman et al., 1986).  
There are various modes of diffusion and active transport through which Cigarette Smoking 
(CS) derived substances could end up in the Seminal Plasma (Zavos et al., 1998). Several 
investigations have been conducted to assess the relationship between cigarette smoking 
and male infertility (Calzada et al., 1992, Merino et al., 1998, Wong et al., 2000) but the exact 
molecular mechanism are not fully understood in most of the cases.  
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3.1. SMOKING AND SPERMATOGENESIS  
  
The effect of nicotine on male fertility remains controversial and several mechanisms have 
been suggested as being responsible for the impairment of spermatogenesis (Weisberg, 
1985), induction of ulrastructural abnormalities (Zavos et al., 1998) and apoptosis (Gandini et 
al., 2000, Sakkas et al., 2002).  
It has been reported that nicotine and its soluble metabolite cotinine could be detectable in 
the seminal plasma of smokers; other harmful tobacco smoke compounds were showed to 
pass through the blood-testis barrier (Vine et al., 1993).  
In habitual heavy smoking, long-term exposure to cigarette smoke, whose by-products move 
across the blood testis barrier and exist in high concentrations in the testis, may adversely 
affect the sperm function.  
3.2. Nicotine induce apoptosis  
The administration of nicotine, a key neuroactive component of cigarette smoke induces 
apoptotic cell death in various organs including brain, spleen, and thymus (Hakki et al 
.,2001).  
Nicotine has received much attention for its interference with normal endocrine function, and 
it has been shown to cause testicular atrophy, gonadal dysfunction, and male factor infertility 
by triggering testicular cytotoxicity (Gocze and Freeman., 2000).  
Lydig cells, which are located in the interstitial component of the mammalian testis, are 
responsible for the bulk of testosterone production in men (Iwabe et al., 2002); and it has 
been reported that nicotine suppresses the secretion of testosterone in adult male rats (Mio 
et al.,1992; Harrada et al., 1997). Leydig cell secretory deficiency, as well as defects in 
epididymal sperm maturation, in rats exposed to cigarette smoke, result in defects in the 
epididymal sperm maturation process and the sperm’s capacity to penetrate the oocyte 
(Yamamoto et al., 1998). Therefore, destruction of leydig cell may cause testicular atophy, 
gonadal dysfunction, and male factor infertility. Kishimoto et al., (1998) reported that nicotine 
administration induces changes in gonadal functions and deficiency in sperm maturation and 
spermatogenesis and has a detrimental effect on the sperm fertilizing potential of the male 
rats. The production and function of healthy normal spermatozoa was affected by the number 
of cigarettes smoked per day, the years of smoking and the level of nicotine by-products 
present in the body fluids, which correlate negatively with semen and sperm quantity and 
quality (Zavos, 1989; Chi et al., 1994). In addition, smoking have been found to affect 
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accessory glands (e.g. prostate and seminal vesicles (Pakrashi and Chatterjeg, 1995) and 
seems to activate bone marrow. It is speculated that blood leucocytosis contribute to the 
chronic inflammation associated with cigarette smoking (Van Eeden and Hogg, 2000).   
The mechanism however, which activates leucocytes in the semen of smokers is unclear. 
The level of leucocytes is elevated in smokers compared with non-smokers was also 
reported (Close et al., 1990). In a small study evaluating the ejaculates of 22 infertile 
smokers observed significantly elevated leucocytes in the peripheral blood of smokers (Parry 
et al., 1997). Leucocytes are the major source of Reactive Oxygen Species (ROS) in the 
ejaculate (Sharma and Agarwal, 1996). Cigarette smoking is also known to increase ROS 
levels through
 
increased leukocyte generation. Infertile smokers are known
 
to harbor 
increased levels of spermatid oxidative stress compared
 
with infertile nonsmokers. This 
increase is associated with
 
increased seminal leukocytes ( Agarwal and Said, 2005 ).   
Therefore, elevated leukocytes may by generate high levels of ROS in semen which may 
overwhelm the antioxidant strategies resulting in oxidative stress and impair fertility (Aitken et 
al., 1995).   
ROS are harmful to sperm DNA and membrane phospholipid (Kim and Parthasarathy, 1998). 
Spermatozoa are particularly susceptible to damage induced by excessive ROS because 
their plasma membrane contains large quantities of poly unsaturated fatty acids  and their 
cytoplasm contains low concentrations of scavenging enzymes (Sikka, 2001).  
3.3. Smoking and semen characteristic  
The effect of smoking on the semen quality is still a controversial issue. Merino et al. found 
that smoking have a negative effect on the parameters of sperm quality (Merino et al., 1998), 
In addition, a number of studies have shown a positive correlation between male smoking 
and decreased concentration and impaired motility and morphology (Evans et al., 1981, 
Handelsman et al., 1984, Mak et al., 2000, Sofikitis et al., 1995). There are also studies 
claiming a relation between cigarette smoking and decreased semen volume (Holzki et al ., 
1991; Saarnen et al .,1987). While some studies did not find any effect on any of the sperm 
characteristics (Goverde et al., 1995 ; Osser et al., 1992). Howeve, The concentration of 
cotinine and hydroxycotinine in the seminal plasma is significantly correlated with total sperm 
motility of spermatozoa (Pacifici et al., 1993). There is a small but significant correlation  
between cotinine concentration in seminal plasma and abnormal sperm morphology, but not 
for other semen variables (Wong et al ., 2000). Cotinine concentration of 400-800ng/ml 
impair sperm motility, membrane function, and their ability to undergo capacitation (Sofikitis 
et al., 2000). In another study, it was demonstrated that semen samples from smokers have 
a significantly higher ratio of single-strand-to double-strand DNA spermatozoa (Sofikitis et al., 
1995). Studies by Zenses (2000) and Zenses et al., (1999) have proposed that smoking 
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induces DNA damage in spermatozoa and in generated preimplantation embryos. Also, 
nicotine at a concenteration of 10mM for 24 hours resulted in the formation of definite 
fragmentation which could be seen via electrophoresis as a characteristic ladder pattern and 
5mM nicotine treatment for 24 hours showed week intensity of DNA laddering (Khae-hawn et 
al., 2005). Moreover, Cigarette smoking is significantly correlated with increased levels of 
seminal oxidative stress, as evidenced by a significant reduction in Reactive Oxygen 
Species-Total Antioxidant Capacity score (ROS-TAC). To strengthen the above hypothesis, it 
should be emphasized that cigarette smoke has been associated with increased frequency of 
aneuploidy in sperm (Twigg et al., 1998a;b), lower seminal plasma antioxidant levels and 
increased oxidative damage to DNA (Fraga et al., 1996; Shen et al., 1997). It is concluded 
that certain life style factors, such as tobacco smoking, may reduce the antioxidant capacity 
of seminal plasma and impair the secretion of accessory sex glands (Depuydt et al., 1996;  
Klinefelterand Hess, 1998). The seminal plasma protects spermatozoa from excessive ROS 
by means of small molecular weight free radical scavengers, such as Ascorbate and 
Tocopheral, Uric acid and ROS-metabolizing enzymes, such as superoxide dismutase, 
catalase, and glutathione peroxidase (Alvarez and Storey, 1989). ROS-TAC scores decrease 
as a result of an imbalance between levels of ROS and antioxidants in semen (Sharma et al., 
1999).  
Cigarette leads to imbalance between antioxidants and ROS mediated lipid peroxidation, 
which is reflected as impaired glutathione redox ratio (GSH/GSSG), with an inverse 
proportion of oxidative stress, and that protection could be provided by supplementing media 
with antioxidants, such as ascorbate and Trolox (a water soluble analog of vitamin E) (Arabi 
et al., 2003). In the testicular tissue there is a significant positive correlation between sperm 
DNA fragmentation and the level of ROS (Barroso et al., 2000; Henkel et al., 2003).   
On the other hand, the existence of high quantities of Polyunsaturated Fatty Acids (PUFA) in 
the human spermatozoa, makes them very sensitive to ROS stimulation (Alvarez and Storey, 
1995). The results of many studies (Alvarez et al., 1987 ; Arabi et al., 2003) in the field of 
peroxidation loss of fatty acids from phospholipids of human spermatozoa, indicate that 
nicotine has a potentially oxidant effect when added to sperm samples, acting by increasing 
the rate of Thiobarbituric Acid Reactive Substance, particularly Malondialdehyde 
(TBARS/MDA) generation significantly and dose-dependently. The end point of lipid peroxide 
process is the thiobarbituric acid-reacted MDA as an index of Lipoprotein (LPO) damage.  
LPO also has a deleterious effect on the aspect of sperm viability. It also impairs plasma 
membrane ion exchange, which is necessary for maintening sperm movements (Rao et al., 
1989). In a high proportion of infertility cases showing defective sperm function as a result of 
oxidative stress which leads to damage of sperm membrane (Aitken, 1994, Sharma and 
Agarwal, 1996).  
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It has been shown previously that oxidative damage to DNA or high intra testicular 
temperature (i.e., presence of varicocele) in rats or rabbits do not preclude the sperm head’s 
ability to transform into male pronucleus. However, the derived embryo has lower capacity to 
implant (Sofikitis et al., 1996). Also, increased damage to DNA has been linked to an 
increase in early embryonic death (Sakkas et al., 1999). Therefore, exposure to cigarette 
smoke influences the sperm’s capacity or epigenetic factor, but does not affect sperm 
capacity to fertilize oocyte (via ICSI) or to trigger early embryonic development. However, it 
can causes an impaired capacity for implantation of blastocyst (Ubaldi et al., 1999). They 
showed that some testicular defects have negative impact on the reproductive performance 
of testicular spermatozoa, resulting in a decreased embryonic potential for implantation, 
without any apparent effect on fertilization and early embryonic development. This is 
supported by previous studies, (Janny and Menezo, 1994; Sofikitis et al., 1998 ; Ubaldi et al., 
1999) showing a parental contribution to embryonic capacity for implantation, resulting in a 
significantly lower number of alive offsprings per transferred embryo and normal blastocyst 
development rate, post ICSI.  
In addition, paternal smoking has been associated with a significant increase in the 
percentage of spermatozoa with DNA damage and higher risk of birth defect and childhood 
cancers in the offspring (Magnani et al., 1990 ; Fraga et al., 1996; Sorahan et al ; 1997; 
Saleh et al 2002):   
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The purposes of current study were  
  
The present prospective study aimed to evaluate the possible relationship between reactive 
oxygen species (ROS), total antioxidants (TAS) concentration in seminal plasma and semen 
quality among andrology referrals with normospermic and severe sperm impairment that 
underwent assisted reproduction treatment and in vitro fertilization (IVF/ICSI) outcome  
  
Besides, the present work intends to evaluate the influence of Cotinine concentration in 
seminal plasma on sperm quality and their impact on the outcome of IVF/ICSI in term of 
fertilization, embryo development on day 2, embryo transfer and pregnancy rate.   
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4-Materials and Methods  
 
 
 
 
  46
 
  
  
  
4. 1. Materials  
Semen samples were collected from unselected male partners
 
of couples consulting for 
infertility at department of obstetrics and gynecology, university of Saarland/Homburg/Saar. 
Ejaculates were obtained in the early morning at the clinic (7.00–9.30 AM) after three days of 
sexual abstinence. The patients underwent either IVFor ICSI therapy according to the basic 
semen analysis (94 (57 IVF and 37 ICSI). All samples were
 
collected by masturbation and 
allowed to liquefy for 30 min
 
at room temperature. The samples were collected in separate 
polypropylene containers and assayed within 2h after collection. After liquefaction, the 
samples were analysed
 
for concentration and motility according to recommendations
 
of 
World Health Organization (World Health Organization, 1999)
 
 
The questionnaire was self-administered and designed to determine current smoking 
behaviour. Out of the 94 patient only 46 patients could be classified as heavy smokers or non 
smokers. Males who smoked >20 cigarettes day were enrolled in this study. They were 
divided into two groups: heavy makers (n=11) and nonsmokers (n=35). Semen 
concentrations of ROS, TAS, and cotinine and sperm quality were compared of these groups 
of patients. Cases with leukocytospermia or varicoceleor were excluded from this study 
because of their well-known high seminal ROS levels.  
  
4.2. Methods  
  
4.2.1 Basic sperm parameters evaluation  
  
In all patients, a standard semen analysis was performed, assessing semen parameters, 
such as sperm count, concentration, and motility according to WHO criteria (World Health 
Organization, 1999). Morphology was evaluated according to strict criteria described by 
Krüger et al. (1987). Liquefied semen samples were layered on a 45% over 90% 
discontinuous density gradient PureSperm
®
 gradients (Nidacon International AB, Sweden) 
and centrifuged at 500xg for 20 minutes at room temperature. The supernatant (seminal 
plasma) was immediately separated, and examined before storage to rule out the presence 
of spermatozoa in the supernatant. The seminal plasma was aliquot into storage ampoules 
and stored at -80°C until the assay was performed (within 3 months). Repeated assays on 
fresh and frozen seminal plasma samples from the same patient showed that sample storage 
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at -80°C did not significantly influence the evaluated parameters.   
The pellet containing the normal spermatozoa was washed again, layered with 1 ml of 
culture media and incubated at 37 °C. The motile sperm was used for injection (ICSI) or 
insemination of oocytes (IVF).  
  
4.2.2. Sperm vitality (Eosin test).  
  
The Eosin test was used to evaluate the viability of spermatozoa before semen processing 
according to the method described by Eliasson and Treich (1971). Briefly, one drop of semen 
was mixed on a slide with 1 drop of 0.5% aqueous yellowish eosin solution and covered with 
a cover slide. After 1-2 minutes observation the spermatozoa which red stained (dead 
spermatozoa) can be distinguished from those unstained spermatozoa (alive spermatozoa). 
100 sperm from each semen sample were evaluated per slide.   
  
4.2.3 Sperm Morphology  
  
Samples were spread on a plain glass slides, air dried for 24 hours and were stained using 
Papanicolaou staining and analysed. A total of 100 spermatozoa were scored per slide using 
bright field illumination and an oil immersion objective with a total magnification of x2000. At 
least ten high power fields from different areas of the slide were examined. The sperm 
morphology was classified according to the strict criteria described by Krüger et al (1987).  
  
4.2.4. Sperm membrane integrity (Sperm Vitality (HOS-Test)  
  
The HOS –test was performed according to the method described by Jeyendran et al (1984). 
100µL of sperm suspension was mixed with 1mL of hypo osmotic solution (equal parts of 
150mOsmol fructose and 150mOsmol sodium citrate solution), and incubated at 37°C for 30 
minutes. After incubation, one drop was observed under the light microscope. A minimum of 
200 spermatozoa were examined per slide and the percentage of spermatozoa that showed 
typical tail abnormalities indicative of swelling were calculated.  
  
4.2.5. Chromatin condensation (DNA integrity) (Chromomycine test CMA
3
)  
  
Chromomycin CMA3 was used to predict the percentage of mature sperm cells. CMA
3
 was 
performed as previously described by Bianchi et al (1996). Briefly, a semen aliquot was 
washed in Dulbecco’s Ca-Mg free phosphate buffer saline (PBS) and centrifuged at 250 xg 
for 10 minutes. The spermatozoa were washed again and then fixed in methanol/glacial 
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acetic acid (3:1) at 4°C for 5 minutes and spread on clean slides.   
The CMA
3
 (Sigma St. Louis, MO, USA) was dissolved in Mc Ilvaine’s buffer (pH, 7.0)  
supplemented with 10 mmol/L MgCl
2
 (17 mL of 0.1 mol/L citric acid mixed with 83mL of 0.2 
mol/L Na
2
 HPO
4
 and 10 mmol/L MgCl
2
,) to a concentration of 0.25 mg/mL. Each slide was 
treated for 20 minutes with 100µl of CMA
3
 solution at 25°C in the dark. Slides were then 
washed in PBS, rinsed in PBS buffer and mounted with buffered-glycerol. The fluorochrome 
was examined using a Zeiss photomicroscope III, via a combination of exciter dichroic barrier 
filters of BP 436/10: FT 580: LP 470. A total of 200 spermatozoa were analysed for each 
sample, at least 200 cells were counted: cells positive
 
for CMA3 displayed bright yellow–
green fluorescence (presumably
 
defective chromatin packaging), while those negative for 
CMA3
 
showed dull yellow staining (normal chromatin packaging).
 
 
  
4.2.6. DNA Fragmentation (TUNEL-Test)  
  
(Terminal deoxynucleotidyltransferase-mediated
 
dUTP nick end labelling (TUNEL).   
DNA fragmentation was assessed using the Terminal deoxyribonucleotidyl transferase-
mediated dUTP nick-end labelling (TUNEL) assay. The TUNEL assay was performed using 
the In-Situ Cell Death Detection
 
Kit: Fluorescein following the manufacturer's guidelines 
(Roche
 
Diagnostics GmbH, Mannheim, Germany).   
Briefly, ejaculated sperm samples were washed from seminal plasma by slow speed 
centrifugation (250xg; 10 minutes), smeared on microscope slides, air dried, fixed with 4% 
paraformaldehyde in phosphate–buffered pH 7.4 saline at 4°C for 25 minutes, and 
permeabilized with 0.1% triton X-100 in 0.1% sodium citrate.  
The TdT-labeled nucleotide mixture was
 
added to each slide and incubated in a humidified 
chamber at
 
37°C for 60 minutes in the dark. Later, slides were rinsed
 
twice in PBS and 
counterstained with 10 mg/mL 4', 6 diamidoino-2-phenylindole
 
(DAPI). Negative controls 
without TdT enzyme were run in each
 
replicate. A total of 500 sperm per individual were 
evaluated
 
using fluorescence microscopy by the same examiner. The number
 
of sperm per 
field stained with DAPI (blue) was first counted;
 
the number of cells with green fluorescence 
(TUNEL positive)
 
was expressed as a percentage of the total sample.
 
 
 
4.2.7. DNA denaturation (Acridine orange Test)  
  
The Acridine orange assay (AO) was used to evaluate the susceptibility of in situ DNA 
denaturation. The AO assay was performed following the protocol of Tejada
 
et al ( 1984 ). 
The fluorochrome AO intercalates into double-stranded DNA as a monomer and binds to 
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single–stranded DNA as an aggregate. The monomeric AO which bound to native DNA 
fluoresces green, whereas the aggregated AO on denatured DNA fluoresces red.   
10 µl of each semen sample was spread onto a pre-cleaned slide that was allowed to dry at 
room temperature. Slides were then fixed overnight in freshly prepared Carnoys solution (3 
parts methanol and 1 part glacial acetic acid) and allowed to air dry for a few minutes before 
being stained with AO (CI 46005; sigma Chemical Company, St Louis, Mo).   
A stock solution of AO was prepared (1g/L in distilled water) and stored in the dark at 4°C. 
The staining solution consisted of  10mL of stock solution, 40 mL of 0.1 M citric acid, and 2.5 
mL of 0.3 M Na
2
 HPO
4
. 7H
2
O. the final pH of the solution was adjusted to 2.5. Slides were 
stained in AO solution for 5 minutes at ambient temperature in the dark in an aluminium foil 
covered 500 mL glass container, gently rinsed with deionised water, and mounted with 
phenylenediamine mounting medium. The AO slides were kept in the dark and analysed by 
means of a fluorescence microscope (Leitz, Oberkochen, Germany) equipped with a 490-nm 
excitation filter and 530-nm barrier. At least 200 spermatozoa were assessed per slide. 
Spermatozoa with normal DNA content revealed a distinct green fluorescent colour, whereas 
sperm heads displaying a fluorescent spectrum varying from yellow-green to red were 
considered as being denatured (Abnormal DNA; Tejada et al., 1984).  
  
4.2.8. Reactive oxygen species measurement  
  
The concentration of ROS was measured by a Colorimetric assay for the quantitative 
determination of peroxides in EDTA–plasma, serum and other biological fluids (Oxy Stat; 
Cat. No. BI-5007 Biomedica Medicine product GmbH & Co KG, Wien Austria).  
Principal of the assay: The peroxide concentration is determined by the reaction of the 
biological peroxides with peroxidase and a subsequent colour–reaction using TMB (3, 3, 5, 
5-Tetramethylbenzidine) as a substrate. After the addition of the stop solution, the coloured 
liquid was measured photometrically at 450nm. A calibrator was used to calculate the 
concentration of circulating biological peroxides in the sample (one point calibrator).   
Assay characteristics: The Biomedica Oxy Stat assay measures the total concentration of 
peroxides, which is formed in the propagation-phase of the low density lipoprotein oxidation 
process using peroxidase/TMB. 12x8 well microtiter plate format (96 tests per kit). Reference 
values EDTA plasma <400µmoll/L, serum <350µmol/L. Measuring range 7-6000µmol/L; 
Detection limited 7µmol/L. Sample volume 10µL /test. Assay time 30 minutes.  
  
4.2.9. Total antioxidants measurements  
Semen antioxidant capacity was determined by a method described by Miller et al., (1993), 
and Rice-Evance and Miller (1994), developed for the evaluation of antioxidant capacity in 
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blood plasma. This is a Colorimetric assay using ABTS
® 
(2, 2’-Azino-di-[3ethylbenzthiazoline 
sulphonate], and a commercially available kit, TAS (Randox Laboratory, Ltd Krefeld, 
Germany).  
Assay Principle: The method is based on the antioxidants inhibition of the absorbance of 
the radical cation 2, 2`-azinobis (3-ethylbenzothiazoline-6-sulphonate (ABTS
. +
) formed by the 
interaction between ABTS and ferrylmyoglobin radical species, generated by activation of 
metmyoglobin with H
2
O
2
. This has a relatively stable blue-green colour, which is measured at 
600nm. Antioxidants added to the sample cause suppression of this colour production to a 
degree which is proportional to their concentration. Range 1.30-1.77mmol/L plasma (Miller et 
al. 1993)   
  
4.2.10. Cotinine measurement: Bio Quant (Cotinine Direct ELISA)  
  
Summary and Explanation: The BQ Cotinine Direct Elisa Kit is a specific and sensitive in –
vitro test to detect the presence of Cotinine in serum and urine. Exposure to tobacco smoke 
can be detected by nicotine and its metabolites. Nicotine has a short half life and is not used 
as a marker for tobacco smoke exposure. Cotinine due to its longer half life has been used to 
research as a reliable marker for smoking status and smoking cessation studies.  
Principles of the test: This continine Direct ELISA Kit is based upon the competitive binding 
to antibody of enzyme labeled antigen and unlabeled antigen, in proportion to their 
concentration in the reaction mixture. A 10 µI aliquot of a diluted unknown specimen is 
incubated with a 100 µl dilution of enzyme (Horseradish peroxidase) labeled Cotinine 
derivative in micro-plate wells, coated with fixed amounts of oriented high affinity purified 
polyclonal antibody. The wells are washed thoroughly and a chromogenic substrate added. 
The color produced is stopped using a dilute acid stop solution and the wells read at 450 nm. 
The intensity of the color developed IS inversely proportional to the concentration of drug in 
the sample. The technique is sensitive to 1 ng/ml.  
  
ASSAY PROCEDURE: All reagents must be brought to room temperature (18-26 °C) before 
use. The procedure as described below may be followed in sequence using manual pipettes. 
Alternatively all reagents may be added using an automated pipettor. Use urine calibrators 
for urine and serum calibrators for serum. Depending on the cut offs a sample dilution may 
be required for urine applications.  
1. Add 10 µl of calibrators and standards to each well in duplicate.  
2. Add 10 µl of the specimens in duplicate (recommended) to each well.  
3. Add 100 µl of the Enzyme Conjugate to each well. Tap the sides of the plate holder to 
ensure proper mixing.  
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4. Incubate for 60 minutes at room temperature (18-26 °C) preferably in the dark, after 
addition of enzyme conjugate to the last well.  
5. Wash the wells 6 times with 300 µl distilled water using either a suitable plate washer or 
wash bottle taking care not to cross contaminate wells.  
6. Invert wells and vigorously slap dry on absorbent paper to ensure all residual moisture is 
removed. This step is critical to ensure that residual enzyme conjugate, does not skew 
results. If using an automated system, ensure that the final aspiration on the wash cycle 
aspirates from either side of the well.  
7. Add 100 µl of Substrate reagent to each well and tap sides of plate holder to ensure 
proper mixing.  
8. Incubate for 30 minutes at room temperature, preferably in the dark.  
9. Add 100 µI of Stop Solution to each well, to change the blue color to yellow.  
10. Measure the absorbance at a dual wavelength of 450 nm and 650 nm.  
11. Wells should be read within 15 minutes of yellow color development.  
The dose/response curve shown above should not be used in assay calculations. It is 
recommended that at least one in-house positive quality control sample be included with 
every assay run. A dose response curve or a cutoff calibrator should be run with every plate.  
Sensitivity: Assay sensitivity based on the minimum Cotinine concentration required to 
produce a three standard deviation from assay A0 is 1 ng/ml.  
  
4.2.11. Selenium and zinc measurement  
Determination of the concentration of selenium and zinc was carried out by means of 
instrumental neutron activation analysis at the Hahn-Meitner –Institute, Department of Trace 
Element in Health and Nutrition, Free University, Berlin, Germany. The method has been 
described in detail elsewhere (Behne and Jürgensen, 1978; Behne et al., 1988). Briefly, 
samples were centrifuged for 20 minute at 10.000Xg. Aliquots of 200 µl of seminal plasma 
were transferred into ampoules made of highly pure silica and lyophilized. The sealed 
ampoules, together with standards, were irradiated for 10 days at a thermal neutron flux 
density of 7x10
13 
cm
-2
 sec
-1
. The gamma ray spectra of the radionuclide thus produced were 
measured by means of a Ge (Li) detector, after a decay time of 3 months, which was 
necessary to reduce sufficiently the interfering phosphorus-
32
 activity. The element contents 
were determined by comparing the intensities of the gamma rays of the selenium-75, and 
zinc-66 in sample and standards.  
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4.2.12. Female patient characteristics.   
The female patients underwent either IVF (n= 57) or ICSI (n=37) therapy. The female 
patients underwent ovarian hyperstimulation as previously described (Hammadeh et al., 
2002). 478 oocytes were retrieved (2798 from IVF and 1666 from ICSI patients). 29 
pregnancies were achieved (30.9%). ROS, TAS, Cotinine concentration were measured in 
the seminal plasma and the results were correlated with sperm parameters and IVF/ICSI 
outcome. The following data were collected from female patients: ovarian stimulation 
protocol, number of retrieved, mature, injected oocytes and the fertilization, cleavage and 
pregnancy rates.   
  
4.2.13. Statistical analysis.  
Data analysis was performed using the personal computer of the local area computer 
network of the Institute of Medical Biometrics and Medical Information, University of 
Saarland, Homburg/Saar, Germany, using the SPSS 11 for Windows Software Package 
(SPSS Inc., Chicago, IL, USA). Data were expressed as mean±SD and range. The 
relationship between ROS, TAS, and DNA integrity, motility and morphology and their effect 
on fertilization rate after IVF and ICSI treatment was analysed. Furthermore, semen 
characteristics, ROS and TAS and cotinine levels were analysed in seminal plasma in 
Smokers and non-smokers and their effect on ART results were analysed using parametric 
and nonparametric methods. Differences in cotinine distribution and characteristics of sperm 
quality were evaluated between smokers and nonsmokers. Statistical significance was 
defined as p<0.05. The Mann-Whitney (U-test) was used for non–paired data. The results 
were presented by the mean ± SD values. Correlations were analysed by means of chi-
square test or exact Fisher-test and by Spearman's test. They were considered statistically 
significant when P<0.05.  
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5-Results  
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Semen and sperm characteristics are illustrated in table 2. A total of 94 semen speciemens 
of men underwent either IVF (n=57) or ICSI therapy (n=37) were analysed for count, motility 
morphology, DNA integrity, DNA fragmentation (TUNEL-Test, Acridine Orange-Test), ROS, 
TAS, Zink and Selenium concentration in seminal plasma. 
Sperm concentration, the proportion of motile spermatozoa, sperm viability and the 
percentage of TUNEL positive spermatozoa are shown in table 2.  
Mean values for the sperm concentration in the native semen samples were 65.32±37.16 
mill/ml and decreased after semen preparation with pure sperm gradients centrifugation to 
31.91±29.33mill /ml.  
Sperm motility increased after semen preparation in comparison to the value in the native 
semen samples (32.69±18.291% versus 62.23±30.68%). Sperm preparation by gradients 
centrifugation increased the percentage of sperm motility compared with the original semen 
sample.  
Besides, 8.02 ±6.57% and 5.83±5.46% of spermatozoa with normal head displayed DNA 
fragmentation after staining with  Tunel and Acridine Orange respectively .  
Moreover, the percentage of sperm parameters such as concentrations, motility, morphology, 
chromatin condensation, CMA3, DNA Fragmentation (Tunel) and ROS, TAS, mean number 
of retrieved, cleaved, transferred and pregnancy were compared between IVF/ICSI patient 
groups and the results were reported in table (3) and figures (4-15). The correlations were 
illustrated in table (4 a,b) and figures (16-21). 
Statistical analysis demonstrated significantly lower semen quality of ICSI in comparison to 
IVF patients. Sperm concentration, motility and vitality were significantly higher in IVF 
patients group in comparison to ICSI group(Fig. 4, 5, 6, 7). The mean percentage of 
morphologically normal spermatozoa was higher, but not significant of patients underwent 
IVF (14.05±15. 87%) in comparison to those of ICSI therapy (10.39±10.34%,) (Fig. 8).. 
Chromatin integrity (sperm stained by CMA3) of ICSI patients group was significantly (p= 
0.001) lower in comparison to IVF group (30.97±20.50% vs. 17.81±9.64%) (Fig. 9). 
Whereras, the DNA fragmentation (TUNEL) in the spermatozoa of ICSI patients group was 
higher (8.14±6.58% vs. 7.95±6.618%; p=0.892) than that in the IVF group (Fig.10). ROS 
concentration in seminal plasma of IVF patients was, non-significant, higher than that of ICSI 
patients (73.7±74.3 versus 50.8±34.63, p= 0.130 respecticvely) (Fig. 11). Whereas, the 
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concentration of TAS in seminal plasma was similar in both groups (1.36±0.52 versus 
1.42±0.510; p= 0.564) (Fig.12). 
Pregnancy rate was higher in patients underwent IVF in comparison to those who underwent 
ICSI therapy (31.5% vs. 29.7%; p=0.392). 
In IVF patients group 18 (18/57) pregnancies were achieved. Whereas only 11 women 
become pregnant (11/37) after ICSI treatment. However, only 40 women became transfer in 
IVF and 18 in ICSI groups, the other patients ended up with total fertilization or cleavage 
failure (Tab. 3; Figure. 15).  
In addition, the semen and sperm quality as well as comparisons between Smokers and non 
smoker’s patient groups were illustrated in table (5-6) and figures (22-34). 
The correlations between semen parameters, ROS, TAS, Cotinine concentration and IVF/ 
ICSI outcome of smokers and non-smokers group were presented in table 7a, b and 
diagrams (35-42). 
A significant difference in sperm concentration, motility and morphology was been shown 
between smokers and non-smokers patient group. Other semen parameters were higher in 
non smoker group in comparison to smokers. However, these values failed to achieve 
statistical significance. The data is summarized in table 6. Eleven pregnancies out of 32 
patients became transfer in the non-smokers groups (34% pregnancy rate). However, in the 
smoker’s patients group only 3 pregnancies were achieved out of 11 patients who became 
transfer (27.3%). The pregnancy rate was significantly higher of non-smokers group in 
comparison to smoker group (p=0.001) (Table 6; Figure 34).  
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Tab. 2: Semen qualitative characteristics of patients undergoing assisted reproduction 
treatments (n= 94)  
 M±SD 
Sperm concentration in the native semen sample(mill/ml)  65.32±37.16 
Sperm concentration after semen preparation 31.91±29.33 
Motility (%) in the native semen sample 32.69±18.291 
Motility (%) after semen preparation 62.23±30.688 
Vitality (stained with Eosin test) (%) 63.66±22.647 
Membrane Integrity (%) HOS-test in the native semen samples 43.66±20.709 
Morphologically normal spermatozoa in the native semen samples 12.63±14.049 
Chromatin condensation in the native semen samples positive  22.99±16.142 
DNA Fragmentation TUNEL-test in the native semen samples 8.02±6.570 
DNA Denaturation (AO) in the native semen samples 5.83±5.467 
ROS (µmol/l)  level in seminal plasma 64.75±62.62 
TAS (mmol/l) level in seminal plasma 1.38±0.516 
Selenium (µgSe/kg dry mass) in seminal plasma 3.504E-02±1.355E-02 
Zinc  in seminal plasma 129.31±69.38 
Mean number of collected oocytes 9.67±6.084 
Mean number of fertilized oocyte 5.41±5.015 
Fertilization rate (%) 53.9±28.1 
Mean number of transferred embryos 1.91±0.86 
Pregnancy  0.93±0.83 
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Tab. 3: Semen qualitative characteristics of patients undergoing assisted reproduction 
treatments 
  
IVF 
M±SD(n=57) 
ICSI 
M±SD (n=37) 
P-Value 
Sperm concentration (mill/ml) in the native semen 
samples 
75.51±31.946 49.63±39.51 0.002 
Sperm concentration (mill/ml) 35.87±28.39 25.82±30.07 0.010 
Motility (%)in the native Semen  39.30±18.16 22.22±12.95 0.001 
Motility (%) after semen preparation 73.68±23.95 44.59±31.82 0.001 
Vitality (%) Eosin test 58.77±21.82 71.19±22.09 0.003 
Membrane integrity (HOS-Test) 41.84±20.49 46.53±21.00 0.277 
Morphologically normal spermatozoa 14,05±15,87 10.39±10.34 0.259 
Chromatin condensation (CMA3) native 17.81±9.64 30.97±20.50 0.001 
DNA Fragmentation TUNEL-test 7.95±6.618 8.14±6.58 0.892 
DNA Denaturation AO test  5.33±4.903 6.63±6.25 0.470 
ROS concentration 73.7±74.3 50.8±34.63 0.130 
TAS concentration  1.36±0.52 1.42±0.510 0.564 
Selenium (µgSe/kg dry mass) in seminal plasma 131.0±77.47 127.31±60.160 0.992 
Zinc concentration in seminal plasma 0.034±0.016 0.036±0.00 0.619 
Retrieved oocytes 10.39±6.85 
2798 
8.57±4.53 
1666 
0.480 
Fertilized oocyte 5.52±5.66 
2578,00 
5.0±3.70 
1793.00 
0.670 
Fertilization rate  50.56±28.89 59.23±26.47 0.124 
Cleaved and transferred Oocytes 1.77±0.86 2.14±0.82 0.036 
Pregnancy 1.55±0.50 
18/57 (31.5%) 
1.39±0.50 
11/37 (29.7%) 
0.392 
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Figure 4: Box-plots showing the mean, median, and range of sperm concentration (mill /ml) 
after semen preparation of IVF/ICSI patients. Sperm concentration, was significantly higher 
in IVF patients group in comparison to ICSI group in comparison to those of ICSI therapy not 
only in the native semen sample (75.51±31.946±49.63±39.51mill/ml P=0.002) but also after 
semen processing (35.87±28.39±25.82±30.07mill /ml; p= 0.010). 
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Figure 5: Box-plots showing the mean, median, and range of sperm motility (%) in the native 
semen samples of IVF/ICSI patients. Sperm motility were significantly higher in IVF patients 
group in comparison to ICSI group. The mean percentage of motile spermatozoa in the 
native semen samples was significantly higher (p=0.001) of patients underwent IVF 
(39.30±18.16) in comparison to those of ICSI therapy (22.22±12.95). 
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Figure 6: Box-plots showing the mean, median and range of sperm vitality (%) assessed by 
Eosin test of IVF/ICSI patients. The mean percentage of vital spermatozoa in the native 
semen samples was significantly higher in IVF patients group in comparison to ICSI group 
(58.77±21.82 versus 71.19±22.09; p=0.003). 
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Figure 7: Box-plots showing the mean, median and range of sperm membrane integrity 
(Hypo-osmotic swell- Test; HOS-Test) of IVF/ICSI patients. The mean percentage of 
membrane integrity was similar in both groups (41.84±20.49 versus 46.53±21.00; p=0.277).  
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Figure 8: Box-plots showing the mean, median and range of morphologically normal 
spermatozoa (%) of IVF/ICSI patients. The mean percentage of morphologically normal 
spermatozoa was higher, but not significant, of patients underwent IVF in comparison to 
those of ICSI therapy (14.05±15. 87% versus 10.39±10.34%; p=0.259). 
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Figure 9: Box-plots showing the mean, median and range of chromatin condensation (non-
condensed chromatin stained with CMA3) of spermatozoa after assessment with 
chromomycin (CMA3) of IVF/ICSI patients. The mean percentage of stained spermatozoa 
with chromomycin CMA3 in spermatozoa of male partner of patients underwent IVF was 
significantly (p=0.001) lower (17.81±9.64%) than those in spermatozoa of patients underwent 
ICSI program (30.97±20.50%; p=0.001). 
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Figure 10: Box-plots showing the mean, median and range of DNA Fragmentation TUNEL in 
spermatozoa of IVF/ICSI patients. DNA fragmentation of IVF patients was 7.95±6.618% and 
similar value was found of ICSI patients (7.95±6.618; p= 0.892). 
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Figure 11: Box-plots showing the mean, median and range of ROS concentration (µmol/l) in 
seminal plasma of IVF/ICSI patients. ROS concentration was higher, but non significant, in 
IVF group in comparison to ICSI group (73.7±74.3 versus 50.8±34.63; p= 0.130). 
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Figure 12: Box-plots showing the mean, median and range of TAS concentration in seminal 
plasma (mmol/l) of IVF/ICSI patients. TAS concentration was slightly higher in IVF vs. ICSI 
patient group (1.36±0.52 versus 1.42±0.510; p= 0.564). 
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Figure: 13: Box-plots showing the mean, median and range of fertilization rate (%) of patients 
underwent IVF/ICSI therapy. The fertilization rate of oocytes in IVF was 50.56±28.89% and 
the corresponding value of ICSI was 59.23±26.47%. no significant difference was found 
bwtween both group (p=0.124) 
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Figure 14: Box-plots showing the mean, median and range of the number of cleaved and 
transferred oocytes of IVF/ICSI patients. The mean number of cleaved and transferred 
oocytes in IVF was 1.77±0.86% and of ICSI was 2.14±0.82%. A significant difference was 
found between the groups ( p=0.036). It should here be mentioned that according to German 
embryo protection law only three embryos can be produced and transferred. 
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Figure 15: Mean number of clinical pregnancy rate of IVF/ICSI patients. Out of the 57 
patients enrolled in IVF program only (n=40) women become transfer and of patient 
underwent ICSI therapy (n=37) only 18 patient became embryo transfer. The other patients 
ended up with total fertilization or cleavage failure. In IVF patients group 18 (18/ 57) 
pregnancies were achieved. Whereas only (11 women become pregnant (11/37) in ICSI 
patients group. 
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A significant positive correlation between semen concentration and motility before (r=0.427; 
p=0.003) and after semen processing (r= 0.326; p=0.027) has been demonstrated. Whereas, 
a negative correlation between DNA integrity (CMA3) (r=-0.418; p=0.004) and DNA 
fragmentation (Tunel) (r=-0.292; p=0.049) was shown. Besides, a linear regression analysis 
of the data in this study indicated that there was a significantly positive relationship between 
Chromatin integrity (CMA3) and sperm vitality (Eosin) (r=0.0332; p=0.029).(Tab. 4a.b)  
The mean percentage of morphological normal spermatozoa correlated positively with sperm 
motility (r=0.382; p=0.010), vitality (r=0.318; p=0.033) and negatively with DNA integrity 
(CMA3) (r= -0.162; p=0.288) (fig; 17), DNA fragmentation (TUNEL) (r=-0.123; p=0.419, ROS 
concentration in seminal plasma (r=-0.347; p=0.20) (Fig.18), fertilization rate (r=-0.021; p= 
0.889) and cleavage rate (r=-0.096; p=0.530). However, the percentage of morphologically 
normal sperm in the specimens did correlate negatively significant with ROS concentration 
(r=-0.347; p=0.020) Fig. 18). However, TAS concentration in seminal plasma correlated 
positively significant with cleavage rate (r=0.313; p=0.034) (Fig. 19). 
A positive correlation was found between chromatin condensation (CMA3) of spermatozoa 
and sperm concentration (r=-0.418; p=0.004), motility (r=-0236; p=0.118), vitality (r=0.322; 
p=0.029) and morphology (r=-0.162; p= 0.288) (Fig. 17). An inverse correlation (but not 
significant) was shown between spermatozoa DNA fragmentation (Tunel) and motility (r= -
0.107; p=0.484), morphology (r=-0.123; P=0.419), fertilization rate (r= -0.175; p=0.245), and 
pregnancy (r=-0.048; p= 0.750) (Fig. 20). ROS correlated negatively with sperm vitality (r=-
0.111, p=0.453), membrane integrity (r=-0009; p=0.953) and morphology (r=-0.347; 
p=0.020)(Fig. 18). Besides, there was an inverse correlation (r=-0.275; p=0.064) between 
ROS concentration in seminal plasma and fertilization rate in IVF/ICSI patients. 
Other inverse correlation, but not significant, was shown between Acridine orange staining 
and sperm vitality (r=-0.048; p=0.765); ROS concentration in seminal plasma (r=-0.072; 
p=0.652); TAS (r=-0.148; p=0.349); fertilization rate (r=-0.211; p=0.180); cleavage rate (r=-0. 
214; p= 0.174) and pregnancy rate (r= -0. 033; p= 0.834) (Fig.21).. 
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Tab 4a: Correlation coefficient of semen parameters and sperm quality of IVF/ICSI 
patients. 
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r 1.000 0.314(*) 0.427(**) -0.264 -0.107 0.074 -0.418(**) -0.292(*) Sperm concentration  
(mill/ml) in the native 
semen p . 0.034 0.003 0.076 0.485 0.629 0.004 0.049 
r 0.427(**) 0.269 1.000 -0.594(**) -0.397(**) -0.143 -0.236 -0.107 Motility in the native  
semen samples (%) p 0.003 0.074 . 0.000 0.008 0.348 0.118 0.484 
r 0.326(*) -0.282 0.233 -0.156 -0.004 0.382(**) -0.256 -0.031 Motility after  
semen preparation (%)  p 0.027 0.058 0.124 0.301 0.978 0.010 0.086 0.839 
r -0.264 -0.110 -0.594(**) 1.000 0.238 0.318(*) 0.322(*) 0.100 Vitality (%) Eosin test 
p 0.076 0.467 0.000 . 0.116 0.033 0.029 0.510 
r -0.107 -0.201 -0.397(**) 0.238 1.000 0.251 -0.251 0.008 Membrane integrity 
HOS-test (%)  p 0.485 0.185 0.008 0.116 . 0.100 0.096 0.956 
r 0.074 -0.360(*) -0.143 0.318(*) 0.251 1.000 -0.162 -0.123 Morphologically  
normal  sperm (%) p 0.629 0.015 0.348 0.033 0.100 . 0.288 0.419 
r -0.418(**) -0.042 -0.236 0.322(*) -0.251 -0.162 1.000 0.287 Chromatin 
condensation CMA3 
(%)  p 0.004 0.780 0.118 0.029 0.096 0.288 . 0.053 
r -0.292(*) -0.122 -0.107 0.100 0.008 -0.123 0.287 1.000 DNA Fragmentation –
TUNEL (%)  
p 0.049 0.419 0.484 0.510 0.956 0.419 0.053 . 
r -0.191 0.096 0.034 -0.048 0.090 0.032 0.077 0.219 DNA denatiuration (AO) 
(%) p 0.227 0.547 0.834 0.765 0.576 0.845 0.628 0.163 
r 0.192 -0.051 0.203 -0.163 -0.009 -0.347(*) -0.127 -0.112 ROS (µmol/l) 
p 0.201 0.738 0.181 0.280 0.953 0.020 0.401 0.460 
r 0.035 -0.154 -0.086 -0.130 0.307(*) 0.045 -0.143 -0.094 TAS (mmol/l) 
 p 0.820 0.306 0.573 0.390 0.040 0.768 0.344 0.532 
r 0.188 -0.028 0.022 0.084 0.023 -0.021 -0.204 -0.175 Fertilization rate 
p 0.210 0.853 0.887 0.579 0.883 0.889 0.175 0.245 
r -0.074 0.095 0.000 0.076 0.235 -0.096 -0.088 -0.215 Cleaved and 
transferred oocytes 
p 0.627 0.528 0.999 0.616 0.120 0.530 0.559 0.152 
r -0.066 0.059 0.070 -0.028 0.012 0.019 -0.072 -0.048 Pregnancy 
p 0.663 0.695 0.648 0.853 0.935 0.900 0.635 0.750 
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Tab:4b: Correlation coefficient of semen parameters and sperm quality of IVF/ICSI 
patients. 
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r -0.191 0.192 0.035 0.188 -0.074 -0.066 Sperm concentration (mill/ml) in the 
native semen   
p 0.227 0.201 0.820 0.210 0.627 0.663 
r 0.034 0.203 -0.086 0.022 0.000 0.070 Motility (%) in the native semen 
  p 0.834 0.181 0.573 0.887 0.999 0.648 
r -0.048 -0.163 -0.130 0.084 0.076 -0.028 Vitality (%) Eosin test  
p 0.765 0.280 0.390 0.579 0.616 0.853 
r 0.090 -0.009 0.307(*) 0.023 0.235 0.012 Membrane integrity (HOS) test (%) 
p 0.576 0.953 0.040 0.883 0.120 0.935 
r 0.032 -0.347(*) 0.045 -0.021 -0.096 0.019 Morphologically normal 
spermatozoa (%)   
p 0.845 0.020 0.768 0.889 0.530 0.900 
r 0.077 -0.127 -0.143 -0.204 -0.088 -0.072 Chromatin integrity (CMA3) 
  p 0.628 0.401 0.344 0.175 0.559 0.635 
r 0.219 -0.112 -0.094 -0.215 -0.048 0.115 DNA fragmentation (TUNEL) (%)  
  p 0.163 0.460 0.532 0.152 0.750 0.447 
r 1.000 -0.072 -0.148 -0.214 -0.033 0.124 DNA Denaturation (AO) (%)  
  p . 0.652 0.349 0.174 0.834 0.434 
r -0.072 1.000 0.033 0.275 0.059 -0.114 ROS (µmol/l) 
  p 0.652 . 0.828 0.064 0.696 0.451 
r -0.148 0.033 1.000 0.071 0.313(*) 0.086 TAS (mmol/l) 
  p 0.349 0.828 . 0.638 0.034 0.571 
r -0.211 0.275 0.071 1.000 0.192 -0.271 Fertilzation rate 
  p 0.180 0.064 0.638 . 0.200 0.069 
r -0.214 0.059 0.313(*) 0.192 1.000 0.019 Cleaved and transferred oocytes  
p 0.174 0.696 0.034 0.200 . 0.900 
r -0.033 -0.114 0.086 -0.271 0.019 1.000 Pregnancy 
  p 0.834 0.451 0.571 0.069 0.900 . 
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Figure 16: Scatter plot of correlation between sperm concentration (mill/ml) in the native 
semen samples and sperm membrane integrity (HOS-Test) of patients underwent IVF/ICSI 
therapy. A negative correlation, but non-significant, was found between sperm concentration 
in seminal plasma and membrane integrity in the of spermatozoa in the native semen 
samples (r=-0.201; p= 0.185). 
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Figure 17: Scatter plot of correlation between morphologically normal spermatozoa and 
chromatin condensation (non condensed sperm after chromomycin staining (CMA3) of 
patients underwent IVF/ICSI therapy. A negative non statistically significant correlation was 
found between  the mean percentage of the morphologically normal spermatozoa in the 
ejaculate and the mean percentage of condensed chromatin (r= -0.162; p=0.288) 
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Figure 18: Scatter plot of correlation between morphologically normal spermatozoa and 
reactive oxygen species concentration (µmol/l) in seminal plasma of patients underwent 
IVF/ICSI therapy. No negatively significant correlation was found between the mean 
concentration of ROS in seminal plasma and the mean percentage of morphologically normal 
spermatozoa (r=-0.347; p=0.020). 
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Figure 19: Scatter plot of correlation between the mean number of cleaved Oocytes 
(Embryo-transferred) and total anti oxidant (mmol/l) concentration in seminal plasma of 
patients underwent IVF/ICSI therapy. A statistically significant positive correlation was found 
between TAS concentration in seminal plasma and the mean number of cleaved (embryo 
transferred) oocytes (r=0.313; p=0.034). 
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Figure 20: Scatter plot of ccorrelation between DNA fragmentation (TUNEL) of spermatozoa 
and pregnancy of patients underwent IVF/ICSI therapy. The percentage of DNA 
fragmentation of spermatozoa correlated negatively, but statistically not significant; with 
pregnancy (r=-0.04; p=0.750).  
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Figure 21: Scatter plot of correlation between DNA denaturation (AO) of spermatozoa and 
pregnancy of patients underwent IVF/ICSI therapy. No statistically significant correlation was 
observed between DNA denaturation (AO)  in native semen samples and pregnancy 
achieved ( r= -0.033; p=0.834). 
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A total of 46 semen samples of smokers (n=11) and non-smokers (n=35) were analysed 
before and after processing by Pure Sperm gradient centrifugation techniques. The results 
are shown in table 5.  
The mean semen parameters were as follows: volume 3.5±1.3, concentration 
70.0±33.42mill/ml, motility 33.22±17.09% motility after semen processing 64.24±31.52%, 
morphology 16.9±18.4%, DNA integrity (CMA3) 16.7±8.23%, DNA fragmentation TUNEL 
11.15±7.04% and membrane integrity 48.89±23.0%. The mean concentration of ROS and 
TAS in seminal plasma was (52.58±27.7µmol/l and 1.29±0.68(mmol/l).(Tab.5). 
The mean number of retrieved oocytes was (5.22±4.52%) and the fertilizationrate and the 
clinical pregnancy rates were (55.40±24.67% and 32.6% respectively) (Tab.5). 
  80
Tab 5: Semen characteristic and sperm quality of smoker and non smoker patients 
underwent assisted reproduction technology program. 
Percentile 
 N M±SD 75. 25. 50 
Volume (ml) 46 3.478±1.27 2.875 3.500 4.500 
pH-value 46 8.659±0.32 8.500 8.700 9.000 
Sperm concentration (mill/ml) 46 70.00±33.42 50.00 75.00 101.00 
Sperm concentration after semen 
preparation 
46 39.55±31.786 14.25 31.00 56.25 
Motility (%)  45 33.22±17.095 20.00 30.00 47.50 
Motility after semen preparation (%)  46 64.24±31.517 38.75 80.00 90.00 
Vitality (Eosin-test) 46 67.83±18.02 57.50 70.00 80.00 
Membrane integrity (HOST-test) 45 48.89±23.00 30.00 50.00 65.00 
Morphologically normal spermatozoa (%) 45 16.89±18.38 4.00 10.00 20.50 
Chromatin condensation (CMA3) 46 16.74±8.231 11.50 15.00 20.00 
DNA Fragmentation TUNEL-Test 46 11.15±7.036 6.75 9.50 14.00 
DNA Denaturation (Acridine Orange-test) 
(AO) 
42 8.36±3.92 5.00 8.00 11.00 
ROS (µmol/l) concentration in seminal 
plasma 
46 52.58±27.77 33.08 44.04 74.347 
TAS-concentration (mmol/l) in seminal 
plasma 
46 1.29±0.681 0.953 1.38 1.757 
Cotinine (µg/dl) concentration in seminal 
plasma  
46 49.19±72.20 10.93 14.93 31.43 
Fertilized Oocytes 45 5.22±4.52 2.00 3.00 8.00 
Fertilization rate (%) 46 55.40±24.67 33.33 57.52 69.67 
Transfer 46 1.89±0.795 1.75 2.00 2.00 
Pregnancy (pregnancy rate)  43 14 (32. 6%)    
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In this study, the ejaculat volume (ml) was similar in both groups (3.66±1.2 vs. 3.04±1.4; 
p=0.365). Vitality of the spermatozoa, membrane integrity (HOS-test), chromatin 
condensation (CMA3), DNA fragmentation TUNEL and DNA denaturation (Acridine orange) 
in the native semen of smokers were (64.6±19.16%, 47.73±16.03%; 15.73±7.18; 12.82±7.9 
and 8.90±3.5) and the corresponding values in nonsmokers were (68.9±17.79; 49.26±25.04; 
17.06±8.61; 10.6±6.8 and 8.2±4.1 respectively). A non significant decline in these 
parameters in somker in comparison to non-smokers was observed. Therefor, a significant 
differences in standard sperm parameters (mean percentage of sperm, motility, percentage 
of sperm vitality, membrane integrity, chromatin condensation, DNA stand breaks and DNA 
naturation) between infertile smokers and infertile nonsmokers could not found. Differences 
in the ROS and TAS values among the infertile smokers (50.94±28.20 and 1.09±0.73) and 
nonsmoker  (53.1±28.03 and 1.35±0.66 ) groups were not statistically significant (Tab. 6).  
On there other side, sperm concentration in the ejaculate of smokers was significantly lower 
than non-smokers (50.7±39.2 vs. 76.16±29.5, p=0.006). Whereas seminal plasma cotinine 
levels were found to be significantly higher (p=0.001) in smokers versus non smokers 
(144.29±82.19 vs. 19.30±32.69µg/ml, p=0.001)). Likewise the mean percentage of of motile 
spermatozoa after semen preparation from smokers (61.36±33.09%) was significantly lower 
in comparison to non-smokers (65.14±31.44%, p=0.021). The mean percentage of cleaved 
and transferred embryos and the pregnancy rate was significantly lower in smokers group 
(1.91±0.70% and 27.3%) in comparison to non smokers (1.89±0.83% and 34%, p=0.001).  
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Tab. 6: Comparison between semen characteristics and semen quality of 
smoker and non smoker patients underwent assisted reproduction treatments. 
Semen characteristics Non-smoker 
35 
Smokers 
11 
P-value 
Volume (ml) 3.66±1.2 3.04±1.4 0.365 
Sperm concentration (mill/ml) of the native 
semen samples 
76.16±29.5 50.7±39.2 
0.006 
Sperm concentration (mill/ml) after Semen 
preparation. 
41.32±29.89 33.91±38.23 
0.412 
Motility in the native semen samples (%) 31.57±15.98 39.0±20.38 0.061 
Motility after semen preparation (%) 65.14±31.44 61.36±33.09 0.021 
Vitality in the native semen samples (%) 68.9±17.79 64.6±19.16 0.107 
Membrane integrity (HOS) in native semen (%) 49.26±25.04 47.73±16.03 0.140 
Morphologically normal spermatozoa (%) 16.06±18.53 19.80±18.52 0.018 
Chromatin condensation in the native semen 
sample (CMA3)  
17.06±8.61 15.73±7.18 
0.210 
DNA fragmentation (TUNEL) (%) 10.6±6.8 12.82±7.9 0.210 
DNA denaturation (Acridine orange) (%) 8.2±4.1 8.90±3.5 0.714 
ROS concentration[µmol/l] 53.1±28.03 50.94±28.20 0.197 
TAS concentration[mmol/l] 1.35±0.66 1.09±0.73 0.589 
Mean number of collected Oocytes 8.9±5.7 (312) 10.82±7.8 (119) 0.018 
Mean number of fertilized Oocytes 5.12±4.2 (174) 5.55±5.7 (61) 0.018 
Fertilization rate (%) 58.5±24.6 45.6±23.5 0.591 
Cleaved and transferred Oocytes 1.89±0.83 (66) 1.91±0.70 (21) 0.001 
Pregnancy (Pregnancy rate)  11 /32 (34%) 3/11 (27.3%) 0.001 
Cotinine (µg/dl) 19.30±32.69 144.29±82.19 0.001 
Statistically significant (p<0.05)  
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Figures (22-34) demonstrate  the standard semen parameters in both smoker and non-
smoker groups. 
Before semen processing the mean number of spermatozoa of non-smokers was 
significantly higher than for smokers (76.16±29.5 versus 50.7±39.2mill/ml)(Fig. 24).  
In addition, the mean number of motile spermatozoa in the native semen samples of non-
smokers and smokers group was similar (31.57 ±15.98% versus 39.0 ±20.30%; p=0.061) 
(Fig. 25). However, the mean percentage of motile spermatozoa of non-smoker group was 
increased significantly (p=0.021) after semen processing in comparison to the smokers 
(65.14±31.44% versus 61.36±33.09%). When the morphological distribution of spermatozoa 
was analysed, smokers spermatozoa had a significantly higher mean percentage 
(19.80±18.52%) of abnormal forms in comparison to non-smoker samples (16.06±18.53%; 
p= 0.018) (Fig.27). However, the percentage of DNA integrity (Chromomycin CMA3) was not 
different  between smokers and non smokers specimens (15.73±7.18% versus 17.06± 8.61% 
; p=0.210)(Fig. 28). No difference in other parameters were seen between smokers and non-
smokers group. Also, There was no statistically significant difference in the mean number of 
sperm concentration after semen processing and the motility, vitality (Fig. 23), and ROS 
(Fig.30), TAS concentration (Fig.31) in the native semen samples between smoker and non–
smokers group. The differences in sperm DNA damage, as assessed by Acridin orange and 
Tunel, between the infertile smokers and non smokers did not reach a statistically 
significance (Fig. 29).  
Cotinine is the main metabolit of nicotine was significantly higher (144.29± 82.19µg/dl) in the 
smoking than non smoking group (19.30±32.69  p= 0.001) (Fig.33).  
Besides, statistically significant difference were found in the mean number of fertilized  (Fig. 
32), cleaved oocytes and pregnancy rates. The ART success rate in 46 patients in term of 
clinical pregnancies in  women with smoking male partners was 27.3%; the rate was 34% 
with non-smoking patients group (Tab. 6 &; Fig. 34). 
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Figure 22: Box-and whisker-plots showing the mean, median, lower and  upper quartiles and 
range of semen volume (ml) of smoking and non-smoking men underwent IVF/ICSI therapy. 
The mean value of ejaculate volume was not different between smoker (3.04±1.4) and non- 
smoker group (3.66±1.2ml; p= 0.365) . 
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Figure 23: Box-and whisker-plots showing the mean, median and range of sperm vitality of 
the native semen samples of smokers and non smoker’s underwent IVF/ICSI therapy. No 
significant difference was found between the groups (64.6±19.16% versus 68.9±17.79%; 
p=0.107).  
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Figure 24: Box-and whisker-plots showing the mean, median, and range of sperm 
concentration in the native semen samples of smokers and non smokers underwent IVF/ICSI 
therapy. A statistically significant higher (p=0.006) sperm concentration could be found in 
non- smokers (76.16±29.5) in comparison to smokers (50.7±39.2). 
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Figure 25: Box-and whisker-plots showing the mean, median and range of sperm motility in 
the native semen samples of smokers (39.0±20.38) and non smokers (31.57±15.98 ) men 
underwent IVF/ICSI therapy. There was no signifant difference (p= 0.061) between the two 
investigated groups.  
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Figure 26: Box-and whisker-plots showing the mean, median and range of semen of 
membrane integrity (HOS-test) of spermatozoa in the native semen samples of smokers 
(47.73±16.03) and non smokers (49.26±25.04) underwent IVF/ICSI therapy. No statistical 
significance was observed between non-smoker and smoker group (p= 0.140).  
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Figure 27: Box-and whisker-plots showing the mean, median and range of morphologically 
normal spermatozoa in the native semen samples of smokers and non-smoker’s underwent 
IVF/ICSI therapy. The men percentage of morphologically normal spermatozoa was 
significantly higher (p=0.018) of spermatozoa of non-smoker (16.06±18.53%)  in comparison 
to smoker patients group (16.06±18.53%)  
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Figure 28: Box-and whisker-plots showing the mean, median and range of sperm chromatin 
condensation (CMA3) in the native semen sample of smokers and non smokers underwent 
ART therapy. The proportion of DNA denaturation (AO-test) was similar between smoker and 
non smoker group (8.2±4.1 VS; 8.90±3.5; p=0.714). 
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Figure 29: Box-and whisker-plots showing the mean, median and range of sperm DNA 
fragmentation (TUNEL) in the native semen sample of smokers and non-smokers underwent 
ART therapy, the proportion of DNA fragmentation (TUNEL-test) was not different between 
smoker and non smoker group (10.6±6.8 versus 12.82±7.9; p=0.210) . 
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Figure 30: Box-and whisker-plots showing the mean, median and range of semen ROS 
concentration (µmol/l) of smoking and non-smoking patients underwent IVF/ICSI therapy. No 
statistical significance (p=  0.197 )  was observed between non-smoker (53.1±28.03) and 
smoker group (50.94±28.20).  
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Figure 31: Box-and whisker-plots showing the mean, median and range of semen TAS 
concentration (mmol/l) of smoking and non-smoking patients underwent IVF/ICSI therapy. 
The mean concentration of TAS in seminal plasma differed non-significantly (p= 0.589) 
between non-smokers (1.35±0.66 mmol/l) and smokers group (1.09±0.73 mmol/l)  
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Figure 32: Box-and whisker-plots demonstate the mean, median, lower and upper quartiles 
and range of fertilization rate of smokers and non smokers group. The pregnancy rate was 
(p=34%) for non smokers and 27% for smokers, resulting in a significant difference between 
non-smokers and smokers (p=0.001). 
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Figure 33: Box–and-whisker plots indicate mean, median, lower and upper quartiles and 
range of semen cotinine concentration of smoking and non-smoking patients underwent 
IVF/ICSI therapy. In this study, the mean semen cotinine levels of smokers and non smokers 
were (144.29±82.19 vs. 19.30±32.69 mg/dl; p=0.001 mg/dl, respectively). 
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Figure 34: Pregnancy outcome of smokers and non-smokers patients underwent IVF/ICSI 
therapy. Eleven pregnancies out of 32 patients became transfer in the non smoker groups 
(34% pregnancy rate). However, in the smoker’s patient group only 3 pregnancies were 
achieved out of 11 patients who became transfer (27.3%). Also the pregnancy rate was 
significantly higher in non-smokers group in comparison to smoker group (p=0.0001). 
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Correlation of semen parameters of smoker patients are demonstrated in Table 7a, b. The 
vitality (Eosin test) showed a non-significant negative correlation with sperm motility (r=-
0.571; p=0.085), membrane integrity (r=-0.015; p=0.965), DNA fragmentation (r=-0.172; 
p=0.613), TAS concentration (r=-0.492, p=0.124), cleaved and transferred embryos (r=-
0.319; p=0.864) and pregnancy (r=-0.342; p=0.303). A more non significant negative linear 
trend could be shown in sperm motility and membrane integrity (r=0.252, p= 0.483) (Fig. 36), 
DNA integrity (CMA3) (r=-319; p=0.369) and Cotinine concentration (r=0.120; p=0.741). 
In addition, sperm membrane integrity (HOS-test) correlated negatively, but non-significant 
with sperm concentration (r=-0.117; p=0.731), DNA integrity (r=0.044; p= 0.899), ROS 
concentration (r=-550; p= 0.079), TAS concentration in seminal plasma (r=-0.270; p=421), 
fertilization rate (r= -0.265; p=0.430) (Fig. 41), cleaved rate (r=-0.059; p=0.864) (Fig.42) and 
pregnancy rate (R= -0.342; p=0.303). 
The mean percentage of morphologically normal spermatozoa demonstrated a negatively 
significant correlation with ROS concentration (r= -0.869; p=0.014), TAS concentration in 
seminal plasma (r=-0.742; p=0.014) and negatively non significant correlation with sperm 
motility (r=-0.104; p=0.776), DNA fragmentation (r=-0.401; p=0.250) and fertilization rate (r=-
394; p= 0.784) (Fig. 37)..A more non significant negative linear trend could be seen in sperm 
motility and membrane integrity (r=-0.252, p= 0.483) (Fig. 36), DNA integrity (CMA3) (r=-319; 
p=0.369) and Cotinine concentration (r=0.120; p=0.741). 
Moreover, a statistical significant negative linear trend in cotinine concentration in seminal 
plasma and sperm DNA fragmentation (TUNEL) was observed (r=-0.791; p=0.004). Besides, 
there were a statistically, non-significant, negative correlations between cotinine 
concentration in seminal plasma and sperm motility (r=-0.120; 0,741), DNA integrity (CMA3) 
(r=-0.058; p=0.865), total anti oxidant concentration (TAS) (r=-0.042; p=0.902), fertilization 
(r=-0.074; p=0.829) and pregnancy rate (r=-0.075; p=0.827) (Tab.7a,b). 
DNA fragmentation (TUNEL) correlate negatively with the following variable: Sperm vitality 
(r=-0.172; p= 0.613), morphologicaaly normal spermatozoa (r=-0.401; p=0.250), fertilization 
rate (r=-0.046; p= 0.894). Seminal plsam cotinine concentration demonstrated a significantly 
negative correlation (r=-0.791; p=0.004 ) with sperm DNA fragmentation (TUNEL) and a 
negative non significant correlation with sperm motility (r= -0.120; p=0.741); chromatin 
condensation (r=-0.058; p= 0.865), TAS concentration ( r=-0.042; p=0.902), fertilization rat 
(r=-0.074; p=0.829), cleavage rate (r=-0.372; p=0.259) and pregnancy rate (r=-0.075; 0.827) 
(Tab. 7a, b). 
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Seminal plasma ROS of smokers demonstrates significant negative correlation with  sperm 
morphology (r=-0.869; P=0.001) and TAS concentration (r= 0.753; p=0.007). Non significant 
correlations were elicited with semen concentration (r=-0.055; p=0.871), motility in the native 
semen sample (r= 0.358; p= 0.310) vitality (r=-0.306; p= 0.360) , membrane integrity (r=-
0.550; 0.079), Chromatin condensation CMA3 (r=0.137; p=0.687), DNA fragmentation 
(TUNEL) (r= 0.313; p=0.349) and cotinine concentration (r= -0.338; p= 0.310), fertilization 
and pregnancy rate (r=0.320; p= 0.338 und r=-0.291; p=0.385 respectively) 
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Table 7a: Correlation of semen parameters of smoker patients (n=11). 
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-0.481 1.000 0.429 0.443 -0.117 0.315 -0.132 0.016 Sperm concention 
(ml) in native 
semen 0.134 . 0.217 0.172 0.731 0.376 0.699 0.962 
0.071 0.429 1.000 -0.571 -0.252 -0.104 -0.319 0.092 Motility in native 
semen (%) 
0.845 0.217 . 0.085 0.483 0.776 0.369 0.801 
-0.557 0.443 -0.571 1.000 -0.015 0.420 0.224 -0.172 Vitality Eosin (%) 
0.075 0.172 0.085 . 0.965 0.227 0.508 0.613 
-0.552 -0.117 -0.252 -0.015 1.000 0.437 -0.044 0.208 Membrane integrity 
(HOS) (%) 
0.078 0.731 0.483 0.965 . 0.206 0.899 0.540 
-0.554 0.315 -0.104 0.420 0.437 1.000 0.201 -0.401 Morphologically 
normal sperm (%) 
0.097 0.376 0.776 0.227 0.206 . 0.577 0.250 
-0.234 -0.132 -0.319 0.224 -0.044 0.201 1.000 0.156 Chromatin 
Condensation. 
(MA3) .489 0.699 0.369 0.508 0.899 0.577 . 0.648 
-0.392 0.016 0.092 -0.172 0.208 -0.401 0.156 1.000 DNA fragmentation 
Tunel -test 0.232 0.962 0.801 0.613 0.540 0.250 0.648 . 
0.438 -0.055 0.358 -0.306 -0.550 -0.869(**) 0.137 0.313 ROS (µmol/l) 
0.178 0.871 0.310 0.360 0.079 0.001 0.687 0.349 
1.000 -0.139 0.174 -0.492 -0.270 -0.742(*) 0.101 0.205 TAS (mmol/l) 
. 0.684 0.630 0.124 0.421 0.014 0.768 0.544 
0.168 0.208 -0.120 0.196 0.045 0.451 -0.058 -0.791(**) Cotinine (mg/ml) 
0.621 0.539 0.741 0.564 0.896 0.191 0.865 0.004 
0.129 0.178 -0.305 0.532 -0.265 -0.394 -0.094 -0.046 Fertilization rate (%) 
0.706 0.601 0.392 0.092 0.430 0.260 0.784 0.894 
0.321 -0.176 0.321 -0.319 -0.059 -0.461 -0.174 0.227 Cleaved and 
transferred oocytes 
0.366 0.605 0.366 0.338 0.864 0.180 0.609 0.503 
-0.132 -0.065 0.268 -0.200 -0.342 0.342 0.032 -0.226 Pregnancy 
0.698 0.848 0.455 0.555 0.303 0.334 0.925 0.503 
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 Table. 7b: Correlation of semen parameters of smoking patients (n=11). 
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0.016 -0.593 -0.055 -0.139 0.208 0.178 -0.176 -0.065 Sperm concentration 
in native semen 
(mill/ml) 0.962 0.071 0.871 0.684 0.539 0.601 0.605 0.848 
0.092 0.416 0.358 0.174 -0.120 -0.305 0.321 0.268 Motility in the native 
semen(%) 
0.801 0.265 0.310 0.630 0.741 0.392 0.366 0.455 
-0.172 -0.720(*) -0.306 -0.492 0.196 0.532 -0.319 -0.200 Vitality (%) Eosin 
0.613 0.019 0.360 0.124 0.564 0.092 0.338 0.555 
0.208 0.114 -0.550 -0.270 0.045 -0.265 -0.059 -0.342 Membrane integrity 
(HOS) (%) 
0.540 0.753 0.079 0.421 0.896 0.430 0.864 0.303 
-0.401 -0.050 -0.869(**) -0.742(*) 0.451 -0.394 -0.461 0.342 Morphologically 
normal sperm (%) 
0.250 0.898 0.001 0.014 0.191 0.260 0.180 0.334 
0.156 0.160 0.137 0.101 -0.058 -0.094 -0.174 0.032 Chromatin 
condensation (CMA3) 
0.648 0.660 0.687 0.768 0.865 0.784 0.609 0.925 
1.000 -0.055 0.313 0.205 -0.791(**) -0.046 0.227 -0.226 DNA Fragmentation 
TUNEL-test (%) 
. 0.880 0.349 0.544 0.004 0.894 0.503 0.503 
0.313 0.239 1.000 0.753(**) -0.338 0.320 0.491 -0.291 ROS (µmol/l) 
0.349 0.507 . 0.007 0.310 0.338 0.125 0.385 
0.205 0.260 0.753(**) 1.000 -0.042 0.237 0.441 -0.323 TAS (mmol/l) 
0.544 0.468 0.007 . 0.902 0.482 0.175 0.332 
-0.791(**) -0.240 -0.338 -0.042 1.000 -0.074 -0.372 -0.075 Cotinine (mg/dl) 
0.004 0.504 0.310 0.902 . 0.829 0.259 0.827 
-0.199 -0.379 -0.065 0.044 0.139 0.896(**) 0.183 -0.327 Fertilized oocytes 
0.558 0.280 0.850 0.898 0.684 0.000 0.589 0.326 
-0.046 -0.165 0.320 0.237 -0.074 1.000 0.438 -0.453 Fertilization rate (%) 
0.894 0.648 0.338 0.482 0.829 . 0.178 0.162 
0.227 0.523 0.491 0.441 -0.372 0.438 1.000 -0.392 Cleaved and 
transferred oocytes 
0.503 0.121 0.125 0.175 0.259 0.178 . 0.232 
-0.226 0.191 -0.291 -0.323 -0.075 -0.453 -0.392 1.000 Pregnancy 
0.503 0.597 0.385 0.332 0.827 0.162 0.232 . 
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Figure 35: Scatter plot demonstrate the correlation between ROS concentration in seminal 
plasma and the percentage of morphologically normal spermatozoa in both groups (r=-0.347; 
p=0.020), in smokers (r=-0.869; p= 0.001) ) and non smokers group (r=-0.228; p=0.188) of 
patients underwent IVF/ICSI therapy. 
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Figure 36: Scatter plot of correlation between sperm membrane integrity of smokers, non 
smokers and motility of patients underwent IVF/ICSI therapy. There was an inverse 
correlation between sperm motility and sperm membrane integrity not only by smoker groups 
(r=- 0.252; p= 0.483) but also by non-smokers too (r= -0.450; p=0.007).  
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Figure 37: Scatter plot of correlation between morphologically normal spermatozoa of 
smokers, non smokers and motility of patients underwent IVF/ICSI therapy. A negative non 
significant correlation was observed between the morphologically normal spermatozoa and 
the mean percentage of motile spermatozoa in the native semen samples of smokers (r= -
0.104; p=0.776) and non –smokers group (r=-0.158; p=0.365).  
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Figure 38: Scatter plot demonstrate the correlation between DNA integrity (CMA3) of 
spermatozoa and fertilization rate in both groups (r=-0.204; p=0.175), in smokers (r=-0.094; 
p= 0.784) ) and non smokres group (r=-0.263; p=0.126) of patients underwent IVF/ICSI 
therapy. 
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Figure 39: Scatter plot demonstrate the correlation between cotinine concentration in seminal 
plasma and fertilization rate in both groups (r=-0.107; p=480), smoker ( r= -0.074; p=0.829), 
non smokers (n=-0.048; 0.786) of patients underwent IVF/ICSI therapy. 
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Figure 40: Scatter plot of Correlation between ROS concentration in seminal plasma of male 
partners of women underwent IVF/ICSI therapy and the fertilization rate of the oocytes. 
Statistically non significant positive correlation was observed between the ROS concentration 
and fertilization rate (r=0.320; p=0.338). Whereas, a negative correlation was shown 
between ROS concentration in seminal plasma and the mean number of fertilized oocytes ( 
r=-0.065; p= 0.850). 
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Figure 41: Scatter plot of correlation between TAS concentrations in seminal plasma of male 
partners of women underwent IVF/ICSI therapy and the fertilization rate of the Oocytes. A 
significant positive correlation between TAS concentration in seminal plasma of smokers 
(r=0.237; p= 0.482) and fertilization rate has been shown. 
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Figure 42: Scatter plot of correlation between TAS concentrations in seminal plasma of male 
partners of women underwent IVF/ICSI therapy and the cleaved Oocytes (Transferred 
Embryos). There was a positive, non significant, correlation between TAS concentration in 
seminal plasma and the mean number of cleaved oocytes in smoker (r=-0.441; p=0.175) and 
non smoker (r=0.269; p=0. 119).  
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6- Discussion 
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Normal spermatozoa are considered those that successfully undergo a number of steps 
necessary for fertilization of the oocyte. When the spermatozoa are unable to lead to natural 
fertilization of an oocyte and nucleolus formation, then we talk about impaired sperm 
function. Oxidative damage to spermatozoa, induced by excessive production of free 
oxidants or impairment of the native antioxidant mechanisms, has been identified as a 
parameter of male subfertility (Sikka et al., 1995). Nevertheless, reactive oxygen species 
have been associated with the pathology of numerous diseases. Small controlled amounts of 
ROS are vital for sperm maturation and development into normal spermatozoa capable of 
fertilization (Gagnon et al., 1991; Aitken et al., 1997; Aitken., 1999). In addition, de 
Lamirande et al. and Zini et al. reported that H
2
O
2
 and O
2
- promote sperm capacitation and 
acrosome reaction, as well as that H
2
O
2
 promotes hyperactivation and oocyte fusion (Zini et 
al., 1996; de Lamirande and Gagnon1993a). Therefore, hydrogen peroxide and superoxide 
anion are of great importance to spermatozoa, necessary for controlling the tyrosine 
phosphorylation events associated with sperm capacitation (Aitken et al., 1991; Aitken et al., 
1998a). Additionally, ROS are produced by leukocytes, which are present in the male 
reproductive system and in the ejaculate, as a result of their role in the immunological 
defense against pathogenic germs (Henkel., 2005; Tomlinson et al., 1992). Only in case of 
excessive production of ROS or malfunction of the native antioxidant-production 
mechanisms, do the free radicals cause problems, by putting the several tissues under 
oxidative stress (OS) (Aitken ., 2005; Balercia et al., 2003; Agarwal et al., 2003). The function 
of controlling excessive production of ROS is carried out by antioxidants (Young and 
Woodside 2001) present in the seminal plasma (Henkel., 2005; Armstronng et al., 1998; 
Sies., 1993). A number of reports have discussed the  
possible origin of antioxidants in semen, but our knowledge on that is still limited. Some of 
the studies supported the testicular origin of semen antioxidants, while others have 
presented evidence that the source of antioxidant activity is post-testicular. Therefore, 
eexcessive ROS production that exceeds critical level can overwhelm all antioxidant defence 
systems of spermatozoa and seminal plasma causing oxidative stress (de Lamirande et al., 
1997; Sikka, 2001). Also, oxidative stress when oxidants outnumber antioxidant (Sies, 1993). 
It is an imbalance between levels of ROS production and antioxidants protection in semen. 
Therefore, assessment of oxidative stress requires the measurement of total antioxidant 
capacity (TAC) and ROS production. Infertile men with male factor or idiopathic diagnosis 
had significantly lower ROS –TAC scores than controls (Sharma et al., 1999).  
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6.1. The relationship between ROS level in seminal fluid and sperm 
quality and IVF/ICSI outcome.  
  
ROS are related to poor sperm parameters such as progressive motility, vitality and 
morphology; they are supposed to be produced by morphologically abnormal spermatozoa 
(Iwasaki and Gagnon, 1992). According to Aitken et al (1998b) reactive oxygen metabolites 
are known to disrupt sperm DNA integrity. According to their study, as the level of oxidative 
stress increased, the spermatozoa exhibited significantly elevated levels of DNA damage 
(p<0.001). Fragmentation of DNA caused by free radical attack induces activation of the poly 
(ADP ribose) synthetase enzyme. This splits NAD+ to aid the repair of DNA. However, if the 
damage is extensive, NAD
+
 levels may become depleted to the extent that the cell may no 
longer be able to function and will die.The relative proportion of ROS–producing immature 
sperm was directly correlated with nuclear DNA damage value in mature sperm and 
inversely correlated with recovery of motile, mature sperm. This led to the hypothesis that 
oxidative damage of mature sperm by ROS-producing immature sperm during their co-
migration from seminiferous tubules to the epididymis may be an important cause of male 
infertility (Agarwal, 2004).  
Increased generation of ROS resulted in a marked decline in sperm motility; the peroxidation 
of polyunsaturated fatty acids (PUFAS) in membrane lipids is one frequently cited 
mechanism for the decline in sperm motility after exposure to oxidative stress (Aitken et al., 
1989, 1998; Armstrong et al., (1999). De Lamirande and Gagnon (1992) suggested that the 
inhibition of sperm motility after incubation with ROS was caused by a depletion of ATP  
In the present study, sperm concentration (75.5±31.9 vs. 49.6±39.5 mill/ml p<0.013), motility 
(39.3±18.16 vs.22.2±12.9% p<0.0012), morphology (14.0±15.8 vs. 10.4±10.3%) vitality 
(58.8±21.8 vs. 71.2±22.1%), and the mean percentage of non condensed chromatin 
(17.8±9.6 vs. 30.9±20.5%) were significantly better in IVF group in comparison to ICSI group 
(Tab.3). Remarkably, the concentration of ROS in seminal plasma was higher in IVF than 
ICSI patients group (73.78± 74.37 vs. 50.84±34.63) (Tab. 3; Fig 11). Though these 
differences were not statistically significant (p= 0.130). Mazilli et al., (1994) found significantly 
high levels of superoxide anion in 87% and 55% of infertile and fertile normospermic patients 
respectively.   
ROS (in both groups, IVF/ICSI) were negatively correlated; but not significant, with vitality of 
the spermatozoa (r=-0.163, p=0.280), membrane integrity (r=-009, p=0.953), morphology (r=-
0.347, p=0.020), Tunel (r=-0112, p=0.460) and pregnancy (r=-0.114, p=0.451) (Tab. 4a,b). 
However, In IVF groups a correlation (but not significant) was found between ROS 
concentration in the seminal plasma and sperm concentration (r=-0.105, p=0.435, motility 
(r=-0.047; p= 0.726), morphology (r=-308; p=0.020), chromatin condensation (r=-0.072; 
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p=0.595), fertilization rate (r=0.047, p=0.733) and pregnancy (r=-0.009; p= 0.719). (Tab.8a b 
Appendix ). this is in agreement with our previous studies (Hammadeh et al., 2006).  
Similar correlation was registered in ICSI group. Also, ROS concentration in seminal fluid 
was negatively significant correlated with sperm concentration (r=-0.357, p=<0.030) and 
none significantly with motility (r=-0.116; P=0.499) (Tab. 9 Appendix). These results are in 
accordance with those of (Zorn et al., 2003) who found that ROS concentration in seminal 
fluid was negatively correlated with progressive motility, normal morphology and positively 
with abnormal sperm head morphology. ROS can directly damage spermatozoa by inducing 
peroxidation of the lipid–containing sperm plasma membrane and may also affect sperm 
motility by damaging the axonemal structure (Saleh et al., 2002).   
  
In addition, during sperm preparation in assisted reproductive techniques, ROS generation 
by defective spermatozoa can be increased by the removal of seminal plasma which has 
endogenous antioxidant mechanisms. Centrifugation of sperm during preparation also plays 
a role in rapid production of ROS (Gagnon et al, 1991) and may enhance the generation of 
ROS 2-5 fold above baseline, within 5 minutes, which can damage sperm membrane and 
DNA. Oxidative stress has also been correlated with high frequencies of single and double 
DNA strand breaks (Twigg et al., 1998a: b; Aitken and Krausz, 2001). Sperm are particularly 
susceptible to oxidative stress due to
 
the high content of unsaturated fatty acids in their 
membranes,
 
as well as their limited stores of antioxidant enzymes ( Baker and Aitken, 2005 ).  
Infertile men with poor sperm
 
motility and morphology have increased DNA fragmentation 
compared
 
with individuals with normal semen parameters ( Lopes et al, 1998b; Irvine et al., 
2000; Zini et al,  2001a, b). 
In many studies, the packaging quality of sperm chromatin in
 
connection with fertility status 
has been assessed by staining
 
the sperm with CMA
3
 fluorochrome. A correlation has been 
reported
 
to exist between abnormal sperm chromatin packaging as evaluated
 
by CMA
3
 
staining, and the presence of DNA strand breaks, decreased
 
sperm penetration, the absence 
of sperm decondensation within
 
the oocyte and IVF and ICSI failure (Sailer et al., 1995; Nasr-
Esfahani et al., 2001; Esterhuizen et al.,
 
2002; Razavi et al., 2003).
 
 
In addition, Gopalkrishnan et al ( 1999 ) observed greater than 50% green fluorescence in 
samples from fertile
 
donors and used this as a normal cut-off value for Acridine orange 
staining test (AOT). Hoshi
 
et al ( 1996 ) also reported that in vitro fertilization (IVF)
 
was 
successful when sperm exhibited more than or equal 50%
 
green Acridine orange 
fluorescence and no pregnancies were obtained when
 
green-fluorescing sperm were less 
than 50% even though an average
 
26% of Oocytes were able to be fertilized using 
intracytoplasmic
 
sperm injection (ICSI). Therefore, Sperm DNA fragmentation is being 
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recognized as an important cause of infertility. In vitro fertilization of metaphase II Oocytes 
with spermatozoa that have damaged DNA could potentially lead to failed fertilization, 
defective embryo development, implantation failure, or early abortion (Genesca et al., 1992; 
Parinaud et al., 1993; Evenson et al., 1999).  
Besides, many clinical studies indicated that DNA fragmentation levels above 30% measured 
by the Sperm Chromatin Structure Assay (SCSA) are not compatible with the initiation and 
maintenance of a term pregnancy (Larson et al., 2000c). Other demonstrated that, 
production of ROS positively correlates with the sperm deformity index, calculated by dividing 
the total number of deformities observed by the number of sperm evaluated (Aziz et al., 
2004). Moreover, Said et al. (2005) suggest that Sperm deformity index (SDI) may be a 
useful tool to detect the prevalence of sperm DNA damage and to identify potential infertile 
men. Infertile patients with semen sample containing high proportion of morphologically 
abnormal spermatozoa and specifically those with cytoplasm droplets may be more 
susceptible to develop ROS–mediated sperm DNA damage (Said et al., 2005). In the current 
study, the mean percentage of non condensed chromatin (CMA
3
) significantly higher of 
spermatozoa of ICSI patients than those of IVF patients (30.97±20.50 vs. 17.81±. 9 64%; 
p=0.001). In addition, DNA denaturation (AO) and DNA fragmentations were higher in ICSI 
than in IVF (Tab. 5). And correlate negatively with fertilization and pregnancy rate (Tab. 3; 
Fig. 9; 10). 
Besides, the main percentage of stained spermatozoa with Chromomycin (CMA
3
) of IVF 
patients correlate significantly negative with sperm concentration (r=-0.424; p=0.001), and 
fertilization rate (r=-0.324; p=0.014) (Tab.8a,b Appendix). In ICSI patient groups a negative 
significant correlations were found between CMA
3
 and sperm motility (r=-0.0333; p=0.048), 
morphologically normal spermatozoa (r=-0.472; mp=0.004) and pregnancy rate (r=-0.550; p= 
0.018). Other authors did not observe any difference between IVF and ICSI in case of 
spermatozoa DNA fragmentation (Ahmadi and Ng, 1999, Host et al., 2000, Zitzmann et al., 
2003) (Tab. 9a,b).   
Spermatozoa with DNA fragmentation can fulfill the fertilization of the Oocytes, but the 
following steps leading to pregnancy may be disturbed. This explains the negative 
correlations of the Tunel with fertilization rate(r= -0.175; p=0.0245) (Tab.4a,b) and with the 
number of pregnancy of both IVF/ICSI program (r=-0.048; p=0.750). Therefore, our data 
showed no correlation between sperm DNA integrity and percentage of morphologically 
normal spermatozoa(r=-0.0162; p=0.288) (Fig. 17) and sperm concentration (r=0.074; 
p=0.629) and confirm previously reported results (Muratori et al., 2000; Tomlinson et al., 
2001). Moreover, these results confirm the previous results of Pasqualotto et al. (2000) who 
found that male partners of couples who achieved pregnancy did not have significantly 
different ROS-TAS scores than controls (Pasqualotto et al., 2000).   
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6.2. TAS concentration in seminal plasma and sperm quality and 
IVF/ICSI outcome.  
  
Mammals have evolved several mechanisms to suppress oxidative stress and minimize 
damage by ROS (Halliwell and Gutteridge, 1998). The enzyme system scavenges harmful 
ROS before they have an opportunity to react with other important molecules and terminates 
the subsequent chain reaction. The concentration of vitamin E in sperm membranes was 
lower in sample with poor motility and was inversely correlated with the concentration of 
leukocytes in the semen (Therond et al., 1996).  
The other system (low molecular weight compounds such as vitamins is a reduction –
oxidation (redox) system that not only functions to detoxify harmful oxidations but reductively 
repairs oxidized molecules as well. However, both systems are involved in cross-talk and are 
not clearly separated (Tanaka et al., 2000). The enzyme scavengers and low–molecular 
weight antioxidant make-up the total antioxidant capacity of seminal plasma (Smith et al., 
1996) Therefore, seminal plasma contain a high concentration of some organic substances 
and enzymes such as fructose, citric acid, glycerylphosphocholine, acid phosphates, 5-
nucleotidase and ascorbic acid. Human seminal plasma contains about 10mgdl
-1
 ascorbic 
acid, which is considerably more than that in the human blood plasma (range: 0.6–2.5mg/dl) 
(Dawson et al., 1992).  
Previous research has shown that seminal superoxide dismutase, catalase, glutathione 
peroxidase and sulfhydryl group levels are significantly lower in infertile patients than those in 
controls, thus, clearly indicating their direct implication in male fertility (Nakamura et al., 
2002). In other studies (Zalata et al., 1995; Smithet al., 1996; Potts et al., 1999) showed that 
fertile males have higher antioxidant capacity than infertile controls, suggesting that 
antioxidant capacity impairment may play a key role in infertility. However, previously 
published data on the effect of antioxidant on sperm concentration, motility, and morphology 
are contradictory (Review in Agarwal, 2004).  
In the present study, no significant difference could be found between IVF and ICSI patients 
group with regard to the concentrations in seminal plasma of total antioxidant level TAS 
(1.36.52 vs. 1.42±0.51 mmol/l, p=0.153), zinc (131.0±77.47 vs.127.3±60.16, p=0.992) 
selenium (3.412E-2±1.681E-02 vs3.614E-02±8.481E-03) (Tab. 3). These results are in 
accordance with those of Greco et al., (2005). Who found no difference in basic semen 
parameters between groups of male treated with antioxidant and those of placebo group 
controlled before and after treatment. However, the percentage of DNA–fragmented 
spermatozoa was significantly reduced (p<0.001) in the antioxidant treatment group after the 
treatment. An improvement of basic sperm parameters by oral treatment with antioxidants 
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has been reported in a number of studies (reviewed in Agarwal, 2004). However, DNA 
damage has been investigated in a few studies and a direct assessment for the detection of 
DNA strand breaks was not used (Geva et al., 1996; Suleiman et al., 1996; Comhaire et al., 
2000). In the present study, an adverse negative correlation was observed between total 
antioxidants concentration, motility (r=-0.086; p=0.573) and the main percentage of 
fragmented DNA assessed by TUNEL (r=-112; p=0. 460) or Acridine orange (r=-0.148; 
p=0.349) (Tab. 4a,b). Besides, TAS concentration in seminal plasma correlate significantly 
positive with sperm membrane integrity (r= 0.307; p= 0.04), fertilization rate (Tab.4a,b) 
oocyte cleavage rate (transfer rate) (r=313; p= 0.034).  
On the other hand, Zinc levels in seminal plasma have been positively associated with sperm 
concentration and motility in some studies (Fuse et al., 1999; Chia et al., 2000), but not 
others (Lewis-Jones et al., 1996). Twigg et al. (1998a, b) examined the use of specific 
antioxidants in order to reduce the oxidative stress of spermatozoa, they showed that 
albumin was effective in reducing NADPH induced oxidative stress, it failed to protect against 
the resultant DNA damage but was beneficial in reducing DNA fragmentation. Furthermore, 
in vitro studies have demonstrated a protective effect of several antioxidants on sperm DNA 
integrity (Twigg et al., 1998a, b; Donnelly et al., 1999; Dobrzynska et al., 2004). Fraga et al 
(1991) found that seminal plasma levels of vitamin C were directly associated with the level 
of oxidative damage in human sperm DNA. Tikkiwal et al. (1987) showed an improvement in 
sperm count and the number of progressive motile and normal sperm after oral intake of 89 
mg zinc sulphate for four months (n=14; idiopathic oligospermia males). Besides, three 
pregnancies occurred during the study. When taking all together as a composite score, 
antioxidant intake was positively related to sperm concentration, motility, and progressive 
motility (Eskenazi et al., 2005). However, zinc intake was somewhat negatively associated 
with volume (Eskenazi et al., 2005).  
In addition, serum selenium is reported to be lower in men with oligospermia and 
azoospermia than in controls (Krsnjavi et al., 1992). Many authors have shown an 
association between high seminal plasma selenium with impaired sperm motility in human 
(Bleau et al., 1984; Takasaki et al., 1987; Hansen and Deguchi, 1996). A significant inverse 
correlation was observed between7-hydro-8-oxy2-Deoxyguanosin [8-OHdG] (a Marker of 
DNA fragmentation) and selenium concentration (r=-0.40, p<0.01). This result indicates that 
selenium could protect against oxidative DNA damage in human sperm cells (Xu, et al., 
2001). In another study Vezina et al. (1996) demonstrated that the combination of vitamin E 
and selenium significantly increases sperm motility and the overall percentage of 
morphologically normal spermatozoa. Also, the sperm quality was significantly better in IVF 
group in comparison to ICSI group, however, the fertilization rate was higher in ICSI than in 
IVF group (50.56±28.89% vs. 59.23±26.47%; p= 0.124). These values failed to achieve 
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statistically significance. The cleavage rate and the mean number of embryos transferred in 
ICSI group was significantly higher (p=0.036) than those in IVF group (2.41±0.82 vs. 
1.77±0.86 respectively). The pregnancy rate was similar in both groups. In the IVF group 18 
patients became pregnant (31.5%) in comparison to 11 pregnancies in ICSI group (29.7%) 
The results of the present investigation also revealed that low quality spermatozoa used for 
intracytoplasmic sperm injection could achieve similar fertilization rate like good quality 
spermatozoa used for IVF.  
6.3. Smoking and male infertility  
Cigarette smoking is a serious health problem of most societies. Consumption of tobacco 
exerts widely adverse effects on different aspects of health (O'Dowd, 2006). Studies about 
the relation between smoking and semen quality reveal conflicting results. The production 
and function of healthy normal spermatozoa was affected by the number of cigarettes 
smoked per day, the years of smoking and the level of nicotine by-products present in the 
body fluids, which correlate negatively with semen and sperm quantity and quality (Zavos, 
1989; Chi et al., 1994a; b). More specifically, a number of studies have shown a positive 
correlation between male smoking and decreased concentration and impaired motility and 
morphology (Evans et al., 1981, Handelsman et al., 1984, Mak et al., 2000, Sofikitis et al., 
1995). Taszarek et al. (2005) and Agarwal et al. (2005) demonstrated that cigarette smoking 
alters semen quality, which could worsen the fertilizing capability in infertile men. On the 
contrary, other studies have not found any significant association between smoking and male 
infertility (Vogt et al., 1986; Dikshit et al., 1987, Vine et al., 1996; Trummer et al., 2002). The 
average values of conventional sperm parameters (sperm density, motility, normal 
morphology, viability) were normal (Sepaniak et al., 2006). Moreover, there was not even a 
trend to an alternation of these conventional parameters in smokers, as has been suggested 
by other (Zavos et al., 1998; Wong et al., 2000).   
6.3.1.1. EFFECTS OF SMOKING ON SEMEN VOLUME  
  
The first variable assessed in a common sperm analysis is the semen volume, and therefore 
several subsequent studies have included that in their assessment of tobacco influence on 
male fertility.  
In 1987, Saaranen et al carried out a study on the effect of smoking on conventional semen 
parameters and especially sperm motility, by assessing men of reproductive age. They found 
that there was an effect of smoking on semen volume and specifically, sperm volume of 
heavy smokers was significantly lower than that of non-smokers (Saaranen et al., 1987). 
However, the same year, Dikshit et al studied tobacco chewers, tobacco smokers and 
controls and found only a small, statistically insignificant effect of tobacco on semen volume 
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(Dikshit et al., 1987). Four years later, Holzki et al, after assessing 90 healthy patients (50 
non- and 40 smokers), showed that smokers had significantly smaller semen volumes 
compared to non-smokers (Holzki et al., 1991), a result which was in agreement with that of 
Saaranen in 1987.  
Following Holzki et al in 1992, Osser et al performed a dose-dependent study on the effect of 
smoking on sperm parameters. Although they did not find any negative effect of tobacco on 
most conventional semen parameters, they noticed, however, a dose dependent deleterious 
effect of tobacco on semen volume and sperm counts (Osser et al., 1992). Two years later, 
Chia et al studied the effects of cadmium concentrations in blood and semen and smoking on 
semen quality and found that cadmium concentration in seminal plasma was negatively 
correlated with years of smoking and semen volume. Given that cadmium is a component of 
cigarettes, they suggested that smoking might be partially responsible for decreased semen 
density and volume (Chia et al., 1994b). Their results supported by second study they carried 
out in the same year (Chia et al., 1994a).  
Four years later, Chia et al conducted another study on Singapore males to assess again the 
effect of smoking on sperm parameters; most male subjects had normal sperm parameters, 
according to WHO guidelines, namely, normal values for volume, concentration, motility and 
viability. Their results showed that cigarette smoking was significantly negatively associated 
with sperm volume, because smoking males presented lower semen volumes than those 
who did not smoke or had no history of smoking (Chia et al., 1998). These results of Chia et 
al were supported by another study in 2000 by Zhang et al, who performed a study on 
infertile males in Shandong Province, China. They concluded that cigarette smoking had a 
detrimental effect on semen volume of smoking infertile males, compared to non-smoking 
infertile and control fertile ones (Zhang et al., 2000).  
Pasqualotto et al carried out a study in 2005, assessing the effect of smoking on the semen 
variables and concluded that male smoking does not significantly impair the usual sperm 
parameters, namely, concentration, motility and morphology. However, they found that 
sperm volume if affected by smoking in a dose-depended manner. More precisely, sperm 
volume declined significantly between non-, mild, moderate and heavy smokers, with a mean 
2.8ml, 2,4ml, 2,3ml and 2.1ml respectively (Pasqualotto et al., 2005).  
Additionally, Sobreiro et al., in 2005 evaluated the effect of smoking, among other 
parameters, on semen characteristics of 500 fertile men, who attended a clinic for vasectomy 
for sterilization purposes. These men were asked to provide samples before the vasectomy 
and the groups results showed that smoking has no influence on semen parameters 
whatsoever (Sobreiro et al., 2005). On the contrary, Ramlau-Hansen et al presented an 
overall study one year later, which supported that there is an inverse dose-response relation 
between smoking and semen volume. This study incorporated seven separate occupational 
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or environmental semen studies performed from 1987 to 2004, resulting in a total of 2562 
men evaluated (Ramlau-Hansen et al., 2006).  
In the present investigation, no significant difference (p=0.365) in the ejaculate volume 
between smokers (3.04±1.39ml) and non smoker groups (3.66±1.2ml) (Tab. 6; Fig 22).  
  
6.3.1.2. EFFECT OF SMOKING ON SPERM CONCENTRATION.  
  
Decreased sperm concentration due to smoking has also been reported (Chia et al., 1994a; 
b.; Handelsman et al., 1984) but there are also contradictory results in this regard (Dikshit et 
al., 1987).  
Osser et al., (1992) have also found no statistically significant effects of cigarette smoking on 
sperm density. However, the difference was disclosed between heavy smokers and non-
smoking men (Goverde et al 1995).  
Other several investigators have evaluated the effect of cigarette smoking on sperm 
concentration (Sofikitis et al., 2000, Wong et al., 2000, Zhang et al., 2000). In 2001, Wang et 
al studied the semen parameters of men that worked at petrochemical plants, smokers and 
non smokers and compared them with non-smoking/not exposed controls. Their findings 
showed that males that were not exposed and smoked regularly had significantly decreased 
sperm density compared to control subjects who did not smoke and were also not exposed 
to any petrochemicals (Wang et al., 2001).  
An association between cigarette smoking and sperm density (10
6
/ml) was found to exist 
according to the investigation carried out by Kunzle et al (2003). The men they included in 
their study had attended the infertility clinic with their couple, seeking for causative factors 
concerning their infertility issues and the overall result was a significant decrease in sperm 
density of smoking males, compared to non-smoking controls (Kunzle et al., 2003). One year 
later, several published studies have conquered and supported the fact that tobacco smoking 
significantly affects semen quality (Chen et al., 2004, Marinelli et al., 2004, Martini et al., 
2004, Pasqualotto et al., 2005, Stutz et al., 2004).  
In more detail; Martini et al showed that tobacco smoking does not significantly alter semen 
parameter. However, smoking in combination with alcohol consumption was found to alter 
semen parameters in general and decreased sperm concentration in particular (Martini et al., 
2004). Stuzt et al also supported the detrimental effect of tobacco smoking on semen 
parameters, although their study concluded that alcohol and tobacco nonsignificantly 
reduced sperm concentration (Stutz et al., 2004). A limited effect of smoking on conventional 
sperm parameters was also reported by Marinelli et al., (2004) and a non-statistically 
significant relationship supported by Chen et al, despite the fact that smoking men in the 
latter’s study generally appeared to have lower sperm concentration (Chen et al., 2004).  
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In 2005, Pasqualotto et al evaluated a group of men who attended the clinic for vasectomy 
for sterilization purposes, by dividing them in non-smokers, mild smokers, moderate smokers 
and heavy smokers. All conventional semen parameters were evaluated and they found no 
significant differences in sperm concentration among the four groups (Pasqualotto et al., 
2005). Similarly, Sobreiro et al found no differences among the evaluated smoker and non-
smoker groups of men, attending the clinic also for sterilization purposes (Sobreiro et al., 
2005). Additionally, Hassa et el.,  also found no significant negative correlation between 
tobacco smoking and sperm concentration (Hassa et al., 2006). On the other hand, Ramlau-
Hansen et al, in a study carried out in 2006, found a 19% lower sperm concentration in 
smoking men, compared to non-smokers (Ramlau-Hansen et al., 2006). Using Meta analysis 
Vine et al., (1996) reported that sperm concentration of smokers was 13-17% lower than that 
of non-smoke.  
In this study, the mean percentage of spermatozoa count of non-smokers patients group 
(76.06±29.48mill/ml) was significantly higher (p=0.006) than those of smokers 
(50.73±30.17mill/ml). This is in agreement with the findings of (Vini et al., 1996, Wong et al, 
2000; Kunzle; 2003; Ramlau-Hansen et al., 2006) (Tab. 6, Fig. 24).   
In addition, Jensen et al., have proposed that prenatal exposure to maternal tobacco 
smoking is a stronger predictor of poor semen quality than current smoking and that the 
association between current smoking and decreased semen quality may be confounded by 
the prenatal exposure. Among 1770 young men from five European countries, current 
smoking had no independent effect on semen quality, whereas prenatally exposed men had 
20% lower sperm concentration and a 25% lower total sperm count compared with prenatally 
unexposed men (Jensen et al., 2004). Prenatally exposed men have also been reported to 
have decreased semen quality compared with unexposed men in two other studies 
(Storgaard et al., 2003; Jensen et al., 2005).  
6.3.1.3. EFFECT OF SMOKING ON SPERM VITALITY  
  
In the category of environmental factors nicotine was shown to be a potential oxidant agent, 
which affects plasma membrane and DNA integrity. In addition there was a strong negative 
correlation between lipid peroxidation (LPO) and percentage of viable sperm cells. Sperm 
viability of smokers patients group (64.60±19.16%) was significantly lower (p=0.107) than 
those of non smokers (68.90±17.79%). (Tab. 6; Fig. 23). Many studies have suggested a 
detrimental direct effect of Cotinine on sperm membrane permeability and sperm membrane 
function. Thus, the spermatozoa may not have optimal ability to undergo capacitation and 
hyperactivation within the female reproductive tract (Sofikitis et al., 2000). 
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6.3.1.4. EFFECT OF SMOKING ON SPERM MOTILITY  
  
The concentration of cotinine and hydroxycotinine in the seminal plasma is significantly 
correlated with total sperm motility of spermatozoa (Pacifici et al., 1993).  
Heavy smokers seem to have an enhancing effect on progressively rapid motile sperm 
compared to light-smoking infertile men (Ozgur et al., 2003). This finding in agreement of that 
of (Dikhitel et al., 1987; Goverde et al., 1995; Vine et al., 1996). The possible explanations 
for this enhancement of rapidly progressive motility due to heavy smoking in comparison to 
light smoking is a definite number of cigarettes per day may constitute a threshold for the 
enhancement of rapid progressive motility in smokers. Some researchers have found a 
significant correlation between smoking and decreased sperm motility or morphology and 
lower sperm density (Evans et al., 2004; Shararwy & Mahmoud 1982; Vine et al., 1994; 
Merino et al., 1998; Zenzes, 2000).  
Besides, smoking has been found to affect the function of accessory glands (e.g. prostate 
and seminal vesicles (Pakrashi and Chatterjeg, 1995). Reduced the secretion may diminish 
the content of chromatin zinc and, thereby, the stability of the sperm chromatin; this 
contributes to reproductive failure or has consequences in fetal development (Oldereid et al., 
1994). Both Zinc and Copper are linked to structure /activity center of superoxide dismutase 
(SOD), which is closely related to sperm motility. Decrease in the Zn and Cu level leads to 
lowering of the SOD activity. In addition, smoking increases the production of free radicals 
(ROS) that synthesis and/or augment the consumption of SOD (Zhang et al., 1999).The 
sperm mitochondrial membrane is a major target of ROS and therefore the sperm midpiece 
is prone to damage due to oxidative stress. The mitochondrial membranes are directly 
exposed to the superoxide anions produced during cellular respiration. Hydrogen peroxide is 
known to directly affect mitochondrial ATP generation (Sikka, 2001). Disruption of sperm 
mitochondrial function directly affects sperm motility by decreasing the intra-cellular ATP 
level and also subsequently affects sperm viability.  
Our results demonstrated that the mean percentage of sperm motility in the native semen 
samples was significantly (p=0.061) higher in smokers than non smokers groups (39.0±20.38 
vs. 31.57±15.98 respectively) (Tab. 6; Fig 25). However, after semen preparation with Pure 
sperm gradient centrifugation the mean percentage of motile sperm was higher of non 
smoker patients groups in comparison to smokers (65.14±31.44 vs. 61.36±33.09; p= 0.021) 
(Tab. 6). The present study showed that initial sperm motility type was higher in specimens 
of smokers, but more spermatozoa with abnormal forms and sperm with cytoplasm retention 
may be presented in the ejaculate. These results are supported by the finding of Jedrzejczak 
et al. (2004) who reported that that smokers had significantly fewer spermatozoa with motility 
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grades A, B and C, and more abnormal forms in the ejaculate especially with head defects 
and cytoplasm droplets. Besides, the results presented here demonstrated that sperm 
motility in the native semen samples correlate negatively with cotinine concentration in 
seminal plasma (r= -0.120; p=0.741) (Tab. 7a,b )  
  
6.3.1.5. EFFECT OF SMOKING ON SPERM MORPHOLOGY  
  
The effects of cigarette smoking on sperm morphology were also evaluated in several 
studies. Namely, the one of (Goverde et al., 1995; Rantala & Koskinies 1987) about smoking 
and sperm morphology and (Chia et al ., 1994a: b ; Osser et al.,1992), who found lower 
percentage of normal sperm morphology. Also, increased head piece abnormalities (Chia et 
al., 1994a; b) have also been reported. A review of the epidemiological studies indicates that 
cigarette smoking is associated with modest reduction in semen quality, including sperm 
concentration, motility and morphology. It also reveals that the association between smoking 
and sperm concentration and motility is stronger among studies of healthy men (e.g. 
Volunteers and sperm donor) than among men attending infertility clinics (Vine. 1996). 
Others have found that cigarette smoking could significantly reduced the mean percentage of 
normal sperm morphology, ejaculate volume and sperm vitality (Kunzle et al., 2003). Ozgur 
et al. (2003) demonstrated that the morphological evaluation results were better for the non-
smokers than the heavy smokers in terms of tail anomalies and the percent of coild tails. Mak 
et al. (2000) indicated that cigarette smoking is associated with retention of sperm 
cytoplasmic droplets in infertile men, a morphologic characteristic associated with impaired 
sperm function. In the present study the mean percentage of morphologically normal 
spermatozoa was significantly higher (p=0.018) of smokers group (19.8±18.5%) than non 
smokers (16.06±18.53%) (Fig. 27).. In this regard, it is noteworthy to mention here that the 
morphology assessment of spermatozoa was carried out according to strict criteria described 
by Krüger et al, (1986), whereas others evaluated sperm morphology according to WHO 
criteria. Therefore, a direct comparison with other study is difficult. 
6.3.1.6.  EFFECT OF SMOKING ON SPERM CHROMATIN INTEGRITY (DNA)  
There are currently various techniques for the evaluation of sperm DNA fragmentation. 
These techniques have been recently reviewed (Evenson and Wixon, 2006 a: b). In the 
present study, Chromomycin (CMA3), Acridine Orange and TUNEL- technique have been 
used to evaluate the DNA integrity, denaturation and fragmentation respectively. 
Furthermore, it has been shown that DNA strand-breaks occur during the process of 
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apoptosis and that the nicks in the DNA molecule can be detected via the Tunel assay (Berg 
et al., 1998).  
The etiology of sperm DNA fragmentation is still poorly understood, but relationship between 
cigarette smoking and increased of DNA damage has been shown in infertile smokers 
compared of non-smokers (Saleh et al., 2003; Zenzes, 2000). Oldereid et al. (1994) pointed 
out that smoking affects the function and may diminish the zinc secretory from accessory 
glands and consequently the stability of the sperm chromatin. Therefore, paternal smoking 
has been associated with a significant increase in the percentage of spermatozoa with DNA 
damage and higher risk of birth defect and childhood cancers in the offspring (Sorahan et al., 
1997; Saleh et al., 2002). However other studies found no correlation between cigarette 
smoking and semen quality, sperm function or sperm nuclear DNA damage (Vogt et al 1986; 
Sergerie et al 2000). In the present study, sperm from smoker showed increased DNA
 
fragmentation compared with sperm from non smoker
 
under CMA
3
 (15.73±7.2% vs. 
17.1±8.6%; p=0.761), and TUNEL test (12.8±7.9% vs. 10.6±6.8%; p=0.430). However, No 
difference was observed
 
for overall DNA fragmentation using AO test between smoker men
 
and non smoking in the present study (Tab. 6; Fig. 29). These results are in close agreement
 
with other reports in which it revealed that semen samples from smokers have a significantly 
higher ratio of single-strand-to double-strand DNA spermatozoa (Sofikitis et al., 1995). 
Studies by Zenses (1999) and (2000) have proposed that smoking induces DNA damage in 
spermatozoa and in generated preimplantation embryos. The percentage of sperm with DNA 
fragmentation is higher in smokers and the repair capacity is significantly decreased in 
ejaculated spermatozoa. Genetic damage is passed on to the embryo and further 
development, in women undergoing both IVF and ICSI, as clinical pregnancy rates are 
drastically reduced in couples with smoking males. This seems to be the case especially in 
older women who undergo ICSI (Zenzes, 2000). Nicotine could induce double-strand DNA 
breaks (11% in 0.75 mM concentration) in the sperm nuclei. Moreover smoking can be linked 
to significantly increased levels of seminal Reactive Oxygen Species (ROS) (Saleh et al., 
2002). It is hypothesized that spermatozoa with some type of DNA damage defects because 
of the male exposure to cigarette smoke may not have impaired capacity (via ICSI) to induce 
fertilization, participate syngamy and trigger embryonic development, but they may be 
responsible for the observed lower implantation rate of the development embryos.   
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6. 4. ASSOCIATION BETWEEN SMOKING AND OXIDATIVE STRESS  
Sperm DNA damage is significantly increased in men with idiopathic and male factor 
infertility and in men who failed to initiate a pregnancy after assisted reproduction techniques. 
Such an increase may be related to high levels of seminal oxidative stress (Saleh et al., 
2003).  
Smoking was associated with a 107% increase in reactive oxygen species (ROS) levels and 
a 10-point decrease in ROS-total antioxidant capacity (TAC) scores (Saleh et al., 2002). DNA 
damage is commonly observed in spermatozoa of infertile patients and may be mediated by 
high ROS (Kodama et al., 1997). The main ROS which create this problem are superoxide 
anion (O
2
.
), hydrogen peroxide (H
2
O
2
) and hydroxyl radical (OH
-
) (Sukcharoen et al., 1996; 
Agarwal et al., 2003). A recent study has reported that sperm DNA damage values greater 
than 27% are highly predictive of pregnancy failure after conventional IVF or intracytoplasmic 
sperm injection (Larson et al., 2000). A significant reduction of ROS-TAC scores associated 
with smoking can be attributed to a significant increase in seminal ROS levels, which is 
related to the significant increase in leukocyte concentration in the semen of infertile smokers 
(Close et al., 1990).  
It should be emphasized that cigarette smoke has been associated with increased frequency 
of aneuploidy in sperm (Twigg et al., 1998a,b), lower seminal plasma antioxidant levels and 
increased oxidative damage to DNA (Fraga et al., 1995; Shen et al., 1997).  
The intracellular antioxidant enzymes can not protect the plasma membrane that surround 
the acrosome and the tail, forcing spermatozoa to supplement their limited intrinsic 
antioxidant defenses by depending on the protection afforded by the seminal plasma, which 
paths these cells (Iwasaki, 1992). Besides, the seminal plasma protects spermatozoa from 
excessive ROS by means of small molecular weight free radical scavengers, such as 
ascorbate and tocopherol, uric acid and ROS-metabolizing enzymes, such as superoxide 
dismutase, catalase, and glutathione peroxidase (Alvarez and Storey, 1989). However, it was 
demonstrated that heavy smoking in males is associated with a 20–40% decrease in serum 
ascorbic acid levels associated with increased sperm abnormalities (Kul'Krauchas et al., 
1985). Dawson et al. (1992) suggested supplementation of ascorbic acid to heavy smokers 
could improve sperm quality. Mehran, (2005) and Arabi and Moshtaghi, (2005) showed that 
exposure of spermatozoa from smokers to the seminal plasma from nonsmokers resulted in 
an improvement of sperm function.   
The results from this work showed that ROS and TAS concentration in seminal plasma of 
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smokers are similar to those of non-smokers groups (53.1±28.03 µmol/l and 1.35± 
0.66mmol/l vs. 50.94±28.20µmol/l and 1.09±0.73mmol/l respectively) (Tab. 6; Fig. 30-31). 
Besides, in both groups, ROS concentration in seminal plasma correlate  negatively with 
sperm motility after semen preparation (-0.172; p= 0.253), with vitality ( -0.163; p= 280) 
membrane integrity (-0.009; p=0.953) morphology  (-0.347; p=0.02) chromatin condensation 
(CMA3).( r=-0.127; p=0.401) DNA fragmentation (TUNEL) (r=-0.112; p=0.460) and DNA  
denaturation AO ( r=-0..072; p=0.652) and positively with cotinine concentration (r=0.017, p= 
0.910) (Tab. 10a,b Appendix). TAS concentration in seminal plasma correlate significant 
positively with membrane integrity of spermatozoa (r=0.307; p= 0.040) (Tab. 10a,p 
Appendix). Similarly (Armstrong et al., 1998) demonstrated that the high levels of seminal 
oxidative stress have been correlated with sperm dysfunction through different mechanisms 
that include lipid peroxidation of sperm plasma membrane and impairment of sperm 
metabolism, motility, and fertilizing capacity (Armstrong et al., 1998).  
6.5. COTININE LEVEL IN SEMINAL PLASMA.  
Exposure to cigarette smoking appears to be an important risk factor for male infertility. 
Significant smoker-non-smoker differences were found in semen cotinine concentration and 
sperm quality. Cotinine may decrease male fertility by inhibiting density, reducing total 
progressively motile sperm count, and increasing the percentage of sperm with abnormal 
morphology. Cotinine is the major metabolite of nicotine, which is the major psychoactive 
substance found in cigarette smoke (Hulka  1991 ; Zenzes et al.  1996 ). Because it is easily 
detectable in human body fluids, such as urine, saliva (Zenzes et al.  1996 ; Wall et al.  1988 
), and seminal plasma (Pacifici et al.  1993 ), cotinine has been used as a specific biomarker 
of cigarette smoking (Hulka  1991 ). Besides, cotinine with a half-life in sperm of 5–7days is a 
better indicator of long-term exposure to cigarette smoke than urinary metabolites index 
(Jarvis et al.  1988 ).   
There is a small but significant correlation between cotinine concentration in seminal plasma 
and abnormal sperm morphology, but not for other semen variables (Wong et al., 2000). 
Cotinine concentration of 400-800ng/ml impairs sperm motility, membrane function, and their 
ability to undergo capacitation (Sofikitis et al., 1995). In assisted reproduction program, 
smokers with high seminal plasma cotinine concentration may be treated with 
intracytoplasmic sperm injection, rather than conventional in vitro fertilization (Sofikitis et al., 
2000).   
Box-plots in Fig. 33 and Table 6 show the difference in semen cotinine levels between 
smokers and non-smokers patient groups. Seminal plasma cotinine level was found to be 
significantly higher in smokers versus nonsmokers. The results were (144.29±82.19µg/l) in 
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the smokers group and (19.30±32.69µg/l) in the non smokers group (p<0.001), (Tab. 6). 
These results demonstrate cigarette smoking is the main contributor to semen cotinine.   
Seminal plasma cotinine of either smokers or nonsmokers demonstrated non significant 
negative correlation with semen volume (r=-0.254; p=0.089) and sperm concentration (r=-
0.144, p=0.341), sperm morphology (r=-0.027; p=0.861), besides, the motility of sperm (r= 
0.103; P= 0.503) and ROS concentration (r= 0.017; p= 0.910) in seminal plasma correlate 
positive with cotinine level. However, non significant negative correlation with sperm DNA 
fragmentation (TUNEl- test) (r=-0.137; p=0.363), DNA denaturation (AO) (r=-0.026, p=0.869), 
TAS concentration (r=-0.215, P=.151) could be found (Tab. 7a,b). 
The relation of semen cotinine characteristics to sperm quality in our study is consistent with 
past reports. Pacifici et al. ( 1993 ) who found that total motility of spermatozoa was 
significantly negatively correlated with concentrations of cotinine and hydroxycotinine.  
Moreover, these results in accordance with Yang’s results (Yang et al.,  2000 ) showing that 
urinary cotinine levels of non-smokers are related to second-hand smoke exposure. The 
results of the present investigation also revealed that nicotine from cigarettes is actively 
transferred from the arterial testicularis via the Sertoli cell into the seminiferous tubules and 
seminal plasma and supported earlier finding. A previous research found nicotine and 
cotinine in the seminal plasma of smokers and suggested that other harmful components of 
tobacco smoke would pass through the blood–testis barrier (Vine et al.  1993).   
   
6. 6. The effect of smoking on IVF/ICSI outcome.  
6.6. 1. EFFECT OF SPERM OF SMOKERS AND NON SMOKERS ON FERTILIZATION, 
EMBRYONAL CLEAVAGE (TRANSFER).  
It is hypothesized that smoking has an adverse effect on all biological endpoints of IVF and 
GIFT including sperm parameters, number of oocyte retrieved, fertilization rates, number of 
embryos transferred and pregnancy rate, resulting in lower success rate in live birth delivery 
rates. Moreover, the thesis that exposure to cigarette smoke influences the sperm’s capacity 
or epigenetic factor does not affect sperm capacity to fertilize oocyte (via ICSI) or to trigger 
early embryonic development, but it causes an impaired capacity for implantation of the 
development blastocyst, is very strongly supported by (Ubaldi et al., 1999). They showed that 
some testicular defects have negative impact on the reproductive performance of testicular 
spermatozoa, resulting in a decreased embryonic potential for implantation, without any 
apparent effect on fertilization and early embryonic development. Recent studies also show 
that smoking may alter uterine-fallopian tube function (Knoll & Talbot, 1998; Saraiya et al., 
1998). Zenzes et al., determined that smoking alters the meiotic spindle of gametes, leading 
to chromosome errors (Zenzes, 2000).  
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6.6.2. EFFECT OF SPERMATOZOA OF SMOKERS AND NON SMOKERS ON 
PREGNANCY.  
Furthermore, cotinine is present in minimal vesicular secretion in rats exposed to cigarette 
smoke. In addition, rat models, show very vividly that male cigarette smoke exposure does 
not alter the potential of spermatozoa, to decondense within the ooplasm, transform into 
male pronucleus and trigger embryonic development up to the blastocyst stage, after ICSI 
techniques. In contrast, other results show that Fertilization Rate (FR), Cleavage Rate (CR) 
and Blastocyst Development Rate (BDR) after ICSI trials are lower when spermatozoa are 
recovered from animals exposed to cigarette smoke, compared with those of the control 
group. It may be of clinical significance that ICSI techniques, in contrast to IVF techniques 
using spermatozoa derived from animal exposed to cigarette smoke don’t generate 
significantly less number of blastocyst compare with control animal (Klonoff-Cohen, 2001). In 
the contrary, (Kapawa, et al., 2004) reported that in rats exposed to cigarette smoke both 
ICSI/IVF trials lead to a significant decrease in the number of alive offspring’s per transferred 
embryo, compared to the control group (Kapawa et al., 2004).  In the resent study, the mean 
number of fertilized oocyte in smokers and non smokers patients groups (5.55±5.7 vs. 
5.15±4.18; p= 0.591) and the fertilization rate (45.6±23.50 vs. 58.48±24.60; p=0.151) were 
similar. However, the Cleavage rate (the mean number of transferred embryo) was 
significantly higher in smokers than in smokers (1.89±0.83 vs. 1.9±0.70; p=0.001). Moreover, 
the pregnancy rate in non smoking patients group (34%) was significantly higher (27%) than 
those of smokers (Tab. 6). 
Semen cotinine concentration was clearly correlated negative with sperm quality (Table 
7a,b). Semen cotinine concentration was highly negatively correlated with total number of 
motile sperm (r =−0.120; p=0.741), with percentage of morphologically normal spermatozoa 
(r =-0.451; p=0.191). Besides, non significant correlation were elicited with fertilization rate 
(r= -0.074; P= 0.829) and transfer rate (r= -0.372, p=0.259) (Tab.7a,b).  
There is a lack of correlation between smoking and DNA damage in sperm cells of healthy 
men. As sperm DNA damage may affect the final events of fertilization, this may results in 
early embryonic death (Sakkas et al., 1999).  
Paternal transmission of altered genetic or epigenetic factors may comprise the embryonic 
capacity for implantation, resulting in failed implantation or early pregnancy loss. In other 
studies, damaged sperm DNA could diminish the chance of successful pregnancy by 
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increasing the spontaneous abortion rate (Ahmedi and Ng, 1999; Host et al., 2000; Zitzmann 
et al., 2003). Although the effects of smoking of male fertility seem to be contradictory 
between researchers, the majority conclude that it has detrimental effects on sperm 
parameters and male partners should refrain from that. In general, male partners are advised 
to quit smoking, among others (e.g. alcohol) and pay attention to their weight, in order to 
present better sperm parameters and have higher chances of achieving fertilization (Larkin, 
1998).  
Furthermore, epidemiological studies in women of reproductive age have shown that 
cigarette smoking has a dose related effect that can delay time of conception by two months, 
advance the start of menopause by two years and that it causes a small but clinically 
significant increase in the risk of spontaneous abortion, reducing fecundity among those 
undergoing assisted conception (Howe et al., 1985; Windham et al., 1992.; Pasqualotto et 
al., 2005). Normal fecundity is re-established then women stop smoking, providing compiling 
evidence of the relationship between smoking and reduced fertility in women.   
In conclusions, the findings of the present study suggest that excessive reactive oxygen 
species production reduces the quality of the spermatozoa and hence its fertilization 
capacity, which in turn may lead to fail fertilization or decrease the embryos implantation 
ability and consequently IVF/ICSI outcome. Besides, the results of the present study suggest 
a negative biological effect of  smoking on spermatozoa quality. Therefore, cigarette smoking 
exposure appears to be an important risk factor for male infertility. Significant smoker-non-
smoker differences were found in semen cotinine concentration and sperm quality. Cotinine 
may decrease male fertility by inhibiting density, reducing total progressively motile sperm 
count, increasing the percentage of sperm with abnormal morphology and increase the 
production of reactive oxygen species.   
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Anhang 
Tab. 8a: Correlation coefficient of semen parameters, sperm quality and IVF outcome. 
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r -0.190 1.000 0.259 0.117 0.283(*) -0.266(*) -0.175 0.120 Sperm concentration (mill/ml)  
in the native semen  
p 0.158 . 0.052 0.384 0.033 0.046 0.193 0.375 
r 
0.052 0.117 0.260 1.000 0.026 -0.485(**) -0.314(*) 0.070 
Motility (%) in the native 
semen sample 
p 0.702 0.384 0.050 . 0.849 0.000 0.017 0.606 
r 
-0.052 -0.266(*) -0.275(*) -
0.485(**) 
-0.078 1.000 0.342(**) 0.087 
Vitality (%)  
  
p 0.701 0.046 0.039 0.000 0.566 . 0.009 0.520 
r 0.253 -0.175 -0.198 -0.314(*) 0.145 0.342(**) 1.000 0.140 Membrane integrity (HOS) 
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(CMA3) 
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oocytes  
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Tab. 8b: Correlation coefficient of semen parameters, sperm quality and IVF outcome. 
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cononcentration(mill/ml) in 
native semen  
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Tab.9a: Correlation coefficient of semen parameters, sperm quality and ICSI outcome. 
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p 0.195 0.773 0.816 0.823 0.014 0.886 0.306 . 
r -0.049 -0.264 -0.121 -0.333(*) -0.440(**) 0.293 -0.296 -0.472(**) Chromatin condensation 
(CMA3) 
p 0.772 0.114 0.476 0.048 0.006 0.079 0.080 0.004 
r -0.134 -0.053 -0.182 -0.007 -0.035 -0.064 0.319 0.116 DNA Fragmentation (TUNEL) 
p 0.429 0.756 0.281 0.968 0.836 0.709 0.058 0.500 
r 0.242 -0.357(*) -0.167 -0.116 -0.313 0.064 0.034 -0.101 ROS (µmol/ml)  
p 0.149 0.030 0.322 0.499 0.059 0.708 0.844 0.556 
r 0.141 0.118 0.218 0.147 0.108 -0.050 0.041 -0.106 TAS (mmol/l) 
p 0.405 0.488 0.194 0.393 0.525 0.770 0.811 0.537 
r -0.037 0.014 -0.060 0.097 0.061 -0.032 -0.053 0.029 Fertilization rate (%)  
p         
r 0.009 -0.112 0.069 -0.237 -0.053 0.226 0.253 0.051 Cleaved and transferred  
oocytes p 0.956 0.510 0.683 0.164 0.755 0.179 0.136 0.768 
r 0.033 -0.275 0.066 -0.013 0.286 0.100 0.355 0.453 Pregnancy 
p 0.896 0.269 0.795 0.961 0.250 0.694 0.162 0.068 
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Tab. 9b: Correlation coefficient of semen parameters, sperm quality and ICSI outcome. 
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r -0.264 -0.053 -0.112 -0.357(*) 0.118 0.014 -0.112 -0.275 Sperm concent.in 
native semen samples 
(mill/ml) p 0.114 0.756 0.522 0.030 0.488 0.934 0.510 0.269 
r -0.333(*) -0.007 -0.047 -0.116 0.147 0.097 -0.237 -0.013 Sperm motility (%) in 
the native semen 
p 0.048 0.968 0.790 0.499 0.393 0.575 0.164 0.961 
r 0.293 -0.064 0.037 0.064 -0.050 -0.032 0.226 0.100 Vitality (Eosin 
test)(%) 
p 0.079 0.709 0.834 0.708 0.770 0.851 0.179 0.694 
r -0.296 0.319 0.051 0.034 0.041 -0.053 0.253 0.355 Membrane integrity 
(HOS) test (%)  
p 0.080 0.058 0.775 0.844 0.811 0.757 0.136 0.162 
r -0.472(**) 0.116 0.000 -0.101 -0.106 0.029 0.051 0.453 Morphologicaly 
normal spermatozoa 
(%)  p 0.004 0.500 0.999 0.556 0.537 0.866 0.768 0.068 
r 1.000 -0.252 -0.095 0.001 -0.109 -0.087 0.083 -0.550(*) Chromatin 
condensation (CMA3) 
(%)  p . 0.132 0.588 0.997 0.521 0.610 0.625 0.018 
r -0.252 1.000 0.012 0.049 -0.226 -0.185 0.140 0.198 DNA Fragmentation 
(TUNEL) (%)  
p 0.132 . 0.944 0.775 0.179 0.272 0.410 0.430 
r 0.001 0.049 0.000 1.000 -0.037 0.154 0.003 -0.494(*) ROS (µmol/l) 
p 0.997 0.775 0.999 . 0.826 0.361 0.984 0.037 
r -0.109 -0.226 0.044 -0.037 1.000 0.279 0.297 -0.011 TAS (mmol/l) 
p 0.521 0.179 0.800 0.826 . 0.094 0.074 0.965 
r -0.087 -0.185 0.033 0.154 0.279 1.000 0.209 -0.077 Fertilized rate 
p         
r 0.083 0.140 -0.133 0.003 0.297 0.209 1.000 0.099 Cleaved and 
transferred oocytes 
p 0.625 0.410 0.446 0.984 0.074 0.215 . 0.697 
r -0.550(*) 0.198 0.014 -0.494(*) -0.011 -0.077 0.099 1.000 Pregnancy 
p 0.018 0.430 0.959 0.037 0.965 0.761 0.697 . 
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Tab 10a: Correlation of semen parameters of smoker and non smoker patients (n=46). 
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1.000 -0.044 0.161 -0.139 -0.093 0.038 0.012 Volume (mll) 
 . 0.774 0.292 0.359 0.545 0.802 0.938 
-0.044 1.000 0.427(**) -0.264 -0.107 0.074 -0.418(**) Sperm concentration 
native semen (mill 
/ml) 0.774 . 0.003 0.076 0.485 0.629 0.004 
0.161 0.427(**) 1.000 -0.594(**) -0.397(**) -0.143 -0.236 Motility (%) of native 
semen samples 
0.292 0.003 . 0.000 0.008 0.348 0.118 
0.176 0.326(*) 0.233 -0.156 -0.004 0.382(**) -0.256 Motility(%)  after 
semen preparation 
0.242 0.027 0.124 0.301 0.978 0.010 0.086 
-0.139 -0.264 -0.594(**) 1.000 0.238 0.318(*) 0.322(*) Vitality (%) 
 0.359 0.076 0.000 . 0.116 0.033 0.029 
-0.093 -0.107 -0.397(**) 0.238 1.000 0.251 -0.251 Membrane integrity 
(HOS) 
0.545 0.485 0.008 0.116 . 0.100 0.096 
0.038 0.074 -0.143 0.318(*) 0.251 1.000 -0.162 Morphological 
normal sperm 0.802 0.629 0.348 0.033 0.100 . 0.288 
0.012 -0.418(**) -0.236 0.322(*) -0.251 -0.162 1.000 Chromatin 
Condensation  CMA3 
0.938 0.004 0.118 0.029 0.096 0.288 . 
-0.115 -0.292(*) -0.107 0.100 0.008 -0.123 0.287 DNA Fragmentation 
TUNEL 
0.448 0.049 0.484 0.510 0.956 0.419 0.053 
0.060 0.192 0.203 -0.163 -0.009 -0.347(*) -0.127 ROS (µmol/l) 
 0.694 0.201 0.181 0.280 0.953 0.020 0.401 
0.223 0.035 -0.086 -0.130 0.307(*) 0.045 -0.143 TAS (mmol/l) 
 0.137 0.820 0.573 0.390 0.040 0.768 0.344 
-0.254 -0.144 0.103 0.009 -0.061 -0.027 0.067 Cotinine (mg/dl) 
 0.089 0.341 0.503 0.951 0.691 0.861 0.657 
0.130 0.188 0.022 0.084 0.023 -0.021 -0.204 Fertilization rate (%) 
0.390 0.210 0.887 0.579 0.883 0.889 0.175 
-0.032 -0.074 0.000 0.076 0.235 -0.096 -0.088 Cleaved and 
transferred oocytes 
0.834 0.627 0.999 -0.102 -0.235 0.075 -0.080 
-0.020 -0.147 0.078 -0.103 -0.084 0.015 -0.128 Pregnancy 
0.897 0.348 0.624 0.511 0.595 0.927 0.412 
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Tab. 10b: Correlation of semen parameters of smoker and  non smoker patients (n=46). 
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-0.115 0.085 0.060 0.223 -0.254 0.113 0.130 -0.032 -.020 Volume (ml) 
  0.448 0.592 0.694 0.137 0.089 0.461 0.390 0.834 0.897 
-0.292(*) -0.191 0.192 0.035 -0.144 0.144 0.188 -0.074 0.147 Sperm concentration 
(mill/ml) in native semen 
0.049 0.227 0.201 0.820 0.341 0.345 0.210 0.627 0.348 
-0.107 0.034 0.203 -0.086 0.103 0.141 0.022 0.000 0.078 Motility (%)  native 
  0.484 0.834 0.181 0.573 0.503 0.363 0.887 0.999 0.624 
0.100 -0.048 -0.163 -0.130 0.009 -0.102 0.084 0.076 -0.084 Vitality (HOS) in  native 
semen samples 
0.510 0.765 0.280 0.390 0.951 0.505 0.579 0.616 0.103 
0.008 0.090 -0.009 0.307(*)  -0.235 0.023 0.235 -0.511 Membrane 
integrity (HOS)  0.956 0.576 0.953 0.040 0.691 0.125 0.883 0.120 0.595 
-0.123 0.032 -0.347(*) 0.045 -0.027 0.075 -0.021 -0.096 0.015 Morphological normal sperm 
(%)  
0.419 0.845 0.020 0.768 0.861 0.629 0.889 0.530 0.927 
0.287 0.077 -0.127 -0.143 0.067 -0.080 -0.204 -0.088 -128 Chromatin condensation 
(CMA3) 
0.053 0.628 0.401 0.344 0.657 0.604 0.175 0.559 0.412 
1.000 0.219 -0.112 -0.094 -0.137 -0.168 -0.215 -0.048 -0.164 DNAFragmentation 
TUNEL-test . 0.163 0.460 0.532 0.363 0.271 0.152 0.750 0.292 
-0.112 -0.072 1.000 0.033 0.017 -0.025 0.275 0.059 -0.214 ROS (µmol/l) 
0.460 0.652 . 0.828 0.910 0.871 0.064 0.696 0.168 
-0.094 -0.148 0.033 1.000 -0.215 -0.022 0.071 0.313(*) -0.026 TAS (mmol/l) 
0.532 0.349 0.828 . 0.151 0.886 0.638 0.034 0.868 
-0.137 -0.026 0.017 -0.215 1.000 0.119 -0.107 -0.077 0.008 Cotinine (mg/dl) 
  0.363 0.869 0.910 0.151 . 0.436 0.480 0.613 0.959 
-0.215 -0.214 0.275 0.071 -0.107 0.658(**) 1.000 0.192 0.154 Fertilization rate (%) 
0.152 0.174 0.064 0.638 0.480 0.000 . 0.200 0.323 
-0.048 -0.033 0.059 0.313(*) -0.077 0.280 0.192 1.000 0.291 Cleaved and transferred 
oocytes  
-0.168 -0.211 -0.025 -0.022 0.119 0.063 0.200 . 0.059 
0.164 0.146 -0.214 -0.026 0.008 -0.077 -0.154 -0.291 1.000 Pregnancy 
  0.292 0.368 0.168 0.868 0.959 0.625 0.323 0.059 0. 
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Tab. 11a: Correlation of semen parameters of non smoker patients (n=35). 
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1.000 0.411(*) -0.505(**) -0.116 0.072 -0.512(**) Sperma 
concentration 
(mill/ml) in native 
semen 
. 0.014 0.002 0.515 0.682 0.002 
0.411(*) 1.000 -0.615(**) -0.452(**) -0.158 -0.191 Motility (%) in the 
native semen 
samples 0.014 . 0.000 0.007 0.365 0.272 
-0.505(**) -0.615(**) 1.000 0.316 0.259 0.401(*) Vitality (%)  (Eosin-
test) 
0.002 0.000 . 0.069 0.133 0.017 
-0.116 -0.452(**) 0.316 1.000 0.213 -0.302 Membrane integrity 
(%) (HOS) Test.  
0.515 0.007 0.069 . 0.227 0.083 
0.072 -0.158 0.259 0.213 1.000 -0.277 Morphology normal 
spermatozoa (%)  
0.682 0.365 0.133 0.227 . 0.107 
-0.512(**) -0.191 0.401(*) -0.302 -0.277 1.000 Chromatin 
condensation 
(CMA3) 0.002 0.272 0.017 0.083 0.107 . 
-0.343(*) -0.153 0.236 -0.015 -0.078 0.343(*) DNA fragmentation-
TUNEL-test (%)  
0.044 0.382 0.173 0.931 0.655 0.044 
0.232 0.144 -0.131 0.098 -0.228 -0.146 ROS (µmol/l) 
0.179 0.408 0.454 0.582 0.188 0.401 
0.019 -0.228 -0.009 0.426(*) 0.285 -0.254 TAS (mmol/L) 
  0.914 0.188 0.958 0.012 0.097 0.141 
-0.100 0.161 -0.036 -0.180 -0.220 0.044 Cotinine (mg/dl) 
  0.566 0.355 0.838 0.307 0.204 0.803 
0.165 0.147 -0.079 0.075 0.086 -0.263 Fertilization rate (%)  
  0.344 0.399 0.652 0.672 0.625 0.126 
-0.013 -0.090 0.199 0.298 0.002 -0.044 Cleaved and 
transferred oocytes 
0.940 0.605 0.252 0.087 0.991 0.800 
-0.157 0.011 -0.054 -0.011 -0.064 -0.189 Pregnancy 
0.391 0.953 0.769 0.951 0.727 0.300 
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Tab. 11b: Correlation of semen parameters of non smoker patients (n=35). 
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-0.343(*) -0.079 0.232 0.019 -0.100 0.180 0.165 -0.013 -0.157 Sperm concentration in  
native semen samples 
(mill/ml) 0.044 0.667 0.179 0.914 0.566 0.308 0.344 0.940 0.391 
-0.153 -0.098 0.144 -0.228 0.161 0.374(*) 0.147 -0.090 0.011 Motility (%) of native 
semen samples 
0.382 0.592 0.408 0.188 0.355 0.030 0.399 0.605 0.953 
0.236 0.159 -0.131 -0.009 -0.036 -0.377(*) -0.079 0.199 -0.054 Vitality (%)(Eosin) 
0.173 0.384 0.454 0.958 0.838 0.028 0.652 0.252 0.769 
-0.015 0.113 0.098 0.426(*) -0.180 -0.273 0.075 0.298 -0.011 Membrane integrity 
(%)(HOS)-test 
0.931 0.543 0.582 0.012 0.307 0.125 0.672 0.087 0.951 
-0.078 0.058 -0.228 0.285 -0.220 0.072 0.086 0.002 -0.064 Morphologically 
Normal sperm 0.655 0.751 0.188 0.097 0.204 0.686 0.625 0.991 0.727 
0.343(*) 0.056 -0.146 -0.254 0.044 -0.106 -0.263 -0.044 -0.189 Chromatin condensation 
(%) CMA3  
0.044 0.763 0.401 0.141 0.803 0.552 0.126 0.800 0.300 
1.000 0.282 -0.199 -0.179 -0.115 -0.143 -0.240 -0.127 0.279 DNA Fragmentation 
(%)-TUNEL-test 
. 0.118 0.252 0.304 0.510 0.419 0.164 0.467 0.122 
0.282 1.000 -0.123 -0.240 -0.124 -0.122 -0.167 -0.184 0.103 DNA denaturation (AO) 
0.118 . 0.503 0.185 0.500 0.507 0.361 0.312 0.590 
-0.199 -0.123 1.000 -0.157 0.080 -0.077 0.211 -0.088 -0.125 ROS (µmol/l) 
0.252 0.503 . 0.367 0.648 0.665 0.224 0.615 0.496 
-0.179 -0.240 -0.157 1.000 -0.226 -0.004 -0.004 0.269 0.064 TAS (mmol/l)  
0.304 0.185 0.367 . 0.192 0.983 0.982 0.119 0.727 
-0.115 -0.124 0.080 -0.226 1.000 0.141 -0.048 0.015 0.025 Cotinine (mg/dl)  
0.510 0.500 0.648 0.192 . 0.427 0.786 0.931 0.892 
-0.240 -0.167 0.211 -0.004 -0.048 0.599(**) 1.000 0.122 -0.050 Fertilization rate (%) 
0.164 0.361 0.224 0.982 0.786 0.000 . 0.486 0.786 
-0.127 -0.184 -0.088 0.269 0.015 0.318 0.122 1.000 -0.252 Cleaved and Transferred 
oocytes 
0.467 0.312 0.615 0.119 0.931 0.067 0.486 . 0.164 
0.279 0.103 -0.125 0.064 0.025 -0.007 -0.050 -0.252 1.000 Pregnancy 
0.122 0.590 0.496 0.727 0.892 0.969 0.786 0.164 . 
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Tab 12: Semen characteristics of patient undergoing (IVF) treatments  
   N Minim Maxim M±SD 
Volume (ml)   57 0.5 6.5 3.59±1.32 
Sperm concentration (mill/ml) in native semen samples  57 5.0 120 75.51±31.95 
Sperm concentration (mill/ml)  57 1.0 101 35.87±28.39 
Motility (%)in the native semen samples   57 5.0 80 39.30±18.16 
Motility (%) after semen preparation  57 5.0 100 73.68±23.95 
Vitality (%) Eosin test (Stained sperm)   57 10 90 58.77±21.82 
Membrane integrity (HOS-Test)  57 5.0 90 41.84±20.49 
Morphologically normal spermatozoa (%) in native semen  57 1.0 72 14.05±15.88 
Chromatinkondensation (%) CMA3. (Stained samples)  57 3.0 49 17.81±9.646 
DNA Fragmentation (%) TUNEL-test  57 0.0 30 7.95±6.62 
DNA Denaturation (%) Acridine orange test AO test   55 0.0 18 5.33±4.90 
ROS  (µmmol/l) concentration in seminal plasma  57 2.84 505.17 73.78±74.37 
TAS (mmol/l) concentration in seminal plasma  57 0.00 2.25 1.36± 0.52 
Selenium (µgSe/kg dry mass) in seminal plasma  26 15 317 E-2 3.412E-2±1.681E-02 
Zinc  concentration  in seminal plasma  26 0.01 0.08 131.0±77.47 
Retrieved Oocytes  57 2.0 30 10.39±6.850 
(2798.50) 
Fertilized oocyte  56 0 24 5.2±5.66 (2578.00) 
Fertilization rate (%)  57 0.00 100.00 50.56±28.89 
Transferred Oocytes  57 0 3 1.77±0.866(2461.50) 
Pregnancy  40 1.0 2.0 1.55±0.504 
(18/22)(45%) 
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Tab 13: Semen characteristics of patient undergoing (ICSI) treatments  
 
   N Minim Maxim M±SD 
Volume (ml)   37 1.0 8.0 3.33±1.50 
Sperm concentration (mill/ml) in the native semen samples  37 1.0 120 49.63±39.52 
Sperm count in the native semen (mill/ml)  37 1.0 101 25.82±30.07 
Motility (%)in the native semen   36 5.0 60 22.22±12.95 
Motility (%) after semen preparation  37 5.0 95 44.59±31.83 
Vitality (%) Eosin test  37 10 95 71.19±22.09 
Membrane integrity (HOS-Test)  36 10 95 46.53±2.00 
Morphologically normal spermatozoa  36 0.0 42 10.39±10.34 
Chromatin condensation-native  37 5.0 92 30.97±20.50 
DNA Fragmentation TUNEL-test  37 0.0 29 8.14±6.58 
DNA Denaturation AO test   35 0.0 23 6.63±6.25 
ROS concentration  37 2.84 143.04 50.84±34.63 
TAS concentration   37 0.00 2.26 3.614-02 
Selenium (µgSe/kg dry mass) in seminal plasma  22 36 268 3.614E-02±8.481E-03 
3.500E-02 
Zinc concentration in seminal plasma   22 0.02 0.06 127.31±60.16 
Retrieved Oocytes  37 2.0 23 8.57±4.537 
1666.50 
Fertilized oocyte  37 0.0 16 5.03±3.700 
1793.00 
Fertilization rate (%)  37 0.00 100.00 59.23±26.47231 
Transferred Oocytes  37 0.0 3 2.14±0.822 
2003 
Pregnancy  18 1.0 2.0 1.39±o.50 
11/7 (61.1%) 
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Tab 14: Semen characteristic and sperm quality of non smoker patients 
underwent assisted reproduction technology program. 
 N Mini Maxi Sum M±SD 
Volume (ml) 35 1.5 6.0 128.0 3.65±1.22 
pH-Wert 35 7.9 9.5 302.5 8.64±0.33 
Sperm concentration (mill/ml) the native semen 
sample 
35 5 101 2662 76.06±29.49 
Sperm concentration (mill/ml) after semen 
preparation 
35 2 101 1446 41.32±29.89 
Motility (%) of native semen samples 35 5 80 1105 31.57±15.99 
Motility after semen preparation (%) 35 5 100 2280 65.14±31.45 
Vitality (%) Eosin-test 35 30 95 2410 68.86±17.78 
Membrane integrity (HOS) test 34 20 95 1675 49.26±25.05 
Morphologically normal sperm 35 0 72 562 16.06±18.53 
Chromatin condensation (CMA3) 35 5 47 597 17.06±8.60 
DNA–Fragmentation (TUNEL-test) 35 2 29 372 10.63±6.77 
DNA-Denaturation Acridine Orange-test (AO) 32 1 18 262 8.19±4.09 
ROS (µmol/ml) level in seminal plasma 35 15.30 111.84 1858.47 53.09±28.03 
TAS (mmol/ml) level in seminal plasma 35 0.00 2.26 47.38 1.35±0.66 
Cotinine (µg/dl) concentration in seminal plasma 35 5 201 676 19.30±32.69 
Oocytes 35 2 22 312 8.91±5.66 
Fertilized Oocytes 34 1 17 174 5.12±4.17 
Fertilization rate (%) 35 18.18 100.00 2046.86 58.48±24.55 
Cleaved (Transferred ) embryos 35 0 3 66 1.89±0.83 
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Tab 15: Semen characteristic and sperm quality of smoker patients underwent 
assisted reproduction technology program. 
 N Mini Maxi Sum M±SD 
Volume (ml) 11 1.0 5.0 32.0 2.909±1.33 
pH-Wert 11 8.3 9.0 95.8 8.709±0.31 
Sperm concentration (mill/ml) in the native semen sample 11 6 101 558 50.73±39.17 
Sperm concentration (mill/ml) after semen preparation 11 2 101 373 33.91±38.23 
Motility (%) of native semen samples 10 15 70 390 39.00±20.38 
Motility after semen preparation (%) 11 10 95 675 61.36±33.09 
Vitality (%) Eosin-test 11 40 90 710 64.55±19.16 
Membrane integrity (HOS)-test 11 30 85 525 47.73±16.03 
Morphologically normal sperm (%)  10 3 61 198 19.80±18.52 
Chromatin condensation (CMA3) 11 7 26 173 15.73±7.185 
DNA–Fragmentation TUNEL-test 11 3 30 141 12.82±7.93 
DNA-Denaturation Acridine Orange-test (AO) 10 3 14 89 8.90±3.51 
ROS (µmol/ml) level in seminal plasma 11 24,72 120,79 560,38 50.94±28.20 
TAS (mmol/ml) level in seminal plasma 11 0,00 2,13 12,09 1.09±0.73 
Cotinine (µg/dl) 11 5 201 1587 144.29±82.19 
Oocytes 11 5 29 119 10.82±7.82 
Fertilized Oocytes 11 1 17 61 5.55±5.68 
Fertilization rate (%) 11 14.29 87.50 501.76 45.61±23.47 
Cleaved (Transferred )embryos 11 1 3 21 1.91±0.70 
 
